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ABSTRACT
The thesis describes synthetic studies towards the marine natural product
phorboxazole A. This unprecedented compound was recently isolated from an Indian
Ocean sponge and displays extraordinary levels of cytostatic activity against a broad
range of human cancer cell lines. The Introduction summarises a variety of different
natural products which have been targeted as anti-cancer agents, and compares their
mode of action with that of phorboxazole A. A review of structurally related natural
products is then included, followed by an account of how phorboxazole A was
isolated and its structure determined. The Introduction concludes with a brief
discussion on our planned retrosynthetic analysis and contemporaneous studies within
our research group towards phorboxazole A.
The Results and Discussion section of the thesis contains details of our synthetic
studies towards two of the key fragments present from our retrosynthetic analysis,
namely the oxazole bis-pyran unit and the side chain. A detailed discussion is
presented throughout this section including a review of the hetero Diels-Alder
reaction and methods of oxazole formation. This section culminates with a successful
synthesis of the entire side chain of phorboxazole A.
The third chapter of the thesis is the Experimental section containing full details of
the preparative work completed and listing spectroscopic and analytical data for all
new compounds synthesised during the study.
The thesis is concluded by a schematic account of the contemporaneous total
synthesis of phorboxazole A by the Forsyth research group at the University of
Minnesota.
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1. INTRODUCTION
1.1 The Quest for a New Anti-Cancer Agent
Cancer, in all its forms, has become one of the most significant causes of mortality in .
the human species. It is estimated that over six million new incidences world-wide will
be reported during the forthcoming year. In the United Kingdom alone, cancer accounts
for a quarter of all deaths, and in 1995 this equated to 160, 000 people, from which
almost a quarter were attributed to lung cancer.'
Horrifying statistics such as these have led scientists to research the causes of cancer
and attempt to provide cures. The search for anti-tumour compounds to combat this
disease has been intense. Scientists have often turned to Nature for 'inspiration' and
'answers' to the 'questions' posed by cancer. Following the initiation of a screening
program for anti-tumour agents from the plant kingdom by the United States National
Cancer Institute (NCI) in 1961, the complex diterpene Taxol™ (paclitaxel) (1) was
discovered in 1971, isolated from the bark of the Pacific Yew tree, Taxus brevifolia.l
But it was not until 1979 when taxol's mode of action was discovered that it was
considered as a candidate for development) Taxol has taken up a major share of the
anti-cancer market and become a billion dollar drug. Developed by Bristol-Myers
Squibb, and currently available in more than sixty countries, taxol is used mainly for
the treatment of a variety of solid tumours, commonly encountered with ovarian and
breast cancer.
Jl~Vo,..
H OH
1 Taxol
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Since the discovery of taxol (1), medicinal chemists have continued to regard natural
products as an excellent starting point in the search for lead compounds for drug
development. The downside to taxol is its scarcity, its highly complex structure and,
also its low aqueous solubility+ Thus, the search for a more superior anti-tumoural
agent has always been of high priority.
In the early 1990s a new chapter in this quest began to unfold, with the isolation of the
cytotoxic agents epothilone A (2) and B (3), by Hofle et ai.5 Two independent groups
of scientists determined that the epothilones had a similar mechanism of action to taxol
and were competitive inhibitors of [3H]taxol binding with almost identical IC50 values
to that of taxol.5b,61t was these observations that stimulated great excitement from the
chemical community, and led to a flurry of activity towards the total synthesis of the
epothilones. Due to their much simplified structure, compared to that of taxol and the
ability to make analogues many research groups have since reported the total synthesis
of the epothilones,? with some of the leading groups in the field developing extensive
libraries and analogues for full biological evaluation and structure activity relationship
(SAR) studies.t-?
2; R =H Epothilone A
3; R =Me Epothilone B
Throughout this period of activity our own research group has had its interest
stimulated by the publication of the structures of a new class of compound; the
phorboxazoles.t? which demonstrate a broad range of biological activity, showing
exciting cytotoxic, cytostatic and anti-fungal activity. Phorboxazoles A (4) and B (5)
3
were isolated from the Indian Ocean marine sponge Phorbas sp. by Molinski and
Searle. lOa Their gross structures were first described in August 1995; encompassing an
unprecedented molecular architecture of four oxane rings, two oxazole rings, and a 21-
membered macrolactone, incorporating fifteen asymmetric centres.
4; RI = H, R2 = OH Phorboxazole A
5; RI = OH, R2 = H Phorboxazole B
The isolation of the phorboxazoles was only the second report of a natural product from
the genus Phorbas sp. Four phenylpyrrolyloxazoles named phorbazoles A-D (6-9)
were isolated in the early 1990s by Kashman et al,l1 representing a new class of marine
alkaloids containing the chlorinated pyrrole moiety.
H-S(I ~ I
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Phorbazoles A-D
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Phorboxazoles A (4) and B (5) exhibit in vitro anti-fungal activity against Candida
albicans at 0.1 ug/disc and extraordinary cytostatic activity (mean Glso < 7.9 x lO-1OM
in the NCI's 60 tumour cell line); however, most cells were still 100% inhibited at this,
the lowest test concentration. lOa Phorboxazole B (5) was marginally less active than
phorboxazole A (4), yet both show activity of the same order of magnitude as that of
spongistatin 1 (10)12 and are among the most potent cytostatic agents yet discovered.
1.2 Biological Mode of Action of Anti-Cancer Drugs
In 1979 Horwitz and co-workers determined the mechanism of action of taxol (1).3 The
ability of taxol to arrest carcinogenesis is accounted for by its interaction with the
polypeptide tubulin. Tubulin exists in two forms, o- and ~-, both of which are
composed of approximately 440 amino acids and have molecular weights of around
50kD.13 Both forms are structurally similar and together form (l-~ dimers. The tubulin
dimers then assemble in a state of dynamic equilibrium to form large hetero-dimeric
bundles called microtubules. Microtubules are the main structural components of the
mitotic apparatus and are implicated in a wide array of cellular processes, including
cellular movement, cell rigidification and mitosis, the mechanism by which cancerous
tumours grow and are spread.
For normal cellular function, there is an absolute requirement that the equilibrium
between tubulin, the tubulin dimer and the microtubule is readily reversible. Any
change in this delicately balanced equilibrium will dramatically affect cellular properties.
Anti-tubulin agents can be classed as two types: i, those that cause its disruption and
ii, those that enhance microtubule polymerisation. The former are exemplified by the
natural products curacin A (11)14 and rhizoxin A (12),15 which disrupt the cell
cytoskeleton by inducing depolymerisation of microtubules to their constituent sub-
units e- and ~-tubulin.
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12 Rhizoxin A
The latter are represented by taxol (1) and epothilones A (2) and B (3), whereby these
compounds have been shown to induce polymerisation of the microtubuli to afford
extremely stable and non-functional microtubules which cannot undergo cell division
and hence cause cell death} Other natural products, also with striking potency, which
have been shown to possess the same mechanism of action are the polyketide
discodermolide (13),16 the recently discovered eleutherobin (14),17 and sarcodictyin
A (15),18
OH
13 Discodermolide
14 Eleutherobin
6
15 Sarcodictyin A
Hence, within a small sub-section of the cell cycle, one can see that there is already
complimentary areas for the inhibition of mitosis. However, unlike the anti-tumour
agents already discussed, phorboxazole A (4) neither inhibits tubulin polymerisation,
nor interferes with the integrity of microtubules. Instead it appears to arrest the cell
cycle at the S-phase, that being DNA synthesis and thus provides a complimentary
mode of action to the many anti-mitotic natural products already known.10c At this time
the precise mode of action of the phorboxazoles is unknown.
1.3 Related Natural Products
With the advent of modem analytical techniques and methods, a number of highly
complex and structurally diverse natural products have been isolated and their structures
determined. Not only are these some of the most potent compounds known but their
fascinating molecular architecture has provided an immense challenge for synthetic
chemists in pursuit of total synthesis, allowing for extensive methodology to be
developed en route.
1.3.1 Oxane Containing Natural Products
The halichondrins are a class of polyether macrolides isolated originally from the marine
sponge Halichondria okadai Kadota.l? Halichondrin B (16) is a tubulin interactive anti-
mitotic agent that exhibits extraordinary in vitro and in vivo anti-tumour activity.l?
Their limited supply and challenging structure, including 32 stereogenic centres,
prompted Kishi et al, amongst others, to attempt the total synthesis of halichondrin B
and this remarkable goal was realised in 1991.20 Kishi used the Ni(II)/Cr(II)-mediated
coupling reaction of vinyl iodides with aldehydes extensively to achieve this target and
demonstrate the potential of this reaction within natural product synthesis.
7
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16 Halichondrin B
During this time, Kishi's research group was also endeavouring to complete the total
synthesis of palytoxin (17). Palytoxin (17) was isolated from the marine soft corals of
the genus Palythoa and its vast structure was elucidated in 1981.21 Until recently, it
was claimed to be the most poisonous non-peptidic substance known to man. At the
outset of this work, palytoxin was uniquely distinct from molecules with which organic
chemists had previously dealt in terms of its size and structural complexity. Palytoxin
(17) possesses 71 stereochemical elements and these were defined by a combination of
degradation, synthetic and spectroscopic techniques allowing its absolute configuration
to be fully determined. Kishi's research group completed this monumental task in 1994,
in the process making extensive contributions towards the Ni(II)/Cr(II)-mediated
coupling reaction, Suzuki's palladium catalysed diene synthesis and the synthesis of N-
acyl vinylogous ureas.22 This synthesis is one of the scientific milestones in modem
organic chemistry in terms of both the planning, execution and completion of the total
synthesis of such a formidable target.
Brevetoxin B (18) is a potent, lipid soluble neurotoxin which is secreted by the algae
Gymnodynium breve Davis.23 Brevetoxin B (18) is responsible for the 'red tide'
catastrophes, resulting in both mass mortality of marine creatures and human
poisoning.e' The imposing structure of brevetoxin B (18) is built up of only carbon,
8
.." Me
OH
OH
HO,
~ R ~e ct>H ~e H~ '::
CN~N~""H H OH OH
OH Me
OH
Me
,
=
OH
i
OH
17 Palytoxin
oxygen and hydrogen and distinguished by 11 trans-fused ring ethers, containing 23
stereocentres. Nicolaou et al described the total synthesis of brevetoxin B (18) in 1995,
having developed a vast array of new technologies for the synthesis of medium ring
ethers in a stereocontrolled manner.t> The completion of brevetoxin B (18) unfolded
over a period of 12 years and consisted of 123 steps, with the longest linear sequence
of 83 steps, with a very impressive average yield of 91%.
H
o
18 Brevetoxin B
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The spongipyran macrolides are a new class of marine natural products, possessing
many structural features in common with the phorboxazoles, including oxane,
hemiketal oxane, macrolide and diene moieties. In 1993, three research groups
independently reported the isolation and structural elucidation of these spongipyrans
derived from the marine sponges Spongia and Spirastrella (spongistatins),12 Cinachyra
(cinachyrolidej= and Hyrtios (altohyrtinsj.t? The spongipyrans appear to be the most
potent inhibitors of cell growth to date, with 0150 values of 2.5-3.5 x 1O-lIM. Further
investigations revealed that spongistatin 1 (10) inhibits mitosis by binding to tubulin
and blocking microtubule assembly.12d Since only the altohyrtins structure elucidation
provided an absolute configuration assignment, it was these that were targeted initially
for synthesis. Very recently (Dec. 1997) Evans et al reported the completion of a
synthesis of altohyrtin C (19) showing it to be identical to spongistatin 2 (19).28
Closely following this was Kishi's disclosure of the first synthesis of altohyrtin A (10)
showing that it was identical to spongistatin 1 (10).29 Both these syntheses used a
plethora of modem chemistry for the assembly of these structurally complex substrates
and thus provided an alternative source of these scarce and highly potent anti-cancer
agents.
OH
10; R = CI Altohyrtin A, Spongistatin 1
19; R = H Altohyrtin C, Spongistatin 2
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1.3.2 Oxazole Containing Natural Products
The occurrence of oxazoles in marine natural products has recently become quite
common. Most of these secondary metabolites contain isolated oxazole rings, but recent
interest has become focused on natural products which contain two or three
contiguously linked oxazoles. This section of the thesis is not intended to be a thorough
treatise of oxazole containing compounds but rather just to highlight some of the many
oxazoles in Nature that have been of interest within our research group and that of
others.
Calyculin A (20) was isolated from the marine sponge Discodermi calyx in 1986.30 Its
structure was elucidated by X-ray crystallography showing the presence of a 2,4-
disubstituted oxazole amongst a wide array of other functionality. Calyculin A (20) has
also aroused considerable interest due to its striking biological activity exemplified by
the inactivation of the serine I threonine protein phosphatases 1 and 2A.31 The total
synthesis of calyculin A (20) has been reported by the research groups of Evans et at in
1992,32 and Masamune et al in 1994,33 with a formal synthesis also described by
Shioiri et at in 1996,34
HO,?!
HO-F\
0,....
OH OH OMs
20 Calyculin A
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The oxazole unit also occurs in many of the virginiamycin family of antibiotics,
produced by several micro-organisms. The group A virginiamycins have a common,
23-membered macrolactone core which accommodates a 2,4-disubstituted oxazole, an
acrylamide unit, a polyene segment and an amino acid residue. The broad spectrum
antibiotic madumycin II (21) was isolated from a culture of Streptomyces
graminofaciens in 197635 but it was not until 1996 that a total synthesis of this
compound was reported by Meyers et al.36 A short time later, the macrocyclic antibiotic
virginiamycin M2 (22) was isolated from Streptomyces virginiae, which has been
recognised as a cholecystokinin antagonist for treating panic, anxiety and cancer
withdrawal.F Schlessinger et al reported its total synthesis in 1996,38 The synthesis of
the related antibiotic 14,15-anhydropristinamycin lIB (23) was accomplished by
Pattenden et al, again in 1996.39
o
N ~ I N ~H HOH I", 0-, 0 0
'1"'" o~~~
21Madumycin II 22Virginiamycin M2
23 14,15-anhydropristinamycin lIB
In 1993, the novel macrolide theonezolide A (24) was isolated from the Okinawan
marine sponge Theonella sp.40 Theonezolide A (24) belongs to a new class of
12
Me
24 Theonezolide
polyketide natural products, with unique structural features, consisting of two principal
fatty acid chains, incorporating a 2,4-disubstituted oxazole, a 2,4-disubstituted thiazole
and a tetrahydropyran. Theonezolide A (24) exhibits cytotoxicity against the murine
lymphoma L1210 and human epidemoid carcinoma K.B cells in vitro.40
Phenoxan (25) was recently isolated from a soil micro-organism and found to exhibit
anti-lllV activity.s! Its structure is characterised by the presence of a 2,4-disubstituted
oxazole bearing a pyran-4-one at the 4-position of the oxazole, analogous to the
oxazole-pyran moiety in the phorboxazoles. To date there have been two published
syntheses of phenoxan (25).42
25 Phenoxan
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Rhizoxin A (26) is a highly functionalised macrolactone from the pathogenic fungus
Rhizopus chinesis.V» It differs from many of the natural products discussed in this
section, by the presence of the oxazole at the terminus of the side chain. Rhizoxin A .
(26) has stimulated much interest within the chemical community,43 not only by its
intriguing structure, but also by exhibiting diverse and significant biological activity.
OMs
26 Rhizoxin A
The presence of oxazoles within cyclic peptide natural products has been well
documented+t The high density of hetero-atoms within the central cavity of the
macrolide has raised questions about their biosynthesis and in vivo function.45 The
hexapeptide raocyclamide A (27) was isolated from the cyanobacterium Oscillatoria
raoi, and incorporates an oxazole, oxazoline and thiazole units.46 The total synthesis of
raocyclamide A (27) has recently been described by Freeman and Pattenden.f
27 Raocyclamide A
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Natural products containing two or three contiguous oxazole units are significantly less
common. Muscoride A (28), is a novel bis-oxazole based peptidic alkaloid isolated
from the terrestrial cyanobacterium Nostoc muscorum, which displays weak
antibacterial activity.48 The molecule is unique because the bis-oxazole unit is derived
presumably from two threonine residues making it the only natural product bearing two
contiguous 5-methyl oxazoles. The total synthesis of muscoride A (28) has been
accomplished recently by two groups, Wipf et al in 1996,49 and Patten den et al in
1997.50
28Muscoride A
The bis-oxazole containing compound diazonamide A (29), isolated from the colonial
ascidian Diazona chinesis is composed of a highly complex bicyclic framework
encompassing a chlorinated indole, a benzofuran and a chlorinated bis-oxazole
moiety.U Diazonamide A (29) displays potent in vitro cytotoxicity, yet its structural
complexity has eluded the organic chemist and a total synthesis has not been reported.
29 Diazonamide A
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A further bis-oxazole containing compound, hennoxazole A (30) was isolated from the
marine sponge Polyfibrospongia sp. and was shown to be highly active against the
herpes simplex virus.52 Its structure is characterised by the presence of a 2,4-
disubstituted bis-oxazole moiety, a pyranoid glycoside and a rather unusual skipped
triene unit. Wipf et al reported the total synthesis of the enantiomer of hennoxazole A in
1995, thus confirming the previous structure elucidation.S'
30 Hennoxazole A
Ulapualide A (31) is a member of a novel family of oxazole containing macrolides, first
isolated from the egg masses of the nudibranch Hexabranchus sanguineusi« It belongs
to an emerging class of secondary metabolites including halichondramides,55
kabiramides,56 and mycalolides.F all of which contain a contiguous tris-oxazole unit as
the rigid backbone of a macrolactone core, only differing in oxidation patterns and
methyl substitution. Ulapualide A (31) shows a variety of interesting biological activity
including anti-leukaemic, anti-fungal and ichthyotoxic properties. Although the
stereochemical integrity of ulapualide A is in some doubt, Chattopadhyay and Pattenden
have recently completed a total synthesis of the entire ulapualide framework. 58
31 Ulapualide A
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1.4 Isolation and Structure Elucidation of the Phorboxazoles
Molinski et al isolated the phorboxazoles from an extract of the Indian Ocean marine
sponge Phorbas sp. and disclosed their structure in August 1995.l0a The methanol
extract of the sponge (236g dry weight) was subjected to solvent partitioning and
extensive chromatography to give phorboxazole A (4; 95.1mg, 0.040%) and
phorboxazole B (5; 40.5mg, 0.017%), both as pale yellow amorphous solids. Both
compounds were shown to be potent cytostatic agents which prompted Molinski to
determine their full structure.
The molecular formula of both (4) and (5) was established as CS3H71N2013Brby high
resolution mass spectrometry. Extensive ID and 2D NMR analysis gave rise to five
substructures which on further examination of the data could be pieced together to give
the gross structure of the phorboxazoles, showing the prescence of two oxazoles, four
pyran rings and a twenty one membered macrolide. The relative stereochemistry of the
side chain hemiketal ring and the macrolide were then determined by analysis of IH-IH
coupling constants and ROESY data, but these could not be correlated together at this
time. By comparison of the nmr spectra for (4) and (5), they showed only a very small
difference in one of the substructures, Molinski suggested that phorboxazole B (5) was
the C-13 epimer of phorboxazole A (4).lOa
Br
4 Phorboxazole A
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The next task was to determine the configuration of the remaining five stereogenic
centres of the side chain and the absolute stereochemistry of the phorboxazoles.
Molinski was unable to obtain satisfactory samples for X-ray analysis and thus
proceeded to use chemical and spectroscopic methods. By application of Kakisawa's
modification of the Mosher's ester method, 59 the absolute stereochemistries of the C-13
and C-38 stereocentres (phorboxazole numbering) were determined, and hence the
absolute stereochemistry of the macrolide. lOb
From the now known C-38 alcohol configuration the stereochemistry of the hemiketal
ring was determined by spectroscopic comparison with a synthetic model and
examination of the H-37 and H-38 vicinal coupling constant. Thus, both erythro (37a)
and threo (37b) model allylic alcohols were synthesised as detailed in Scheme 1.1Ob
The threo isomer (37b) possessed a H-37 to H-38 coupling constant of 8.0Hz which
matched that of phorboxazole A (4) (J = 7.9Hz), proving the threo configuration
exhibited in phorboxazole A. Using this in association with the relative stereochemistry
of the hemiketal ring, as determined previously, allowed fourteen of the fifteen
stereogenic centres to be determined.
It only remained at this time for the determination of the stereochemistry of the
remaining C-43 stereocentre. Due to the remoteness of this centre, this proved to be a
difficult task but Molinski was able to solve this problem by degradation of the natural
product.10c Thus, ozonolysis of phorboxazole A (4), followed by oxidation of the
resulting mixed ozonides with performic acid and subsequent treatment of the residue
with diazomethane gave a mixture of methyl esters. Separation of this mixture by silica
gel chromatography gave a non-polar fraction containing 38, determined to be dimethyl
methoxy succinate (38). Co-elution of the degraded product with synthetic samples of
(S)-dimethyl methoxy succinate (39) and racemic dimethyl methoxy succinate, showed
that the C-43 stereocentre of phorboxazole A had the R configuration (Scheme 2).lOc
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chromatography (Et20 elution); v, Mel, Ag20, E~O, 65%.
Scheme 2
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Thus, the complete configuration of phorboxazole A (4) was determined as 5S, 9R,
lIS, 13R, 15R, 22R, 23S, 24S, 25R, 26R, 33S, 35R, 37R, 38R, 43R. With the task
of elucidating the full structure of the phorboxazoles complete, we were now in a
position to proceed towards a total synthesis of the phorboxazoles with the correct
choice of chiral pool starting materials.
1.5 Retrosynthetic Analysis
With the unprecedented structure of the phorboxazoles now known, we set ourselves
the task of devising a retrosynthetic analysis to provide the key target fragments for
assembly in an efficient and convergent manner. Our choice of disconnections was
based on the flexibility we wished to employ when we arrived at the assembly stage.
Thus, disconnection across the three olefin units and the lactone unit gave us many
viable options for both the type of coupling to be used and the order. This gave rise to
three key fragments, the side chain (40), the central pyran (41) and the oxazole bis-
pyran (42), each containing five stereogenic centres and a variety of functionality
(Scheme 3).
We envisaged assembly of these fragments by a combination of methods including the
Wittig reaction, Wadsworth-Emmons reaction, Julia reaction and esterification. It was
our initial thought to make use of Still's modification of the Wittig reaction60 to form
the (Z)-olefin as the macrocyclisation step.
We thank Professor Molinski for providing preprints of the subsequent
communications detailing the side chains chirality and the absolute configuration of the
phorboxazoles.10b,c
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An alternative method of assembly of the key fragments is by amide bond formation,
prior to oxazole formation. Many of the compounds en route to these fragments have
the functionality for an amine or a carboxylic acid terminus, which would be necessary
to make use of this route. One further strategy would be to make use of the Stille
reaction for coupling appropriately functionalised vinyl halides with oxazole stannanes
or vice versa. This approach would be particularly attractive in view of the Pattenden
group interest in the application of the Stille reaction to natural product synthesis
(Scheme 4).39,61
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1.6 Synthetic Work Towards the Central Pyran Core
Detailed in this thesis are the author's synthetic studies towards two of the key
fragments of the phorboxazoles, namely the oxazole bis-pyran (42) and the side chain
(40). One of my colleagues Dr Tao Ye simultaneously exacted a synthesis of the central
pyran core (41) using a strategy based on the Lewis acid mediated ring closure of a
hydroxyl group onto an epoxide, ultimately derived from the chiral pool material (S)-3-
hydroxy-2-methyl propionate (48) (Scheme 5).62
22
HO
..'
"
""'OPMB""'OPMB HO
47
Scheme 5
48
Thus, (S)-3-hydroxy-2-methyl propionate (48) was converted into the corresponding
aldehyde (49), which was next subjected to crotylboration conditions to give the
secondary alcohol (50) in 76% yield and with excellent diastereoselectivity (92% de),
Functional group manipulations then gave rise to the aldehyde (51), which was next
allylated under substrate control with allyltributyltin and under Lewis acid catalysis to
give the homoallylic alcohol (52) in 94% yield and with >95% diastereoselectivity.
Transformations next gave rise to the allylic alcohol which was then treated under
Sharpless epoxidation conditions to give the corresponding epoxide (54) in 94% yield.
Treatment of 54 with TBAF gave the alcohol (47) which upon treatment with titanium
tetra-isopropoxide in refluxing benzene gave the 2,6-cis-tetrahydropyran (46) in 76%
yield (Scheme 6).62 The stereochemical outcome of the ring closure was determined
by extensive ID and 2D NMR analysis.
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Reagents: i, a) (-)-f3-(E)-crotyl-(ipchB; b) Et~, H202, 76%; ii, PMBOC(NH)CCh,
TfOH, Et20; iii, TBAF, THF; iv, PhCOCI, DMAP (cat.), Py., 49% (3 steps); v, OS04'
NMO; vi, NaI04, THF, H20, 87% (2 steps); vii, SnBu3Allyl, BF3.Et20, 94%; viii,
TES-OTf, 2,6-lutidine; ix, DIDAL-H, hexane, 82% (2 steps); x, Swern ox.; xi,
(EtOhP(0)CH2C02Et, NaHMDS, 63% (2 steps); xii, DIDAL-H, hexane, 89%; xiii,
(+)-DET, Ti(OiPr)4, TBHP, 95%; xiv, TBAF, THF, 94%; xv, Ti(OiPr)4, C6H6, s.
76%.
Scheme 6
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2. RESULTS AND DISCUSSION
2.1 Synthetic Studies Towards the Oxazole bis-Pyran Unit
2.1.1 Retrosynthetic Analysis
At the outset of this period of research, only the relative stereochemistry of the
macrolide portion of the phorboxazoles had been determined. lOa For this reason we
directed our initial efforts towards this fragment. We believed that upon the
development of the necessary methodology, we would be able to apply it to the correct
enantiomer, once the absolute stereochemistry had been determined. As previously
discussed, we devised a retrosynthetic strategy making use of the extensive array of
functionality present. Thus, the macrolide was disconnected to the central pyran (41)
and the oxazole bis-pyran unit (42) (Scheme 3). Further disconnection of the oxazole
bis-pyran (42) across the trans-pyran gave rise to our initial target, the oxazole cis-
pyran (55), incorporating three stereogenic centres (Scheme 7).
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We envisaged the possibility of utilising the hetero Diels-Alder reaction as a highly
regio- and stereoselective method for the construction of the tetrahydropyran moiety in
55. Furthermore, this approach allows for the introduction of the requisite functionality
for installation of all three stereocentres in a very short sequence of steps.
2.1.2 The Hetero Diels-Alder Reaction
The Diels-Alder reaction= is one of the most powerful carbon-carbon bond forming
reactions in organic chemistry, allowing the creation of two new bonds and up to four
new stereocentres simultaneously, usually in a highly regio- and stereoselective
manner. The Diels-Alder hetero atom counterpart has received much less attention until
recently, where it has been recognised as a useful tool in the synthesis of heterocycles,
with a wide variety of hetero atom containing dienes and dienophiles being employed.
Several comprehensive reviews have been written on this subject and the reader is
referred to these for a more thorough treatise on all aspects of the hetero Diels-Alder
reaction.s+
This section of the thesis is intended to be a brief review on the hetero Diels-Alder
reaction applicable to the project and will concentrate solely on carbonyl dienophiles,
more specifically aldehydes, and their reactions with oxygenated dienes.
The reaction of a carbonyl compound with a l,3-diene unit gives rise to a 2,3-dihydro
pyran derivative. This approach has been used widely in the formation of oxygen
containing heterocycles, but is limited by the reactivity of the carbonyl dienophile and
diene partners. In general, reactions of this type proceed poorly with aliphatic and
aromatic aldehydes. unless highly reactive dienes and/or Lewis acid catalysts are used.
Electron deficient aldehydes are generally more reliable dienophiles in both thermal and
acid-catalysed cycloadditions with alkyl substituted l,3-dienes. It has been shown that
chloral (60), reacts with simple l,3-dienes to afford reasonable yields of [4+2]
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cycloadducts.st The stereochemistry of the Diels-Alder reaction of cyclohexadiene (59)
and chloral (60), under thermal conditions has been investigated and was established
unambiguously to give the endo-adduct (61) (Scheme 8).66
o
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Scheme 8
In view of the low reactivity of simple aliphatic and aromatic aldehydes with dienes,
Jurczak and co-workers have shown that the scope of carbonyl dienophile
cycloadditions may be broadened if reactions are carried out under neutral conditions at
high pressure (Scheme 9).67
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In an extension of this methodology Jurczak et al found that under high pressure trans-
l-methoxybutadiene (62) reacts with (R)-glyceraldehyde acetonide (63) to give
adducts with a high degree of stereoinduction (Scheme 10).68 Significantly the
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cycloaddition shows a 82: 18 facial selectivity with respect to the diene, (i.e. anti:syn),
which can be rationalised by a "Felkin-like" mode of approach.
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Without any doubt, the most pioneering work in this field was developed by
Danishefsky et al, by the recognition that simple aldehydes will react readily with many
electron rich oxygenated dienes under Lewis acid catalysis. In their initial reports the
Danishefsky group described the reactions of the oxygenated diene (68), which became
known as Danishefsky's diene, with a wide range of unactivated aldehydes using zinc
chloride or boron trifluoride diethyl etherate as a catalyst.69 This furnished a 2,3-
dihydro-y-pyrone (70), presumably via the intermediacy of a transient [4+2]
cycloadduct (69) (Scheme 11).
The Danishefsky research group has described a series of detailed investigations into
the mechanism,70 stereochemistry.l! and the synthetic applications'P of this process.
Mechanistically the cycloaddition reaction is rather complex. Depending on the catalyst
or solvent used and the reaction substrates; pericyclic and/or Mukaiyama aldol-like
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pathways may be involved. With zinc chloride it is assumed that chelation of the
aldehyde with the Lewis acid occurs in an anti manner, and that the steric bulk of the R-
group is less than that of the Lewis acid-solvent complex L.This favours a Diels-Alder
transition state with the R-group in an endo orientation, resulting in the adducts having
cis relative stereochemistry at C-5,6 (71) (Scheme 12). Furthermore, this selectivity
could be reversed to give a C-5,6 trans arrangement (72) by employing boron
trifluoride diethyl etherate as the catalyst, which doesn't exhibit such a steric preference
for an endo approach. It was postulated that reactions catalysed by boron trifluoride
diethyl etherate were not concerted, but probably involved an aldol-like pathway
(Scheme 12).70
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High levels of stereochemical induction can also be achieved by the use of an a-
substituted chiral aldehyde."! These cycloadditions show excellent facial selectivity
depending on the nature of the a-substituent used and the Lewis acid employed.
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Scheme 13 shows the facial control obtained with a-methyl phenyl acetaldehyde (74)
and a highly oxygenated diene (73) using two different catalysts,?la,b In both cases the
facial selectivity was the same (i.e. Cram), but as shown previously the C-S,6
stereochemistry was reversed using boron trifluoride diethyl etherate as the catalyst.
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Good facial selectivity was also found in the case of a-alkoxyaldehydes (ef 78), but
again this was highly dependant on the Lewis acid and substrates used. With
magnesium bromide as catalyst cyc1oaddition was shown to occur via a chelated
aldehyde (79) with the diene (73) attacking from the least congested face. For steric
reasons an exo transition state in a pericyclic process is favoured in this case, giving
rise to a single diastereomer of the dihydropyran (80) (Scheme 14).71e
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Scheme 14
Danishefsky and co-workers have also examined chiral induction in [4+2]
cycloadditions of aldehydes to oxygenated dienes bearing chiral auxiliaries.U'' Optically
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inactive europium(lll) catalysis proved effective in promoting the cycloaddition reaction
but did not give favourable diastereomer ratios. However, combination of the chiral
diene (81) with a chiral lanthanide catalyst and reaction with benzaldehyde (82)
provided the reinforcement needed to generate one diastereomer of the dihydropyran
(84) in large excess (Scheme 15).
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This methodology has been extensively applied towards the total synthesis of several
natural products by the Danishefsky group,72 providing a pathway to several types of
carbohydrates. One example is the monosaccharide l-talose (88), which was prepared
in just a few steps using a hetero Diels-Alder reaction between the aldehyde (86) and
the diene (85) to give the dihydropyrone (87), which was subsequently converted to
the natural product (Scheme 16).71a
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Reagents: i, BF3.Et20, CH2C12• 42%.
Scheme 16
The use of the hetero Diels-Alder reaction is not limited to the formation of natural
products containing six-membered ring ethers. Upon formation of the [4+2]
cycloadduct these can be transformed to a linear ether bearing the stereochemistry
inferred from the hetero Diels-Alder reaction. Thus, this reaction can be implemented as
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a template for the formation of many stereocentres in a controlled fashion. Palenzuela et
al have employed this approach for the preparation of a,a'-disubstituted cyclic ethers
of various ring sizes.73 The utility of this approach has been shown in their formal
synthesis of laurencin (Scheme 17).73b An endo-Cram hetero Diels-Alder reaction
between the diene (89) and (S)-glyceraldehyde acetonide (90) gave the dihydropyran
(91) in 82% yield and 88:12 ratio favouring the diastereomer shown. Having now
provided the two asymmetric centres, which will form the a,a'-positions of the
oxocene, Palenzuela et al cleaved the olefinic unit in 91 with ozone to give an acyclic
ether. Further manipulations eventually gave the oxocene (95), which constituted a
formal synthesis of laurencin.73b
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Danishefsky et al have also made extensive use of the hetero Diels-Alder reaction to
form dihydropyran templates for the stereocontrolled construction of two fragments
used in their total synthesis of epothilone A nad B.74 Thus, a Lewis acid mediated
hetero Diels-Alder reaction of the aldehyde (96) with Danishefsky's diene (68) gave,
after mild acid hydrolysis, the dihydropyran (97). The racemic dihydropyran (97) was
subsequently resolved and then converted into the acyclic aldehyde (99), containing the
requisite stereocentres, in a short sequence of steps (Scheme 18).7Sa
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The second fragment synthesised by Danishefsky et al used a similar approach, but
relied on the chiral aldehyde (100) as the stereocontrol element.75b Thus, hetero Diels-
Alder reaction between the aldehyde (100) and the more complex diene (73) gave rise
to the dihydropyrone (101) in excellent yield and high selectivity. Installation of the
geminal methyl group was achieved by cyclopropanation and ring opening, giving rise
to the mixed methyl ketal (103), which could then be unmasked leading to the acyclic
fragment (104) bearing four chiral centres, all installed in a highly selective manner
(Scheme 19).
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The most significant development in recent years however, has been the application of
chiral Lewis acids to the hetero Diels-Alder reaction to provide pyrans with high
enantiomeric excess directly.Iv The ready availability of optically active NMR
lanthanide shift reagents first led Danishefsky et al to investigate the possibility of
inducing absolute chirality in these cycloadditions.I? Employing Eufhfc), (107) as the
catalyst they were able to induce modest (20-50%) enantiomeric excesses (ees),
depending on the diene used and the reaction conditions (Scheme 20).
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Reagents: i, Eu(hfc)3, CHCI3; ii, TFA.
Scheme 20
Many research groups have since contributed towards this asymmetric variant,
employing a vast array of conceptually different Lewis acids, to achieve ees in excess
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of 90%.78 In most cases however, substrate structure and reaction conditions have a
large influence on the degree of enantioselectivity.
2.1.3 Initial Hetero Diets-Alder Approaches
It was our initial intention to examine whether a 4-formyl oxazole (cf. 113) would
participate as the dienophile in a [4+2] cycloaddition with an appropriate diene to give
rise to a pyran moiety which could be elaborated subsequently to the 2,6-cis-pyran
present in the phorboxazoles. As this was to be a simple model study at this time, we
made use of the Cornforth oxazole, ethyl 2-methyloxazole-4-carboxylate (111). The
procedure of Cornforth,79 employing some modifications developed by Meyers,80
provided large quantities of the desired oxazole (Ill) quite readily. Thus,
condensation between ethyl acetimidate hydrochloride (108) and glycine ethyl ester
hydrochloride first gave the imidate (109) in 50% yield. The imidate (109) was next
formylated using the improved procedure of Meyers (KtBuO I HCOzEt) to provide the
enolate salt (110) which was then cyclised immediately to the oxazole ester (111) by
refluxing in acetic acid in a yield of 55% over the two steps (Scheme 21).
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Scheme 21
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The required 4-fonnyl oxazole (113) was secured by a two step procedure, involving
reduction of the ester (111) to the alcohol (112) with 2.5 equivalents of DIBAL-H,
followed by oxidation of the alcohol with manganese dioxide to give the aldehyde
(113) in good overall yield (Scheme 22).
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Scheme 22
We were now in a position to examine the hetero Diels-Alder reaction and we initially
chose to use the commercially available Danishefsky's diene, trans-l-methoxy-3-
(trimethylsilyloxy)-1,3-butadiene (68). Danishefsky et al had previously shown that
{l,J3-unsaturated aldehydes reacted with this diene (68) under Lewis acid catalysis to
give y-pyrones rather than carbocyclic adducts.s! With this in mind we anticipated that
a 4-fonnyl oxazole would undergo this [4+2] cycloaddition to give a 2-oxazole
substituted 2,3-dihydro-y-pyrone. This system was attractive to us as it provided
functionality for nucleophilic attack at the C-6 position, in a Michael type reaction, for
further elaboration to the macrolide fragment. Thus, treatment of the diene (68) and the
aldehyde (113) with zinc chloride in benzene gave the desired dihydropyrone (115)
after brief exposure to trifluoroacetic acid in a satisfactory 76% yield (Scheme 23).
We anticipated that conjugate addition of an alkyl group to the vinylogous ester (115)
would give rise to the desired tetrahydropyran (116). We were also interested in the
level of stereoselectivity we could achieve favouring the requisite cis-configuration.
Using the cuprate reagent derived from methyl lithium and copper(I) iodide, and
adhering to a literature procedure,82 we were successful in obtaining a single. new
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product. On analysis of the reaction product we were dismayed to find that although
nucleophilic attack had proceeded, it actually gave rise to opening of the pyran,
regenerating the (l,~-unsaturated carbonyl system which underwent addition of a
second equivalent of the cuprate reagent, to generate the 1,3-hydroxy ketone (117)
(Scheme 24).
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Scheme 24
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We anticipated that by only using one equivalent of cuprate reagent the intramolecular
ring closure would predominate so as to re-form the pyrone system. Treatment of
dihydropyrone (115) with one equivalent of dimethylcuprate failed to deliver any
isolable product, and instead only starting material or decomposition products were
observed. Similar observations were made with the cuprate reagent derived from
copper(I) bromide and methyl magnesium bromide.
Rather than overcome this problem and the issue of stereoselectivity, we decided to
make use of a timely publication by Palenzuela et al.83 Palenzuela et al studied the effect
of various Lewis acids on the reaction of 2-monoactivated dienes and aldehydes in
search of more general reaction conditions for the hetero Diels-Alder reaction than those
previously published. They found that boron trifluoride diethyl etherate in diethyl ether
gave the highest yields of hetero Diels-Alder adducts, with good endo:exo selectivity.
With benzaldehyde (82) and the diene (118), the hetero Diels-Alder adduct (119) was
prepared in 86% yield as a 6:1 ratio of cis.trans isomers (Scheme 25).
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The diene (118) has the advantage over Danishefsky's diene in that once the pyran is
formed no Michael addition step is required. This diene (118) also uses the more
robust tert-butyldimethylsilyl group to trap the enol ether and so unlike that with
Danishefsky's diene the [4+2] cycloaddition product is isolated and reasonably stable.
We have developed a more efficient route to the diene (118) described by Palenzuela,83
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employing a highly selective Wittig reaction. 3-Buten-l-01 (120)was protected as the
benzyl ether (121) and then cleaved to the corresponding aldehyde (122)with ozone in
dichloromethane in 80-90% yield. Wittig reaction of 122 with 1-
(triphenylphosphoranylidene)-2-propanone gave a 27: 1 ratio of E:Z isomers, which
could be separated readily by flash chromatography to give the (E)-a.,~-unsaturated
ketone (123) in over 90%. Formation of the diene (118) was achieved using
triethylamine and tert-butyldimethylsilyl triflate in quantitative yield (Scheme 26).
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We once again employed our model oxazole aldehyde (113) to demonstrate the
potential of this hetero Diels-Alder reaction, at this stage not being concerned with
enantioselectivity. Using the conditions of Palenzuela,83 reaction of the diene (118)
with the aldehyde (113) mediated by boron trifluoride diethyl etherate at -7S·C, gave
the desired cycloadduct (124) exclusively as a single diastereomer in a modest 60%
yield. Exposure of the silyl enol ether (124) to TBAF led smoothly to the 4-pyrone
(125) in 70% yield (Scheme 27).
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Determination of the stereochemical outcome of this hetero Diels-Alder reaction was
made by NOE studies. A 10.3%NOE was observed at H-6 upon irradiation of the H-2
proton of the 4-pyrone (125), thus confirming the cis-configuration (Figure 1).
Furthermore, this demonstrates that if the hetero Diels-Alder reaction is concerted, then
as expected it passes through an endo transition state.
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Figure 1: NOE analysis of the pyrone (125).
41
Gratified by this result we then focused on a route towards controlling the absolute
stereochemistry of the pyran ring adjacent to the oxazole. We anticipated that by making
use of a chiral oxazoline, the pyran could be formed stereoselectively via a hetero Diels-
Alder approach. Grieco et al84 had shown that hetero Diels-Alder adducts can be
formed with good diastereoselectivity from N-BOC protected a.-amino aldehydes. The
best result came from the N-BOC oxazolidine aldehyde (126), also known as Gamer
aldehyde,85 and trans-l-methoxy-3-[(tert-butyldimethylsilyl)oxy ]-1 ,3-butadiene (127)
resulting in a 10: I ratio of dihydropyrans in favour of the threo isomer (128) (Scheme
28). The formation of major adducts possessing the threo configuration as exhibited by
128 is consistent with a chelation controlled process.
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We proceeded to make the oxazoline (132) derived from cinnamic acid (129) and
serine methyl ester hydrochloride (130) by amide formation followed by a DAST
mediated cyclisation.86 The amide (131) was prepared using standard peptide coupling
reagents in 78% yield. Subsequent cyclisation using DAST afforded the oxazoline
(132) in an excellent 86% yield. We anticipated that reduction of the oxazoline ester
(132) to the alcohol (133) with DffiAL-H would be straightforward; however on all
occasions only decomposition products were observed (Scheme 29).
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We attributed this failure to the conjugated nature of the oxazoline and so decided to
reduce serine methyl ester prior to coupling and cyclisation, thus avoiding the
problematic reduction step. Furthermore it has been shown that the enantiomeric purity
of hydroxymethyl oxazolines has been found to vary due to racemization during the
reduction.s? We were able to prepare the amino alcohol (137) in two steps from d-
serine methyl ester hydrochloride (134) according to the procedure of Meyers.s? d-
Serine methyl ester hydrochloride (134) was liberated to the free amine and then treated
with tert-butyldimethylsilylchloride and imidazole to furnish the corresponding silyl
ether (135) in 99% yield. The ester (135) was then reduced using sodium borohydride
in methanol at 35°C to give the free amino alcohol (137) in 80% yield after treatment
with pH 4 buffer to hydrolyse any boron ate ester (136) present (Scheme 30).
Coupling of the TBDMS protected amino alcohol (137) with cinnamic acid (129) was
achieved in a 75% yield leading to the amide (138) which was cyclised subsequently
with DAST to afford the corresponding oxazoline (139) in a satisfactory 77% yield
(Scheme 31).
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Scheme 31
With the oxazoline (139) in hand we only needed to deprotect the silyl ether, followed
by oxidation to obtain our desired chiral aldehyde. Deprotection of the silyl ether (139)
to give the alcohol (140) was accomplished with TBAF in 88% yield. Unfortunately,
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we were unable to isolate any of the chiral oxazoline aldehyde (141) under various
oxidation conditions including; Swem,88 pyridine sulfur trioxide modification of the
Swern reaction.s? Dess-Martin periodinane'v or manganese dioxide. Most notably
under Swern conditions over-oxidation to the oxazole aldehyde (142) was observed in
60% yield (Scheme 32).
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Reagents: i, TBAF, THF, 88%; ii, (COClb DMSO, Et3N, CH2CI2, 60%.
Scheme 32
Disappointed by our inability to prepare the desired oxazoline aldehyde (141), we
considered the use of Garner aldehyde (145)85 which we anticipated could be
elaborated to the desired oxazole subsequent to the hetero Diels-Alder step. The Gamer
aldehyde (145) can be prepared in excellent yield with high enantiomeric excess in
three steps from d-serine methyl ester hydrochloride (134) using the modified
procedure of Taylor et al (Scheme 33).91
The carbamate (143) was routinely obtained in 90% yield from d-serine methyl ester
hydrochloride (134) by treatment with di-tert-butyl dicarbonate in THF and
triethylamine. Treatment of 143 with 2,2-dimethoxypropane and boron trifluoride
diethyl etherate in acetone at room temperature gave the oxazolidine (144) in 88%
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Scheme 33
yield. Subsequent reduction of the ester (144) with DIBAL-H in toluene at -78"C
afforded the aldehyde (145) in 80% yield. We anticipated that this aldehyde (145)
would undergo a facile hetero Diels-Alder reaction with the diene (146), through a
similar chelation-controlled reaction as described by Grieco,84 to give the cycloadduct
(147) stereoselectively (Scheme 34).
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We have shown that cycloadducts from 2-metbyl-4-formyl oxazole (113) and dienes of
this type (146) can be achieved in good yield. However, with the Gamer aldehyde
(145) only low yields of cycloadduct were obtained initially. We extensively examined
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this reaction and were able to achieve a yield of 65% with good stereoselectivity using
zinc chloride in hexane (Table 1).
Aldehyde Diene Conditions Yield (%) Stereoselectivity
145 148R = TBDPS LiCIO,JEt20 a 0 -
145 118 R = Bn BF3.Et20lEt20 a 31 ~
145 118 R = Bn BF3.Et20ffHF c 0 -
145 118 R = Bn ZnCI/Benzene a 35 ~
145 118 R = Bn ZnCIz/Et20 a 25 ~
145 118 R = Bn ZnCI/Hexane c 65 ~
145 118 R = Bn Et2AlClIHexaneb 55 X
145 149 R = PMB ZnCliHexane c 65 ~
145 149 R = PMB ZnCliCH2Clz d 31 ~
Relative to leq. of diene: a l.4eq. aldehyde, leq. Lewis acid; b 1.5eq. aldehyde, 1.5eq.
Lewis acid; c 1.5eq. aldehyde, leq. Lewis acid; d 1.5eq. aldehyde, 2eq. Lewis acid.
Table 1
We were unable to determine the diastereoselectivity of the hetero Diels-Alder reaction
directly by IH or I3C NMR as all the cycloadducts existed as rotameric species. By
removal of the acetonide in 150 with PTSA in methanol (Scheme 35), the dimethyl
ketal (151)was formed in 80%.
OTBDMS Mea OMe
\
NHBOC
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Reagents: i, PTSA, MeOH, 80%.
Scheme 35
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Examination of the IH NMR spectra of the ketal derivatives was not very informative.
However the derivatives no longer existed as rotameric species. The 13e NMR spectra
proved to be far more useful, and the dimethyl ketal from the hetero Diels-Alder
reaction with diethylaluminium chloride clearly showed two sets of peaks of similar
intensities. With the other Lewis acids only one set of peaks were observed in the 13e
NMR spectra, indicating the presence of a single diastereomer, though at this stage we
could not determine whether we had a cis- or trans-pyran from the hetero Diels-Alder
reaction. Now satisfied that some degree of asymmetric induction had been achieved,
we continued to elaborate the dihydropyran (150) to the oxazole-pyran fragment and to
establish the stereochemistry en route.
It was our intention to obtain the alcohol from the Diels-Alder adduct (150) by
hydrolysis and selectively reducing the ketone (152) to the axial alcohol using K-
selectride®. We deemed it necessary to reduce the ketone (152) at this stage in order to
prevent any elimination to the dihydropyran under the conditions required later for
oxazole formation,
Desilylation of the silyl enol ether (150) was achieved in 95% yield with TBAF to give
the ketone (152), which was then reduced with K-selectride® leading to a 5:1 ratio of
isomers of the corresponding alcohol (153) in 80% overall yield. Subsequent
acetylation under standard conditions gave the acetate (154) in quantitative yield. The
acetonide group was then cleaved by exposure to acidic methanol to furnish 155 in
80% yield (Scheme 36).
Our next intention was to examine possible routes for the formation of the second
adjacent pyran ring in phorboxazole A (4). The trans-stereochemistry of this pyran
presents a far more challenging problem, and possible approaches would involve many
additional steps with the need for the control of several newly formed chiral centres. A
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Scheme 36
number of possible pyran ring closure protocols were available. One such approach
was a second hetero Diels-Alder reaction with Danishefsky's diene (68), with the
possibility that f3-chelation control would be inferred through a chelate such as 156.
R
OAe
H
156
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We chose to protect the alcohol (155) as its TBDPS ether and use this material to
examine possible approaches towards the second pyran. This protection was achieved
in 92% yield and subsequent hydrogenation of the benzyl group gave the alcohol (157)
in quantitative yield. Oxidation of this alcohol with pyridine sulfur trioxide,
triethylamine and DMS089 next gave the aldehyde (158) in 75% yield. The aldehyde
(158) was then treated with Danishefsky's diene (68) in the presence of zinc chloride.
After six hours all the aldehyde (158) had been consumed, and work up followed by
purification by flash chromatography gave a 57% yield of the cycloadduct (159)
(Scheme 37).
OAe
l
OAe,
i, ii
\
NHBOC
ISS
OBn
\
NHBOC
OH
157
1m
OAe,
iv
OAe,
o 158
Reagents: i, TBDPS-CI, Et)N, DMAP (cat.), CHzClz, 92%; ii, Hz, PdlC, MeOH,
100%; iii. Py.SO), Et)N, DMSO, 75%; iv. Oanishefsky's diene, ZnC12, benzene,
57%.
Scheme 37
At this stage we were unable to determine whether any diastereoselectivity was being
inferred by analysis of the IH NMR spectrum. The newly formed stereogenic centre in
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159 may be too remote from the pre-existing chiral centres for any diastereomers to be
distinguished by IH NMR. The l3C NMR spectrum however, displayed an extra
signal, which we believe is due to a mixture of diastereomers at the newly formed
stereogenic centre in 159, indicating that no stereochemical induction had been
achieved. Also, due to the difficulty in assigning a configuration to this stereo genic
centre, we decided not to pursue this route. Instead, we decided to focus on formation
of the oxazole prior to the elaboration of the trans-pyran.
2.1.4 Oxazole Formation
The widespread occurrence, uses and synthesis of oxazole derivatives have been the
subject of extensive reviews.92 Because of the many roles that these compounds play in
natural product and synthetic organic chemistry, many methods have been developed
for their efficient construction. The 2,4-disubstituted oxazole is by far the most
common type of oxazole found in natural products and the vast majority of research has
been towards those compounds possessing a 4-carboxyl group. Many of these methods
also have the flexibility for inclusion of a substituent at the 5-position.
Early methods for oxazole formation focused on the combination of imidates with
amino acids, eg glycine, followed by addition of ethyl formate and a base, to generate
an enolate, which could then form the oxazole by cyclodehydration (see earlier work,
Scheme 21).19 Alternatively, combination of an imidate (160) with serine methyl
ester hydrochloride (130) under mild basic conditions gives rise to an oxazoline
(161),93 which can subsequently be oxidised to an oxazole (Scheme 38).
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Reagents: i, Et3N, CH2CI2, 75%.
Scheme 38
a-Diazocarbonyl compounds (162) have also been shown to participate in oxazole
formation by undergoing reactions with nitriles (163) (Scheme 39).94 Reactions of
these compounds can be induced either thermally, photochemically, or by metal
catalysis. This method can provide oxazoles (164) bearing much different, simple
functionality, but has not yet been widely applicable towards very complex systems.
R'~ JtIf 'R'
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Scheme 39
Konopelski et al have shown the utility of this reaction in their studies towards
diazonamide A (29).95 Treatment of the a-diazo-~-keto ester (165) under Lewis acidic
conditions in acetonitrile furnished the desired 2-methyl oxazole (166) in 64% yield
(Scheme 40). This approach is limited by the need to employ the nitrile as solvent to
obtain the best results, and thus limits the functionality that can be incorporated.
An alternative method for oxazole formation is the Hantzsch synthesis,96 which has
been widely used for the synthesis of thiazolesf? but less so for oxazoles. This method
involves condensation of an amide with a halo-keto-ester, giving rise to a 2,4-
disubstituted oxazole after acid-mediated dehydration. The utility of this method has
recently been demonstrated by Panek et ai, in their synthesis of the tris-oxazole unit of
ulapualide A (31) (Scheme 41).98
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Perhaps the most widely used route towards oxazole formation within highly complex
natural products involves amide (174) formation followed either by i) cyclisation to an
oxazoline (175) and subsequent oxidation to give the oxazole (164) (Scheme 42) or
ii) oxidation to a 1,3-dicarbonyl species (176), followed by cyclodehydration
(Scheme 43). These methods allow for the formation of oxazoles with high levels of
functionality at each position by the union of corresponding acids and amines to give
amides which serve as the oxazole precursors.
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Over recent years many research groups have developed efficient syntheses based on
these type of reactions, and a whole variety of reagents and conditions are now
available to effect these transformations. Initial formation of the oxazoline can be
achieved in many ways. Essentially activation of the hydroxy amide is required for
cyclisation to occur. Activation can be promoted by thionyl chloride, followed by
treatment with silver triflate;99 methanesulfonyl chloride and triethylamine;lOO
triphenylphosphine, carbon tetrachloride and DIPEA; 100 under Mitsunobu
conditions;lOl phosphorus oxychloride;102 or the more commonly encountered
Burgess reagentl03 or DAST.86 Careful considerations must be taken when choosing a
suitable reagent for this transformation, as elimination, aziridine formation or
epimerisation may also occur.104
The oxidation protocol has also been developed extensively and in general proceeds by
either a radical pathway or an addition-elimination sequence; in either case, the need for
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an enolisable group at the 4-position seems necessary to effect this transformation in
good yield. Methods that have been examined and shown to be successful include
nickel peroxide in refluxing benzene.F" copper(II) bromide and DBU;t06 copper(I)
bromide and t-butyl peroxybenzoate; 107formation of 5-seleno-oxazoles, oxidation and
elimination; 108 carbon tetrachloride, pyridine and DBU in acetonitrile,109 and
bromotrichloromethane and DBU.ltO Again careful choice of reagent is required for
oxidation depending on the substrate.
An alternative pathway developed by Wipf has also proven to be extremely useful in
oxazole formation en route to natural products. Wipf, having encountered problems
with the capricious oxidation of oxazolines to oxazoles, pursued a Robinson-Gabriel
type cyclisation of a ~-keto amide to furnish an oxazole.U! Thus, oxidation of a ~-
hydroxy amide with the Dess-Martin reagent,90 followed by mild cyclodehydration of
the intermediate ~-keto amide with triphenylphosphine, iodine and triethylamine
allowed the rapid synthesis of highly substituted and functionalised oxazoles in good
overall yield. Amido-aldehydes derived from serine residues were found to cyclise to
the oxazole in a much less facile manner. Wipf overcame this problem by changing the
reaction conditions and so used the bulky base 2,6-di-tert-butyl-4-methyl pyridine, with
dibromotetrachloroethane and triphenylphosphine. Under these conditions elimination
did not occur spontaneously and required subsequent treatment with DBU to furnish
the oxazole.S'
The use of both these approaches is shown by Wipf s total synthesis of the enantiomer
of hennoxazole A (177).53 Thus, condensation of the acid (178) with serine methyl
ester hydrochloride (130), via the mixed anhydride, gave the ~-amido alcohol (179)
which was cyclised to the oxazoline (180) with the Burgess reagent.103 Oxidation of
180 with copper(II) bromide and DBU then gave the desired oxazole (181) in 37%
overall yield (Scheme 44).
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Scheme 44
Elaboration of the side chain in 181 and saponification of the ester gave the acid
precursor (183) to the second oxazole. The acid (183) was next coupled to the
tetrahydropyran-amine unit (182) under standard peptide forming conditions to give
the ~-amido alcohol (184) in 63% yield. Oxidation of 184 with Dess-Martin
periodinane then gave the intermediate amido aldehyde, which was smoothly
cyclodehydrated using the conditions described previously to give the enantiomer of
hennoxazole A (177) after desilylation with TBAF in 42% overall yield (Scheme
45).53
Returning to our own system, we were now in a position for N-BOC deprotection of
the carbamate (155) and formation of a suitable amide precursor (185) for oxazole
formation. We chose crotonic acid to couple with the amine as it was a readily available
synthon for a protected alcohol. Once the oxazole has been formed the olefin can then
be functionalised by dihydroxylation and diol cleavage. Thus, treatment of the
carbamate (155) with trifluoroacetic acid in dichloromethane proceeded smoothly to
give the corresponding amine which was then treated directly with triethylamine, EDC,
HOBT and crotonic acid to give the desired hydroxy amide (185) in 68% overall yield
(Scheme 46).
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In view of all the literature methods towards oxazole formation, we anticipated that
cyclisation of 185 to the oxazoline (186) and subsequent oxidation would furnish the
desired oxazole (187). Treatment of the P-hydroxy amide (185) with DAST86 at -78°C
yielded, upon aqueous work up, the oxazoline (186) in 68% yield. We then attempted
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to oxidise 186 to the corresponding oxazole (187) using the conditions described by
lung et al,109 which had previously been used within our research group with
success.so However, stirring 186 with DBU, carbon tetrachloride and pyridine in
acetonitrile at room temperature for four days provided no evidence of oxazole (187)
formation; instead only starting material was recovered (Scheme 47).
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Reagents: i, DAST, CH2Ch, 68%; ii, DBU, CCl4, Py., CH3CN.
Scheme 47
This outcome prompted us to examine a simpler, model oxazoline (139) which was
synthesised as described previously (Scheme 31). Under no circumstances could we
prepare the desired oxazole (188) using lung's conditions109 or nickel peroxide or
manganese dioxide in refluxing benzene (Scheme 48).105
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In almost all the examples encountered in the literature the need for a 4-carboxyl group
or unsaturation at the 4-position to accelerate these oxidations is evident. Barrish and
Singh et al106 were unable to oxidise the oxazoline (189) to the corresponding oxazole
(190) under their conditions (CuBrz, DBU), but with a benzyl ester at the 4-position
they achieved a satisfactory yield of the oxazole (192). They suggested the
intermediacy of a copper(ll) enolate reinforcing the need for an enolisable group at the
4-position (Scheme 49).
-(:~( ~ -(yR
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Reagents: i, CuBrz, DBU, EtOAc, CHeI3•
Scheme 49
In light of this we decided that the conditions described by WipfS3 (Dess-Martinf?
oxidation and cyclodehydration with tetrachlorodibromoethane, triphenylphosphine,
2,6-di-tert-butyl-4-methylpyridine and DHU) might be useful for obtaining the oxazole
(187) directly from the hydroxy amide (185).
Thus, we decided to apply these conditions to our own system. Oxidation of the amido
alcohol (185) proceeded smoothly with Dess-Martin periodinane,90 to give the
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corresponding amido aldehyde. After filtration of the reaction mixture through a short
column of silica, the aldehyde was cyclised directly to the bromo-oxazoline with
tetrachlorodibromoethane, triphenylphosphine and 2,6-di-tert-butylpyridine. Without
further purification, dehydrohalogenation (DBU, CH3CN) of the intermediate bromo-
oxazoline then gave the desired oxazole (187) in 58% overall yield (Scheme SO).
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Reagents: i, Dess-Martin periodinane, CH2CI2; ii, BrCI2CCCI2Br, PPh3, 2,6-di-tert-
butylpyridine, CH2Ch; iii, DBU, CH3CN, 58%.
Scheme SO
2.1.5 Coupling Protocol
With the oxazole-pyran fragment (187) in hand, our next task was to cleave the
crotonyl residue in 187 to the corresponding aldehyde (193) in readiness for further
functionalisation. It is known that oxazole rings are sensitive to ozone,92 so we chose
to dihydroxylate the olefin in 187 with catalytic osmium tetroxide and NMO and then
subject the crude 1,2-diol to oxidative cleavage with sodium periodate. This procedure
afforded the corresponding aldehyde (193) in 88% overall yield. Subsequent reduction
of the aldehyde with sodium borohydride then gave the primary alcohol (194) in 89%
yield (Scheme 51).
We anticipated that conversion of the primary alcohol group in 194 into a phosphonate
would provide a useful precursor for a Wadsworth-Emmons reaction with a suitable
aldehyde. Thus, the alcohol (194) was converted into the corresponding bromide
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(195) in 80% yield with carbon tetrabromide and triphenylphosphine. Conversion of
the bromide (195) into the phosphonate (196) then proceeded quantitatively via an
Arbusov reaction with triethylphosphite (Scheme 52).
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Reagents: i, CBr4, PPh3, CH2CI2, 80%; ii, P(OEt)3' toluene, tJ., 100%.
Scheme 52
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Having prepared the desired oxazole-pyran fragment bearing a phosphonate at the 2-
methyl position of the oxazole, we then considered possible conditions for the
Wadsworth-Emmons coupling reaction. We chose to model the system with a simple
oxazole-phosphonate (198). This compound (198) could be accessed via
deprotonation of 2-methyl-4-(tert-butyldimethylsilyloxymethyl)oxazole (197) with n-
butyl lithium and quenching with diethyl chlorophosphate (Scheme 53). This led to
only modest yields of the desired phosphonate (198), but sufficient material for our
model studies. The oxazole phosphonate (199) resulting from deprotonation at the 5-
position of the oxazole was also observed in a similar yield. Using a more bulky base
(LiHMDS) or changing the protecting group at the 4-position led to no significant
increase in the yield or ratio of the two phosphonates. These regioisomers were
separated by careful flash chromatography.
~)OTBDPS 7jOTBDPS 7~OTBDPS
o -----1- ~O + Ao PO(OEt),
PO(OEt)2
197 198 199
Reagents: i, n-BuLi, diethyl chlorophosphate, THF, 25%.
Scheme 53
We decided that with phosphonates of type 198, which mimic ~-keto phosphonates,
the Wadsworth-Emmons reaction could be carried out under the mild Masamune-Roush
conditions.1l2 Thus, treatment of the phosphonate (198) with DBU, lithium chloride
and a simple aldehyde, in this case 3-benzyloxy-propionaldehyde, in acetonitrile at
room temperature gave a very satisfactory 74% yield of the desired olefin (200) as a
10: 1 mixture of trans:cis isomers which could be separated by flash column
chromatography (Scheme 54).
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Gratified by this result we then decided to examine whether the functionality contained
in our oxazole-pyran fragment (196) would tolerate these reaction conditions. Again
we chose to use a simple aldehyde, 3-(p-methoxybenzyloxy)-propionaldehyde and
under Masamune-Roush conditions 112 we were pleased to obtain a 70% yield of the
desired olefin (201) in exclusively the trans geometry(3Jerans= 16.1 Hz) (Scheme 55).
Thus, we have shown the utility of this approach for the formation of the C-19-C-20
olefin with good selectivity and we hope we can employ this strategy in future
approaches.
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Reagents: i, LiCI, DBU, 3-(p-methoxybenzyloxy)-propionaldehyde, eH3CN, 70%.
Scheme 55
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2.1.6 Stereochemistry Determination
Throughout the period of this research we believed we had the desired 2,6-cis-
tetrahydropyran, by virtue of an endo selective hetero Diels-Alder reaction, as
demonstrated by our model studies. We still thought it necessary, however, to
unambiguously determine the relative configuration of the pyran before coupling to any
other key fragments. This proved to be very difficult initially, due to the lack of a
suitably crystalline derivative for X-ray analysis. Also, by the complexity of the IH
NMR spectra as a result of the rotameric nature of these compounds, and the high
number of proton signals adjacent to a hetero atom, giving a congested region in the
area of interest, making any irradiation studies difficult.
Throughout the series of compounds from the initial cycloadduct (150) to the oxazole
phosphonate pyran (196), only the aldehyde (193) had the three protons at the C-2, C-
4, C-6 positions of the tetrahydropyran sufficiently separable for NOE analysis.
Initial NOE experiments were encouraging, showing only one enhancement between
two protons as expected. It was not until after careful examination of the COSY
spectrum and reassignment of the protons at the C-2 and C-4 positions (the
transformation from the crotonyl group to the aldehyde causes the C-2 proton to shift
further downfield than the C-4 proton), that we realised we actually had a trans-
tetrahydropyran! (Figure 2)
We decided at this time, for final clarification, to synthesise an oxazole-pyran fragment
which we knew to be cis, and elaborate that to a common intermediate with the hetero
Diels-Alder route from Gamer aldehyde, for comparison by NMR. We had previously
shown that oxazole aldehydes would participate in a hetero Diels-Alder reaction to give
cis-tetrahydropyrans. Thus we decided to synthesise the oxazole aldehyde (207). The
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Figure 2: NOE analysis of the oxazole aldehyde (193).
amide (203) was achieved under standard amide forming conditions, and converted
into the oxazoline (204) by a DAST mediated cyclisation. Using the conditions of
Williams the oxazole (205) was achieved in an excellent 94% yield. Conversion to the
aldehyde (207) was effected by a DmAL-H reduction to the alcohol (206), followed
by oxidation with manganese dioxide (Scheme 56).
The dihydropyran (208) was then obtained via a hetero Diels-Alder reaction between
the aldehyde (207) and the diene (118), in a modest 54% yield as a single
diastereomer. The dihydropyran (208) was shown to be cis by an NOE enhancement
of 13% between the C-2 and the C-6 protons. Desilylation with TBAF gave the ketone
in 84% yield, which was reduced stereoselectively with L-selectride® to give the axial
alcohol in 82% yield. Again, NOB data indicated the alcohol to be axial. Acetylation
under standard conditions finally gave the acetate (211) in quantitative yield (Scheme
57).
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By comparison of the IH NMR data of 187 and 211, we observed a significant
difference in chemical shifts, giving conclusive proof that 187 did indeed possess the
(Table 2).
incorrect stereochemistry for incorporation into the phorboxazole macrolide
IHCHEMICAL SHIFfIPPM
PROTON 211 187 ~
C-2 4.7 5.1 -0.4
C-4 5.3 5.1 0.2
C-6 4.0 3.9 0.1
Table 2
We believe the explanation for this disappointing exo-selectivity comes from the bulky
nature of the BOC group of Gamer aldehyde, which prevents the diene approaching in
an endo manner, due to it's steric requirements. Thus, an exo-approach is favoured and
the trans-tetrahydropyran predominates (Figure 3).
OBn
TBDMSO~
: H
~! exo-approach
H~O
H~~
BOC
OBn
TBDMSO~
><. ~ ~..H endo-approach
o : 0
r~~
H
Figure 3
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2.1.7 Conclusions
Although the outcome of the hetero Diels-Alder reaction between the diene (118) and
the aldehyde (145) gave the undesired trans-product (150), there still remains much
synthetic scope for this approach. Deamination could provide a facile entry towards
trans-tetrahydropyrans of polypropionate origin. The possibility also exists for
epimerising the trans-product (212) to the more thermodynamically favoured cis-
product (213) if a one carbon shorter diene fragment was used, which could be
elaborated to an aldehyde terminus (Scheme 58).
OPG, OPG,
H
epimerisation
H
Scheme 58
Another approach would be to use the known oxazoline aldehyde (214).113 We
anticipate that this compound is not as sterically demanding as Garner aldehyde, and so
may participate in an endo-selective hetero Diels-Alder reaction to give the desired cis-
product. The oxazoline can be cleaved subsequently to the hydroxy amide, for
elaboration to the oxazole.
We have demonstrated the effective use of the hetero Diels-Alder reaction with oxazole
aldehydes to give cis-tetrahydropyrans, albeit with a racemic system. The facile entry to
the desired oxazole-pyran system through this route has since prompted us to examine
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the use of chiral Lewis acids with this system, giving rise to products with high levels
of enantiomeric excess (Scheme 59). This research is currently being investigated by
colleagues in Nottingham.
OR OR
H
~fo chiral Lewis acid N
OPG (1--0' OPGOPG
58 59 OPG 56
Scheme 59
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2.2 Synthetic Approaches Towards trans·Tetrahydropyrans
2.2.1 Retrosynthetic Analysis
During the course of our hetero Diels-Alder studies we decided that we would probably
require a more convergent strategy towards the oxazole bis-pyran unit (215). We
decided on the possibility of starting with the trans-pyran (217) and elaborating it
towards the oxazole through the cis-pyran. Ideally we would have liked to make use of
the hetero Diels-Alder chemistry we were currently developing for the cis-pyran. We
envisaged that the stereochemical outcome of any hetero Diels-Alder reaction may be
controlled by the existing chirality of the trans-tetrahydropyran aldehyde (217)
(Scheme 60).
OTBDMS OTBDMS
N!-o~
OTBDPS
H
OPG
OPG
215 216
Scheme 60
Alternatively, if problems were encountered in the stereoselective formation of the cis-
pyran (215), we could extend the pyran aldehyde (217) to the diene (219) and use
this as the diene in a hetero Diels-Alder reaction with (S)-glyceraldehyde acetonide
(90), which is known to participate in a hetero Diels-Alder reaction with dienes of this
type (Scheme 61).73b
70
OTBDMS OTBDMS
OPGOPG
Scheme 61
2.2.2 Intramolecular Michael Cyclisation - Literature
Precedent
We initially decided to try and elaborate the trans-tetrahydropyran (222). It was our
intention to investigate whether we could obtain cis- or trans-tetrahydropyrans
selectively by the intramolecular cyclisation of an alkoxy nucleophile onto a Michael
acceptor (Scheme 62).
.--~
................................
....
OPG
PGO , ...
220 C02Me
Scheme 62
Recently, two examples of this approach have appeared in the literature leading to 2,6-
disubstituted tetrahydropyrans.l14,115 However, neither have dealt with a system
incorporating a substituent at the 4-position of the tetrahydropyran. We were interested
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in determining whether the presence of this additional chiral centre would have any
effect on the Michael cyclisation, and whether it could help influence a trans-geometry.
Banwell et al have shown that double bond geometry may be the main control element
for the formation of tetrahydropyrans by this route. 114 Banwell's research group was
able to selectively synthesise both trans- (224) and cis-tetrahydropyrans (226) by
cyclisation onto a (E)-acrylate (223) or a (Z)-acrylate (225) respectively (Scheme
63). Under these conditions (NaH, THF, _78°C - RT), equilibration of the trans-
isomer (224) to the more thermodynamically stable cis-isomer (226) was not
achieved, indicating to us that this approach may well be viable for the synthesis of our
desired trans-tetrahydropyran.
223
225 226
Reagents: i, NaH, THF.
Scheme 63
However, in contrast to Banwell's results, Edmunds et al have shown that cyclisation
of an alkoxide on to an (E)-acrylate gives rise to a 1:1 mixture of cis:trans
tetrahydropyrans very rapidly.l15 This mixture can then be equilibrated to the more
thermodynamically stable cis-isomer (228) by prolonged exposure to the reaction
conditions at room temperature (Scheme 64). These contrasting results may simply be
due to the different substrates used for each study, so we decided to pursue our own
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approach towards forming the trans-tetrahydropyran bearing the extra functionality
required for incorporation to the phorboxazoles.
227
229
Reagents: i, NaH, THF, 93%.
Scheme 64
2.2.3 Intramolecular Michael Cyclisation - Synthetic Studies
We anticipated securing the desired Michael precursor, enantiomerically pure, by
employing two successive allylborations following the Brown protocol.Us Thus, 3-
buten-I-ol (120) was protected as the tert-butyldiphenylsilyl ether (230) and then
cleaved to the corresponding aldehyde (231) with ozone. The chiral allyl boron reagent
(238) was prepared according to the literature procedure described by Brown et al.ll6b
This reagent has been shown to give enantiomeric excesses significantly higher than
those reported with previously explored reagents. Hydroboration of (+)-2-carene (235)
with borane dimethylsulfide complex gave the crystalline bis(2-isocaranyl)borane
(236), which was readily methanolysed. Treatment of the methoxy derivative (237)
with allylmagnesiun bromide then led to the desired reagent (238) in good yield.
Addition of a solution of 3-(tert-butyl-diphenyl-silanyloxy)-propionaldehyde (231) to
the chiral allylborane (238) gave, after oxidative workup, a 70% yield of the
homoallylic alcohol (232). The enantiomeric excess of the alcohol (232) was
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determined to be 93% by Mosher's estert!? analysis and comparison with a racemic
sample. Protection of the alcohol (232) as the triethylsilyl ether (233) was
accomplished with triethylsilyl chloride, triethylamine and catalytic DMAP in
quantitative yield. Ozonolysis and reductive work up of the olefin (233) was achieved
in 85% yield to give the aldehyde (234) (Scheme 65).
HO~
120
i.ii
iii
235
[
236 L=H
iv
237 L=OMe
v [ 238 L = CH2CH=CH2
OTES H
TBDPSO~O
234
viii
o
TBDPSO~H
231
OH,
TBDPSO~
232!vii
OTES,
TBDPSO~
233
Reagents: i, TBDPS-CI, Et3N, DMAP (cat.), CHzClz, 86%; ii, a) 03, CHzClz; b)
PPh3, 91%; iii, BH3.DMS, THF; iv, MeOH, THF, 73% (2 steps); v, AllylMgBr, EtzO;
vi, a) 231, Et20; b) H202, NaOH, 70%; vii, TES-CI, Et3N, DMAP (cat.), CHzClz,
100%; viii, a) O:h NaHC03, CHzCI2; b) PPh3, 85%.
Scheme 65
Treatment of the aldehyde (234) with (+)-J3-allyldi-isopinocampheylborane in diethyl
ether, followed by oxidative work up and chromatography, gave the homoallylic
alcohol (239) as a single diastereomer in 72% yield. Protection of the alcohol (239) as
the tert-butyldimethylsilyl ether (240) was achieved in 80% yield, and subsequent
ozonolysis gave the corresponding aldehyde (241) in 89% yield. The aldehyde (241)
was then treated with carbomethoxymethylene triphenylphosphorane to give the
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unsaturated ester (242) in an excellent 95% yield as a single geometric isomer. A small
amount of the corresponding (Z)-olefin was also synthesised by employing Still's
modification of the Wittig reaction.s" Finally, selective deprotection of the triethylsilyl
ether in 242 was achieved in 81% yield (based on recovered starting material) with
trifluoroacetic acid in aqueous THF to give the desired Michael precursor (243). This
selective deprotection had to be monitored extensively by TLC to prevent cleavage of
the TBDMS ether, and often the reaction was stopped prior to completion in order to
prevent diol formation (Scheme 66).
OTES H
TBDPSO~O
234
OTES OH, ,
TBDPSO~
239
OTBDMS,
v OTES OTBDMS, ,
TBDPSO TBDPSO
242
Reagents: i, a) (+)-~-Allyl(lpc)2B, Et20; b) H202, NaOH, 70%; ii, TBDMS-OTf,
Et3N, CH2Ch, 80%; iii, a) 03, NaHC03, CH2CI2; b) PPh3, 89%; iv, Ph3PCHC02Me,
CH2Ch , 95%; v, TFA, THF, H20, 81%.
Scheme 66
The configuration of the new stereogenic centre of the alcohol (239) derived from the
allylboration reaction was confirmed as syn by analysis of the l3Cchemical shifts of the
derived acetonide (244), as described by Rychnovsky1l8 and Evans.U? Thus, the
homoallylic alcohol (239) was converted into the acetonide (244) in one pot by
treatment with PTSA in 2,2-dimethoxypropane in 76% yield. The 13Cchemical shifts
of the acetonide methyl groups in 244 are in accord with a chair conformation giving
rise to a large difference in chemical shift between axial and equatorial methyl groups
indicating the desired syn configuration. Acetonides from anti diols give rise to a twist
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boat conformation, placing the methyl groups in a similar chemical environment and
thus the l3C chemical shifts of the methyl groups would have similar values (Scheme
67, Figure 4).
OTES OH
i ,
; I
TBDPSO~
239
oXO
------;~~ "
TBDPSO~
244
Reagents: i, PTSA, 2,2-DMP, 76%.
Scheme 67
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Figure 4: BC chemical shifts of the acetonide (244) illustrating a syn configuration.
The syn arrangement was carefully chosen as we thought that if an anti arrangement
was used then one product of the Michael reaction would have a quasi-equatorial
arrangement of substituents. We believed the thermodynamic preference of having all
three substituents equatorial would be much favoured and predominate. By having a
syn arrangement this would force one substituent to be in an axial position in whichever
diastereomer is formed, thus lowering the difference in energy of the two cyclisation
products. Hopefully this approach would create a more favourable chance of obtaining
the cis- or trans-tetrahydropyran selectively. Furthermore, we deemed it necessary for
the substituent at the C-4 position to be at the alcohol oxidation state. We believed that
if this was to be converted into the exo methylene group, then it may undergo
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isomerisation into the ring, in conjugation with the unsaturated ester under the reaction
conditions. Also a ketone would not be suitable at this position as it may undergo a
retro-aldol transformation under the reaction conditions.
With the desired Michael precursors (243, 245, 246) in hand we attempted the
cyclisation to the tetrahydropyran (Scheme 68) under a variety of conditions, with the
main emphasis being on temperature and base, as summarised in table 3.
OR
T
OR, C02Me
247R=TBDMS
248R=H
OR,
TBDPSO
TBDPSO
243 E, R=TBDMS
245E,R=H
246 Z, R=TBDMS C02Me
TBDPSO 249 R=TBDMS
Scheme 68
Entry Precursor Conditions, i Yield cisttrans
1 243 NaH, THF, -7SoC-O°C 100% 1.4:1
2 243 NaH, THF, RT 70% 1:1
3 243 KtBuO, THF, -7SoC 90% 1.5:1
4 243 KtBuO, THF, RT 25% cis only
5 243 LiHMDS, THF, -7SoC 82% 8:1
6 245 NaH, THF, RT 50% cis only
7 246 NaH, THF, RT 90% 7:1
Table 3
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Our determination of the cis:trans ratios was based on integration of the proton signals
alpha to the ester. The protons alpha to the ester of the trans-pyran resonate further
downfield (2.76 - 2.53ppm) than those of the cis-pyran (2.53 - 2.32ppm) based on
literature comparison.l++ To verify that this was indeed the case, the product from entry
6 (248) was benzoylated in quantitative yield (Scheme 69) and NOE experiments
were performed on 250 which showed a strong enhancement of 5.5% between the
protons at the C-2 and C-6 positions of the pyran. No enhancement was observed
between the proton at C-4 and the protons at the C-2 and C-6 positions indicating the
benzoyl group is axially disposed (Figure 5).
OH
l
OBz,
TBDPSO TBDPSO
Reagents: i, Bz-CI, Et3N, DMAP (cat.), CH2CI2, 100%.
Scheme 69
TBDPSO
H
Figure 5: NOE irradiation studies of the pyran (250) indicating cis-substitution.
Under no circumstances could the desired trans-isomer (249) be obtained as the major
product. Itwas apparent that the substituent at the C-4 position of the pyran was having
some effect on the outcome of the cyclisation. When the diol (245) was cyclised a
stronger preference for the cis-isomer (248) resulted, indicating that in this case the cis-
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isomer is the thermodynamic product with the two largest groups at the C-2 and C-4
positions occupying equatorial orientations. These observations follow the results of
Banwell et al, 114 showing that the (Z)-olefin (246) gives the cis-isomer (247) with
good selectivity.
2.2.4 Allylation Approach
Disappointed by the low levels of selectivity in favour of the trans-pyran (249) from
the Michael cyc1isation, we turned our attention to an alternative method of forming the
desired trans-pyran by an allylation approach. We anticipated that we could make use of
the two chiral centres in the material that we had prepared previously for the Michael
addition study. We hoped that the stereochemical control of the allylation could be
realised by nucleophilic addition to a pyran oxonium ion (251) (Scheme 70). The
oxonium ion should preferentially accept nuc1eophiles from the <X (axial) face due to the
anomeric effect from the ring oxygen, giving rise to a trans-tetrahydropyran (252).
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Indeed, Kishi et al have shown the synthetic utility of this reaction by the synthesis of
a-C-glycopyranosides required for their synthetic studies towards palytoxin.120 Thus,
2,3,4,6-tetrabenzyl-<x-(p-nitrobenzoyl)glucopyranose (253) was reacted with allyl
trimethylsilane and boron trifluoride diethyl etherate in acetonitrile at room temperature
for three hours to give a 10:1 mixture of allylglycopyrans in 80% yield, in favour of the
trans-pyran (254) (Scheme 71). Several other research groups have also used this
strategy with success. Indeed both Nicolaou and Paterson have successfully used this
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strategy in their independent syntheses of the trans-tetrahydropyran present in
swinholide A.121
OBn
Bno~A ....OBn
PNBO .....~O~
253 OBn
OBn
_ __.;._~~~Bno:A·;OBn
~., ~O~
) 254 OBn
Reagents: i, AllyITMS, BF3.Et20, CH3CN, 80%.
Scheme 71
Thus, we were able to use the tris-silyl ether (240) derived from the allylboration
sequence as discussed previously. Exposure of 240 to trifluoroacetic acid in wet THF
resulted in a mixture of the alcohol (255) and the diol (256). Further exposure of the
alcohol (255) to trifluoroacetic acid gave the desired diol (256). The diol was then
treated with ozone to give, after reductive work up, the hemi-acetal (257) as a 3:1
OTES OTBS, ,
TBDPSO~
240
OH OR
---~~~ "TBDPSO~
.. [ 255 R=TBDMS
II
256 R=H
~ iii
OAe, OH,
iv
OAe
TBDPSO TBOPSO
Reagents: i, TFA, THF, H20, 57% (255),42% (256); u, TFA, THF, H20, 61%; iii,
a) 03, CHzClz; b) PPh3, 95%; iv, AczO, Et3N, DMAP (cat.), ca.ci, 86%.
Scheme 72
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mixture of anomers in 95% yield, which were taken through without separation.
Acetylation of the diol (257) then furnished the bis-acetate (258), the allylation
precursor (Scheme 72).
Treatment of the his-acetate (258) with allyltrimethylsilane, catalytic TMS-OTf and
boron trifluoride diethyl etherate at -78°C led, via kinetically controlled axial attack on
the oxonium ion (259), to the rapid and clean formation of the trans-substituted
tetrahydropyran (260) as a single diastereoisomer in an excellent 94% yield (Scheme
73). The use of the strong Lewis acid TMS-OTf as described by Hosomi et al allows
for the allylation to take place at low temperature, very quickly, and with enhanced
levels of stereoselectivity.I22 The low temperature must be maintained to prevent Lewis
acid mediated silyl ether cleavage, which was observed on allowing the solution to
warm up to O°C.
OAe, H
TBDPS~ L
O~OAe
~"I H 1OAe
259 Axial
1
OAe,
TBDPSO
Reagents: i, AllyITMS, BFJ.Et20, TMS-OTf, CH3CN, CH2CI2, 94%.
Scheme 73
The stereochemical outcome of the allylation was proven to be trans by the observation
of an NOE between the protons at the C-2 and C-4 positions of 260, indicating that
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these two protons are in axial positions. The absence of an NOE from the proton at the
C-6 position with either of the protons at the C-2 and C-4 positions, indicates that the
C-6 substituent is axially disposed and therefore a trans arrangement exists
(Figure 6).
OAe,
H OAe
TBDPSO
TBDPSO
Figure 6: NOE analysis of the trans-pyran (260).
2.2.5 Conclusion
Although we were unsuccessful in utilising a Michael cyclisation to form the trans-
tetrahydropyran, we have demonstrated the efficiency of cis-tetrahydropyran formation
by this approach. This general approach is currently being pursued by my colleague
Alleyn Plowright for the formation of the cis-tetrahydropyran (55) present within the
macrolide.
We have also described a highly efficient and stereoselective route towards the trans-
tetrahydropyran (260) which is suitably functionalised for further elaboration towards
the oxazole bis-pyran unit (215). This material could be used, as described earlier, in a
hetero Diels-Alder reaction to from the cis-pyran (Scheme 60), or just taken as a
model study showing the utility of the allylation protocol for the formation of trans-
tetrahydropyrans.
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2.3 Synthetic Studies Towards the Side Chain
2.3.1 Retrosynthetic Analysis
The side chain unit (40) of phorboxazole A provides a significant challenge to the
synthetic organic chemist. The vast array of functionality present in this unit leaves the
way open for many possible synthetic approaches. Disconnection of phorboxazole A
across the C-27-C-28 double bond (Scheme 3) gives the target fragment (40),
incorporating a 2,4-disubstituted oxazole, a hemi-acetal pyran, an (E,E)-1,3-diene unit
and a (E)-vinyl bromide terminus. The fragment also bears eight stereochemical'
elements in five stereogenic centres and three olefin units. At the outset of my project
we were unsure whether to include the oxazole unit, or omit it for inclusion at a later
stage. Proceeding without the oxazole gives us extra flexibility when we attempt
coupling protocols in assembling the various fragments. During our studies towards the
side chain (40) we have pursued several approaches including oxazole formation at an
early stage and a complementary approach to the side chain in the absence of the
oxazole.
Our general retrosynthetic analysis was focused towards implementing two successive
olefination reactions to introduce the (E,E)-1,3-diene unit in 40 in a highly selective
manner. Unravelling the hemi-acetal portion in 40 gives the polyol fragment (263)
containing three chiral centres. We gave ourselves the option of installing the oxazole as
a single unit by means of a nucleophilic displacement reaction or alternatively allowing
the oxazole to be built up in a stepwise manner via a hydroxy-amide. We anticipated
that a protected acetylene would serve as a suitable precursor to the vinyl bromide unit
in 40 at a late stage (Scheme 74).
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2.3.2 The Chiral Pool Approach
It was our first concern to establish the necessary methodology for the central hemi-
acetal pyran precursor (263) incorporating the majority of the chirality in the side
chain. We anticipated that we could produce the desired material from a chiral pool
sugar. Gray et al have shown that 2-deoxy sugars can be synthesised in a short
sequence of steps from their parent sugars,123 The utility of this route has been
demonstrated by White et al in their synthesis of constanolactone from the sugar
arabi nose ,124 The configuration required for incorporation to the side chain of
phorboxazole A necessitates the use of (D)-xylose. (D)-Xylose (265) was converted
into the 2-deoxypentose dithioacetal (268) in a similar manner to that described by
White et al for arabinose,l24 although a few slight modifications were required as the
intermediate dithioacetal was not crystalline, and so isolation became slightly more
difficult.
Thus, (D)-xylose (265) was first converted to the dithioacetal which was next
protected as the bis-acetonide (266). Without purification the bis-acetonide (266) was
subjected to a base-promoted elimination to give the dithioketeneacetal (267) in an
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overall yield of 35% for three steps on a 50g scale. Hydroxyl directed reduction of 267
with lithium aluminium hydride gave the desired deoxy sugar derivative (268) in 90%
yield (Scheme 75).
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OH OH
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iv
266
l
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Reagents: i, EtSH, 6M HCI; ii, Me2CO, H2S04; iii, KtBuO, DMSO, THF, 35% (3
steps); iv, LiAIH4' THF, 90%.
Scheme 75
Installation of the third stereogenic centre in 263 to complete the fragment was the next
requirement. We believed that an allylation reaction would provide the desired anti-
geometry under substrate control, whilst also including a functional group for further
elaboration. Thus, protection of the alcohol (268) as the p-methoxybenzyl ether (269)
was achieved with p-methoxybenzyl bromide and potassium tert-butoxide in 98%
yield. Deprotection of the dithioketal with buffered mercury perchlorate gave the
aldehyde (270) in 91% yield. We were now in a position to investigate the conditions
required for the allylation. Treatment of the aldehyde (270) with allyltrlmethylstannane
and boron trifluoride diethyl etherate gave the alcohol (271) as an inseparable 3.5:1
ratio of diastereomers in an excellent 98% yield. We were slightly disappointed by the
low levels of stereoselectivity under the substrate controlled conditions and so we
turned our attention to a reagent controlled allylation. Treatment of the aldehyde (270)
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with (-)-~-allyl diisopinocampheylborane1l6a followed by oxidation with basic
hydrogen peroxide solution led to the homoallylic alcohol (271) in over 80% yield,
with an enhanced stereoselectivity of 8: 1. Subsequent methylation under standard
conditions gave the desired fragment (272) and facilitated isomer separation (Scheme
76).
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Reagents: i, KtBuO, PMB-Br, BU4NI,THF, 98%; ii, Hg(CI04)2, CaC03, THF, 91%;
iii, a) (-)-f3-AUyl(lpc)2B, Et20; b) H202, NaOH, 82%; iv, KtBuO, Mel, THF, 98%.
Scheme 76
The anti-configuration of the new stereogenic centre of the alcohol (271) derived from
the allylboration reaction was confirmed by analysis of the J3Cchemical shifts of the
derived acetonide, using the method of Rychnovsky118 and Bvans.U? Thus, the
alcohol (271) was converted to the acetonide (274) in two steps by hydrogenation of
the p-methoxybenzyl ether and olefin to give the diol (273) followed by acetonide
formation under standard conditions in an overall yield of 81%. The l3e chemical shifts
of the acetonide methyl groups are in accordance with a twist boat conformation giving
rise to very similar chemical shifts of the two methyl groups, indicating the desired anti
configuration (Scheme 77, Figure 7).
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Figure 7: l3C chemical shifts of the acetonide (274) indicating an anti-configuration.
2.3.3 Dithiane Approach for Oxazole Introduction
It was now our intention to convert the olefin (272) into the corresponding 1,3-dithiane
(276) for subsequent coupling to an oxazole. Although the coupling of 1,3-dithianes to
electrophiles have been exploited in the total syntheses of many natural products, the
general utility of this approach has been problematic. Metallation of a substituted
dithiane usually requires the use of a strong base, solvent additive and a myriad of time
and temperature regimes. However, in the course of synthetic studies towards
rapamycin by Smith et al they demonstrated the generality of the tert-butyl lithium
HMPA I THF protocol for the rapid metallation of highly functionalised 2-alkyl-l,3-
dithianes.U> We anticipated we could use these conditions within our own system.
Thus, dihydroxylation and oxidative cleavage of 272 proceeded uneventfully to give
the aldehyde (275) in excellent overall yield. However, formation of the dithiane (276)
proved to be very difficult. Under acidic conditions, the acetonide was cleaved giving
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rise to a mixture of products. Under milder conditions (ZnI2 (cat.), (TMS-
SCH2hCH2),126 we were able to obtain the dithiane (276) but only in poor ~ield
(Scheme 78).
PMBO OMe
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i, ii
PMBO OMe 0
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276
272
Reagents: i,OS04,NMO, Acetone, H20; ii, NaI04, Si02, CH2CI2,96% (2 steps); iii,
(TMS-SCH2)2CH2,ZnI2(cat.), Et20, 15%.
Scheme 78
We decided at this stage to adjust our protecting group strategy, prior to olefin
formation. Thus, the acetonide in 272 was cleaved with acidic methanol leading to the
diol (277) in 88% yield. The diol (277) was protected sequentially as a pivalate ester
on the primary hydroxyl and then as a tert-butyldimethylsilyl ether on the secondary
hydroxyl, both in good yield. Dihydroxylation and diol cleavage of 279 then gave the
aldehyde (280) in excellent yield. Dithiane (281) formationl26 from the aldehyde
(280) was then achieved in an acceptable 65% yield (Scheme 79).
An electrophilic oxazole unit was now required for the key alkylation step. Thus, the
oxazole alcohol (206) was protected as the tert-butyl diphenylsilyl ether (282)
followed by oxidative cleavage of the olefin to give the aldehyde (283). Sodium
borohydride reduction of the aldehyde (283) led to the alcohol (284), which was
subsequently converted to the bromide (285) in good overall yield (Scheme 80).
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Scheme 80
The key coupling step between the dithiane (281) and the bromide (285), using the
Smith protocol,125 proved to be exceptionally difficult, especially on a very small scale.
Each investigation led to many products and only on one occasion was the desired
product (286) obtained, albeit in a mixture of seven other compounds in less than 10%
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yield (Scheme 81). A major by-product observed was loss of the pivolate ester in
281. Employment of the corresponding oxazole mesylate as an alternative electrophile
also failed to give an increased yield of the desired product (286). Several other
research groups have also encountered the often capricious nature of highly oxygenated
dithiane anions,127 for this reason and the instability of both substrates under the
reaction conditions we decided not to pursue this approach. We believe the strongly
basic conditions may be responsible for oxazole decomposition, as we were unable to
recover any of the oxazole.
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Scheme 81
2.3.4 Olefination Protocol
Due to the difficulties experienced with installing the oxazole as a single unit via the
dithiane lithiation approach, we decided to omit the oxazole at this stage and concentrate
on elaborating the side chain (40) via the diene unit. We anticipated that we could make
use of the highly versatile olefin fragment (272) that we had synthesised earlier. A few
functional group manipulations would then allow us to investigate possible options for
the two successive olefination reactions that we planned to use. We believed that the
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trisubstituted olefin in 40 could be derived via a Wittig reaction with a stabilised ylid,
resulting in high selectivity in favour of the desired trans-isomer. The Julia olefination
seemed an attractive possibility for the construction of the second olefin unit giving rise
to the diene (40). The classical Julia reaction developed by Marc Julia et al,128 suffers
from the need for three separate steps to facilitate olefin formation, including reductive
removal of the arylsulfone moiety. Recently, Sylvestre Julia and co-workers reported a
new one-pot modification of the Julia reaction by employing a benzothiazole sulfone
moiety. 129 This variant had the great advantage that the intermediate hydroxy sulfones
were, in most cases, unstable and underwent a series of transformations resulting in the
expulsion of sulfur dioxide and the lithium derivative of 1,3-benzothiazol-2-one (291)
with concomitant formation of the desired olefin product in one step (Scheme 82).
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s. Julia et al studied this reaction in great detail with over 100 examples revealing some
important limitations to this method.129b,c They found that: 1) high stereoselectivities
were only obtained in certain cases, e.g. the formation of conjugated dienes; and 2)
some lithiated benzothiazolyl sulfones were unstable and underwent self condensation.
On further investigation of this approach Kocienski et al used this method with success
to form the (E,E)-diene unit in their studies towards the natural product herboxidienelw
(Scheme 83) and also to form the triene unit in the immunosuppressant rapamycinl-!
(Scheme 84).
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Scheme 83
In both cases the union of the complex fragments proceeded excellently, to give the
desired trans-geometry in good yield, with less than 5% of the undesired geometric
isomer. Kocienski and co-workers also attempted the formation of the central triene
olefin of rapamycin by this method,131 but found that the selectivity in this case was
very poor, indicating that the nature of this reaction is both substrate and base
dependant.
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Scheme 84
Furthermore, Kocienski et al have extended this approach in the search for. more
general conditions applicable to isolated olefin formation with good selectivity. 132 They
have shown that phenyltetrazolyl sulfones participate in the reaction with aldehydes to
give simple alkenes with good selectivity and high yield. Optimum conditions for this
approach make use of the bases sodium or potassium hexamethyldisilazide in the more
polar solvent dimethoxyethane. This work extends the scope of the Julia reaction and
should be applicable to a wide variety of substrates as a useful alternative method for
olefin construction.
Gratified by this successful literature precedent, we then embarked on our synthesis of
the precursors for the coupling of 305 to 312. We first had to address our protecting
group strategy and differentiate between the primary and secondary alcohol groups in
277. We also needed to transform the terminal olefin in 277 into a suitably protected
unit, as we did not want to risk a selective olefin cleavage at a later stage. We
anticipated that formation of a his-sHyl ether from the diol (277) would then allow for
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selective cleavage of the primary silyl ether, thus differentiating between the two
alcohols. For reasons of efficiency, we decided to cleave the olefin (298) to the
aldehyde (299), which could be protected as a dimethyl acetal, so as to maintain this
functionality at the aldehyde oxidation state.
Thus, protection of the diol (277) as the corresponding bis-tert-butyldimethyl silyl
ether (298) followed by oxidative cleavage of the terminal double bond gave rise to the
aldehyde (299). Treatment of the aldehyde (299) with camphorsulfonic acid in
methanol resulted in acetal formation and to our delight simultaneous deprotection of
the primary silyl ether leading to the alcohol (300) in a very appreciable 89% yield
(Scheme 85).
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Reagents: i, TBS-OTf, Et3N, CH2CI2, 98%; ii, OS04' NMO, Acetone, H20; iii, NaI04,
Si02, CH2Clz, 94% (2 steps); iv, CSA, MeOH, 89%.
Scheme 85
Oxidation of the alcohol (300) with Dess-Martin periodinane,90 buffered with 2,6-di-
tert-butylpyridine gave the aldehyde (301), without any epimerisation of the a-chiral
centre. When this oxidation was buffered with the less bulky base, 2,6-lutidine, we
observed up to 10% of the epimerised aldehyde (301). Wittig reaction between the
resulting aldehyde (301) and CH3C(PPh3)C02Et (302) then led exclusively to the (E)-
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unsaturated ester (303) in a very pleasing 91% yield. Finally, the desired (E)-a,~-
unsaturated aldehyde (305) was obtained by reduction of the ester (303) using
DIBAL-H and oxidation of the product alcohol (304) with Dess-Martin periodinane'f
in excellent overall yield (Scheme 86).
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Reagents: i, Dess-Martin periodinane, 2,6-di-tert-butylpyridine, CH2CI2, 93%; ii,
CH3C(PPh3)COzEt (302), CJi6, s. 91%; iii, DIBAL-H, ca.ci, 89%; iv, Dess-
Martin periodinane, 2,6-lutidine, CH2C12• 94%.
Scheme 86
The stereochemical outcome of the Wittig reaction between the aldehyde (301) and the
ylid (302) was determined as (E) by the observation of an NOB enhancement between
the methylene protons and the olefinic proton, indicating that they are both on the same
side and thus an (E) arrangement exists (Figure 8).
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Figure 8: NOE analysis of the allylic alcohol (304).
The synthesis of the sulfone partner was exacted by my colleague Alleyn Plowright and
again made use of chiral pool material as a source of the initial chirality. Thus, (D)-
malic acid (306) was first converted into the differentially protected triol (307) using
six straightforward steps in 43% overall yield. Deprotection of the PMB ether group in
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Reagents: i, DDQ, CH2Cl2, H20, 95%; ii, (COCI)2, DMSO, Et3N, CH2Ch, 90%; iii,
(MeO)2PCHN2, KtBuO, THF, 75%; iv, TBAF, THF, 96%; v, TMS-CI, nBuLi, THF,
70%; vi, 2-mercaptobenzothiazole, PPh3, DEAD, CH2C12,94%; vii, m-CPBA,
NaHC03, THF, 85%.
Scheme 87
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307 using DDQ,133 followed by oxidation of the resulting primary alcohol under
Swem conditions'f next led to the aldehyde (308) which was then converted into the
terminal acetylene (309) using Seyferth's reagent. 134The primary alcohol function in
309 was unmasked and the terminal acetylene residue was then protected as the
corresponding trimethylsilane derivative (310). Treatment of 310 with 2-
mercaptobenzothiazole under Mitsunobu conditions next gave the sulfide (311), which
on oxidation with m-CPBA finally gave the benzothiazole sulfone intermediate (312)
as a stable crystalline solid (Scheme 87).
With the required fragments now available, we were ready to attempt the key one-pot
Julia olefination step. Thus, deprotonation of the sulfone (312) using NaHMDS in
THF at -78°C in the presence of the (E)-unsaturated aldehyde (305) resulted in
stereoselective formation of the (E,E)-diene (313) in a satisfying 74% yield. The
stereochemical outcome of the olefination was determined by examination of the
olefinic coupling constants. We observed a coupling constant of 15.7Hz, across the
newly formed C-41-C-42 olefin, indicating the desired (E)-geometry, which compared
very favourably with phorboxazole A (JC-41-C-42 = 15.7Hz).10a Approximately 5% of the
undesired (Z,E)-isomer was also observed, but this could be readily removed by
chromatography (Scheme 88).
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Scheme 88
We were unable to deprotect the dimethyl acetal group in 313 under mild acidic
conditions (PPTS, CSA or Amberlyst). However we were able to effect this
transformation using the highly versatile reagent dimethylboron bromide,135 to give the
aldehyde (314) in an excellent 95% yield. Treatment of the aldehyde (314), under the
conditions described by Roskamp et al,136 with ethyl diazoacetate and catalytic tin(ll)
chloride next provided the ~-keto ester (315).Removal of the PMB protecting group in
315 using DDQ in wet dichloromethanelP resulted in spontaneous cyclisation of the
intermediate O-hydroxy ketone producing a single diastereomer of the cyclic hemi-acetal
(316) in 90% yield (Scheme 89). Protection of the hem i-acetal (316) as the mixed
methyl ketal (317) was achieved by exposure to a very mild acidic methanol solution.
This compound (317) represented the complete carbon backbone of the side chain
bearing an ester terminus, which is suitable for elaboration to the corresponding
oxazole.
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Scheme 89
The synthesis of the vinyl bromide (318) was then completed by my colleague Alleyn
Plowright, demonstrating the ability for vinyl bromide formation in the presence of a
vast array of functionality. Deprotection of the terminal trimethylsilyl acetylene unit in
317, followed by hydrostannylation and treatment of the intermediate vinylstannane
with NBS in acetonitrile at ODC gave the (E)-vinyl bromide (318), completing the
C-31-C-46 side chain fragment of phorboxazole A (4) (Scheme 90).137
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Scheme 90
2.3.5 Oxazole Inclusion
Unfortunately due to shortage of material, we were unable to elaborate the ester in 317
to the oxazole unit. Instead we decided to modify our strategy slightly, so as to install
the oxazole prior to the Wittig and Julia reactions. Throughout this approach we have
made extensive use of the methods discussed previously for the assembly of the entire
side-chain. Thus, from the aldehyde (275) we were able to elaborate the ~-keto ester
(319) in good yield using Roskamp's procedure. 136Attempts to increase this yield by
using Nomura's modification138 using zirconium tetrachloride instead of tin(ll)
chloride, failed to improve the yield, resulting in decomposition of the aldehyde,
possibly due to the necessity for a stoichiometric amount of Lewis acid. Treatment of
319 with DDQ then effected removal of the PMB group,l33 giving rise to the desired
hemi-acetal (320) simultaneously as a single diastereomer. One pot deprotection of the
acetonide and mixed methyl ketal formation was then achieved by exposure of the
hemi-acetal (320) to a solution of PPTS in methanol. On a small scale this provided
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good yields of the desired diol (321), however on a larger scale, with prolonged
exposure to acid, we observed up to 40% of a side-product which we have tentatively
assigned as the [6,5]-bicycle (322), the result of an intramolecular ketalisation
(Scheme 91).
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Scheme 91
Protection of the diol (321) as the bis-sHyl ether (323) and saponification of the ethyl
ester with aqueous lithium hydroxide furnished the precursor (324) for oxazole
formation. Amide formation was achieved in good yield, installing the hydroxy-amide
(325), which was cyclised to the oxazoline (326) in 80% yield with DAST.86 The
oxazole (327) was finally obtained using the conditions of Williams et al,IIO by
treatment of the oxazoline (326) with bromotrichloromethane and DBU (Scheme 92).
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Scheme 92
In order to follow our previous synthetic approach. we deemed it necessary to replace
the ester moiety in 327 with a suitably protected alcohol. Given the functionality
present in this fragment. and the reaction conditions that would have to be tolerated we
gave careful consideration to our protecting group strategy. We had previously shown
that a p-methoxybenzyl group would tolerate these reaction conditions, so we decided
to reduce the ester (327) and protect it as the PMB ether (329). Reduction to the
alcohol (328) was achieved in good yield. However we were unable to produce the
desired PMB ether (329).and only decomposition of the alcohol was observed
(Scheme 93).
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Scheme 93
Rather than pursue this troublesome protection we decided to maintain the ester
functionality and make use of the Wittig reagent CH3C(PPh3)CHO (262)~so avoiding
the subsequent reduction, oxidation steps to obtain the Julia precursor (332). Thus,
once again the primary silyl ether was cleaved in acidic methanol, and the resulting
alcohol (330) was oxidised with Dess-Martin periodinane'f to give the aldehyde
(331). We then attempted the Wittig reaction of the aldehyde (331) with the ylid
(262). The reaction seemed to progress quite cleanly, but on workup we were
dismayed to find that we had a very poor yield of the product (332), contaminated with
some starting material, it also appeared that there was up to 10% epimerisation product.
A difficult purification of this material gave an approximate yield of 25% of the
unsaturated aldehyde (332), containing some contaminants. We then subjected this
material to the Julia olefination conditions with the sulfone (312) and we were
delighted to isolate a 6: 1 ratio of isomers, which could be separated to give the desired
(E,E)-1,3-diene (333) in 59% yield, displaying spectral characteristics very similar to
that of phorboxazole A (4) (Scheme 94).
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Scheme 94
2.3.6 Conclusions
We have demonstrated the use of the recently developed one pot Julia olefination129 as
an extremely efficient method for the construction of highly oxygenated 1,3-dienes with
good stereo selectivity and yield. Making use of chiral pool materials we were able to
produce the desired Julia precursors in good overall yield. Furthermore, we have
shown that an oxazole unit will survive the Julia olefination conditions, and this is a
viable syn~etic approach if the oxazole is to be included. Although a very poor yield in
the penultimate Wittig step was observed, the approach did reduce the number of
additional steps to (333) by four. We anticipate that both of these approaches to the
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diene unit (40) will be important for final assembly of phorboxazole A from the three
units (40), (41) and (42).
2.4 Research Summary
The main emphasis throughout this period of research has been towards the efficient
construction of two subunits (40) and (42), resulting from the disconnection of
phorboxazole A (Scheme 3). We initially sought to apply hetero Diels-Alder
methodology to furnish the cis-tetrahydropyran present in the oxazole bis-pyran unit
(42). We were encouraged by our early studies with simple oxazole aldehydes to give
reasonable yields of oxazole cis-tetrahydropyrans and aimed to create a synthesis which
would provide this fragment as a single enantiomer. This approach relied on a chiral
oxazoline or oxazolidine aldehyde to provide the initial chirality, both ultimately derived
from the amino acid serine. We were able to utilise Gamer aldehyde (145) and obtain
hetero Diels-Alder cycloadducts in modest yield which were readily scaled up. The
initial cycloadduct was elaborated so that oxazole formation could be investigated.
Under the recently described conditions of Wipf,53 cyclodehydration of an intermediate
amido-aldehyde led to the desired 2,4-disubstituted oxazole pyran in a reasonable yield.
With this newly formed oxazole pyran we were able to demonstrate the synthetic utility
of a Wadsworth-Emmons type coupling to form the C-19-C-20 trans-olefin of the
macrolide in a very facile manner exhibiting high selectivity. We had been unable to
prove the relative stereochemistry of the tetrahydropyran, formed by the hetero Diels-
Alder reaction, until late in the synthetic sequence, and to our disappointment we
determined it to have a trans- relative geometry. We believe that this is as a result of a
large deviation in aldehyde substrate from our initial model studies. The use of the
bulky Garner aldehyde prevents the diene approaching in an endo manner, as we
postulated for the oxazole aldehyde, and thus the approach of the diene and the
aldehyde is exo, resulting in the undesired trans-tetrahydropyran.
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Studies were also undertaken to elaborate the trans-tetrahydropyran in 42, by
examining an intramolecular conjugate addition onto an unsaturated acrylate.
Unfortunately we were unable to achieve trans.cis ratios which were sufficiently high
enough to be synthetically useful, in most cases the more thermodynamically favoured
cis-isomer prevailed. We were able to overcome this disappointing selectivity by
utilising an alternative strategy. Using material that we had previously synthesised we
were able to furnish a pyran oxonium ion precursor (258), treatment of 258 with
Lewis acid and allyltrimethylsilane led to an excellent yield of a single diastereomer of a
trans-tetrahydropyran. This approach can provide a very useful intermediate towards
the synthesis of the bis-pyran unit (42) in reasonable quantities.
The C-27-C-46 side chain (40) provided yet another challenge en route to the vast
structure of phorboxazole A. We were able to provide large quantities of a three chiral
centred, pivotal intermediate (272), in a short sequence of steps from (D)-xylose. We
initially examined the use of lithiated dithiane chemistry for installation of the oxazole
unit, but found difficulties with this approach. We thus turned our attention to the
formation of the C-39-C-42 diene unit prior to oxazole formation. Elaboration of 272
to an orthogonally protected aldehyde set the platform for the initial Wittig reaction,
which provided a (E)-trisubstituted olefin in excellent yield and selectivity. This was
then elaborated to an aldehyde for the key olefination reaction. We chose to make use of
a modified Julia reaction for diene formation, and thus a benzothiazole sulphone was
prepared from malic acid to incorporate the C-43 stereogenic centre. The Julia
olefination between the aldehyde (305) and sulphone (312) gave the desired diene,
once again with good yield and selectivity. In a short number of steps we were able to
elaborate this through to the C-31-C-46 side chain unit, incorporating the vinyl bromide
and hemi-acetal pyran moiety.
In an attempt to make this strategy more convergent we sought to install the oxazole
unit prior to Julia olefination. We were able to take our pivotal intermediate (272) and
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extend this to include the oxazole unit in a stepwise manner. Subsequent functional
group manipulations were performed so that the olefination reactions could be
attempted. Wittig reaction proceeded in low yield but remained unoptimised. This
material was then subjected to the Julia olefination conditions and to our delight
provided a good yield of the desired diene, representing the entire C-27-C-46 side chain
unit. This work has demonstrated the scope of this Julia olefination reaction, and
shown that it will tolerate much functionality and can be used as an important tool in the
final assembly of the various subunits.
A concise synthesis of the side chain unit of phorboxazole A has been described. This
and the previously published synthesis of the central pyran core62 gives two of the key
fragments required for final assembly of phorboxazole A. Hopefully the research
carried out towards the final subunit, the oxazole bis-pyran (42), described in this
thesis will be valuable in future synthetic efforts towards this fragment, and allow for
the rapid construction of 42. Once all the various precursors are available it remains of
my colleagues to draw on the wealth of literature available to devise a strategy for the
successful coupling of these units and completion of a total synthesis of
phorboxazole A.
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3. EXPERIMENTAL
3.0 General Details
All melting points were determined on a Kofler hot-stage apparatus and are
uncorrected. Optical rotations were recorded in spectroscopic grade chloroform or
dichloromethane on a Jasco DIP-370 polarimeter, [a]D values are recorded in units of
10-1 deg em- g+. Ultraviolet spectra were recorded on a Philips PU 8700
spectrophotometer as solutions in spectroscopic grade ethanol, E values are recorded in
units of dm! mol-' cm+. Infrared spectra were obtained using a Perkin-Elmer 1600
series Ff-IR instrument or a Nicolet Magna 550 instrument either as liquid films or as
dilute solutions in spectroscopic grade chloroform. Proton nmr spectra were recorded
on either a Bruker WM 250 (250MHz), a Broker DPX 360 (360MHz), a Broker AM
400 (400MHz), a Bruker DRX 500 (500MHz), a Varian Unity 300 (300MHz), a
Varian Inova 400 (400MHz) or a Jeol EX 270 (270MHz) spectrometer as dilute
solutions in deuterochloroform, unless otherwise stated. The chemical shifts are quoted
in parts per million (ppm) relative to residual chloroform as internal standard (a 7.27)
and the multiplicity of each signal is designated by the following abbreviations: s,
singlet; d, doublet; t, triplet; q, quartet; quin., quintet; br, broad; m, multiplet; app.,
apparent; obs., obscured. All coupling constants are quoted in Hertz. Carbon-13 nmr
spectra were recorded on either a Bruker DPX 360 (at 90.6MHz), a Bruker DRX 500
(at 125.8MHz), a Varian Unity 300 (at 75.5MHz) or a Jeol EX-270 (at 67.8MHz)
instrument as dilute solutions in deuterochloroform, unless otherwise stated. Chemical
shifts are reported relative to internal chloroform standard (a 77.0) on a broad band
decoupled mode, and the multiplicities determined using a DEPT sequence. Where
required, H-H COSY, H-C COSY, NOESY and NOE spectra were recorded on a
Bruker DPX 360 (360MHz) or a Bruker DRX 500 (500MHz) instrument using
standard Bruker software with no modifications. Mass spectra were recorded on a VO
Autospec, a MM-701CF or a VG Micromass 7070E spectrometer using electron
ionisation (EI) or fast atom bombardment (FAB) techniques. Microanalytical data were
obtained on a Perkin-Elmer 240B elementalanalyser.
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Flash chromatography was performed on Merck silica gel 60 as the stationary phase
and the solvents employed were either of analytical grade or were distilled before use.
All reactions were monitored by tlc using Merck silica gel 60 F254precoated aluminium
backed plates which were visualised with ultraviolet light and then with either acidic
alcoholic vanillin solution, basic potassium permanganate solution, or acidic
anisaldehyde solution.
Routinely, dry organic solvents were stored under nitrogen and/or over sodium wire.
Other organic solvents were dried by distillation from the following: THF and benzene
(potassium benzophenone ketyl), dichloromethane (calcium hydride) and methanol
(magnesium methoxide). Other organic solvents and reagents. were purified by the
accepted literature procedures. Dess-Martin periodinane was prepared according to the
modified procedure of Ireland and Liu.139 All organic extracts were dried with
magnesium sulfate unless otherwise stated. Solvent was removed on a Buchi rotary
evaporator. Where necessary, reactions requiring anhydrous conditions were
performed in a flame or oven dried apparatus under a nitrogen or argon atmosphere as
stated.
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3.1 Hetero Diels-Alder Studies
Ethyl a-(ethoxyethylideneamino)acetate (109)79
A cooled suspension (O°C) of ethylacetimidate hydrochloride (SOg,0.41mol) in diethyl
ether (l00ml) was shaken for lOmin in a separating funnel with a cooled solution (O°C)
of potassium carbonate (69.7g, O.SOmol) in water (7Sml). The organic layer was
separated and shaken with a cooled solution (O°C) of glycine ethyl ester hydrochloride
(S6.Sg, 0.41mol) in water (7Sml) for lOmin. The organic layer was separated and
washed with water (3 x 7Sml) and brine (7Sml), dried and concentrated in vacuo to
give the imino ether (33.Sg, SO%) as a colourless oil, which was used immediately
without characterisation.
Ethyl 2-methyloxazole-4-carboxylate (111)79
The imino ether (109) (57g, 0.33mol) was added dropwise over 20min to a stirred
solution of potassium tert butoxide (40.4g, 0.36mol) in THF (2S0ml) at -20°C, under a
nitrogen atmosphere. Ethyl formate (21g, 0.36mol) was added dropwise over 20min
and the resulting mixture was stirred at -20°C for a further 1.5h. The solvent was
removed in vacuo to leave the crude enol ate salt as a yellow solid. Glacial acetic acid
(lOOml) was added to the enol ate salt and the mixture was then heated under reflux for
30min, until all the solid had dissolved. After cooling to room temperature the resulting
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solution was diluted with water (100mI) and neutralised with solid sodium carbonate.
The mixture was filtered and extracted with diethyl ether (3 x 250mI), the extracts were
then dried and concentrated in vacuo to leave a brown oil. Distillation gave the oxazole
as a pale yellow oil (28g, 55%); b.p. 118-120°C/13mmHg, which solidified on
standing; m.p. 24-25°C; Umax (film) 3160, 2980, 1740, 1500cm-1;OR (250MHz) 8.13
(s, 1H, Ox-H), 4.37 (q, J 7.1, 2H, CH2CH3), 2.51 (s, 3H, Ox-CH3), 1.37 (t, J 7.1,
3H, CH2CH3); Oc (67.8MHz) 162.2 (s), 161.1 (s), 143.6 (d), 133.3 (s), 61.0 (t),
14.1 (q), 13.7 (q).
(2-Methyl-oxazol-4-yl)-methanol (112)140
»s>o
A solution of di-isobutylaluminium hydride (107ml, 1.5M in toluene, 160mmol) was
added dropwise over 1h to a solution of ethyl 2-methyloxazole-4-carboxylate (111)
(lOg, 64mmol) in dichloromethane (200ml) at -78°C, under a nitrogen atmosphere.
Stirring was continued for 4h at -78°C and then the solution was allowed to warm to
room temperature and stirred for a further 12h. The mixture was quenched with
methanol and then stirred until the mixture solidified.Dichloromethane and magnesium
sulfate were added, which resulted in the formation of a granular precipitate. The
mixture was stirred for 1h, then filtered and the solid residue washed with
dichloromethane (400ml). The filtrate was concentrated in vacuo to leave a yellow solid
which was purified by chromatography on silica, eluting with ethyl acetate to give the
alcohol (6.28g, 86%) which crystallised as a yellow solid; m.p. 49-50°C (Et20lPet.),
[Lit. m.p. 40-41°C]l40; 'Umax (soln., CHCh) 3400, 1710, 1583, B02em-I; ~H
(250MHz) 7.49 (s, IH, Ox-H), 4.55 (s, 2H, CH20H), 3.80 (br s, IH, OH), 2.46 (s,
3H, Ox-CH3); Oc (67.8MHz) 162.7 (s), 140.6 (s), 135.3 (d), 56.4 (t), 14.2 (q).
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2-Methyl-oxazole-4-carbaldehyde (113)141
Activated manganese dioxide (l5.37g, 177mmol) was added in one portion to a
solution of the oxazole alcohol (112) (2.0g, 17.7mmol) in dichloromethane (400ml).
The solution was stirred at room temperature for 16h until all the starting material had
been consumed. The mixture was then filtered through Celite and the filtrate was
concentrated in vacuo to leave the aldehyde (1.67g, 85%) which crystallised as a white
solid; m.p. 75-76°C (Et20lHex.), [Lit. m.p. 71-73"C (Et20lHex.)]l41; umax (soln.,
CHCI3) 2843, 1701, 1591, 1564cm-1; BH (250MHz) 9.90 (s, 1H, CRO), 8.21 (s, 1H,
Ox-H), 2.52 (s, 3H, Ox-CH3); Be (67.8MHz) 183.6 (d), 162.9 (s), 144.7 (d), 140~8
(s). 13.7 (q).
2-(2'-Methyl-oxazol-4'-yl)-2,3-dihydro-pyran-4-one (115)
2-Methyl-oxazole-4-carbaldehyde (113) (1.60g, 14.4mmol) followed by zinc chloride
(1.96g, 14.4mmol) were added to a solution of trans-1-methoxy-3-trimethylsilyloxy-
l,3-butadiene (2.73g, 15.8mmol) in dry benzene (lOOml), under a nitrogen
atmosphere. The reaction was stirred at room temperature for 24h after which time a
saturated solution of sodium bicarbonate (50ml) was added. The organic phase was
separated and the aqueous layer was extracted with diethyl ether (4 x 75ml). The
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combined extracts were dried and the solvent was removed in vacuo to leave a brown
oil. Dichloromethane (40ml) and trifluoroacetic acid (3ml) were added to the crude
product and the mixture stirred for lOmin.A saturated solution of sodium bicarbonate
(20ml) was then added and stirring continued for a further lOmin. The organic layer
was separated and the aqueous phase was extracted with dichloromethane (3 x 50ml),
dried and concentrated in vacuo to leave a brown residue. The residue was purified by
chromatography on silica, eluting with 50% ethyl acetate in petroleum ether (b.p. 40-
60·C), to give the dihydropyrone (1.96g, 76%) which crystallised as a yellow solid;
m.p. 87"C (EtOAclPet); Umax (soln., CHCI3) 3683, 3619, 3028, 2976, 1674, 1594,
1522cm-1; OH (250MHz) 7.57 (s, IH, Ox-H), 7.38 (d, J 6.1, IH, H-6), 5.49 (dd, J
6.1, 0.9, IH, H-5), 5.42 (dd, J 13.1, 3.9, IH, H-2), 3.03 (dd, J 16.9, 13.1, IH, H-
3), 2.70 (ddd, J 16.9, 3.9, 1.1, IH, H-3), 2.48 (s, 3H, Ox-CH3); Oc (67.8MHz)
192.0 (s), 162.5 (d), 137.0 (s), 135.9 (d), 135.9 (s), 107.5 (d), 73.6 (d), 40.3 (t),
13.9 (q); m/z (EI) Found: 179.0592 (M+ C9H9N03 requires 179.0582); Found: C,
60.0; H, 4.9; N, 7.3%, C9H9N03 requires C, 60.4; H, 5.1; N, 7.8%.
3-Benzyloxy-but-1-ene (121)142
3-Buten-l-01 (10.0g, 139mmol) was added dropwise over 15min to a stirred
suspension of sodium hydride (6.1g, 60wt% in oil, 153mmol) (washed previously
with pentane) and tetrabutylammonium iodide (2.5g, 6.9mmol) in THF (5OOml)at O·C,
under a nitrogen atmosphere. The suspension was stirred at O°C for 30min and then
benzyl bromide (16.5ml, 139mmol) was added dropwise over 15min.The suspension
was allowed to warm to room temperature and stirred for 24h. The reaction was
quenched with water (3Oml)and the solvent removed in vacuo. An aqueous solution of
brine (300ml, 50%) was added to the residue which was then extracted with ethyl
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acetate (3 x 250ml), the combined extracts were then dried and concentrated in vacuo to
give the benzyl ether as a yellow oil (22.0g, 98%), which was used without further
purification; 'Umax (film) 3065, 2926, 2855, 1641, 1454, 1361, l lulcm+; OH
(360MHz) 7.37-7.27 (m, 5H, Ar), 5.92-5.81 (m, IH, CH2CH=CH2), 5.15-5.04 (m,
2H, CH=CH2), 4.54 (s, 2H, OCH2Ar), 3.54 (t, J 6.8, 2H, CH20Bn), 2.43 (tddd, J
6.8, 6.8, 1.4, 1.4, 2H, CH2CH=CH2); oe (90MHz) 138.4 (s), 135.2 (s), 128.3 (d),
127.6 (d), 127.5 (d), 116.3 (t), 72.8 (t), 69.5 (t), 34.2 (t); mlz (EI) Found: 162.1040
(M+ CllH140 requires 162.1045).
3-Benzyloxy-propionaldebyde (122)143
A stirred solution of 3-benzyloxy-but-l-ene (121) (21.0g, 130mmol) in
dichloromethane (400ml) at -78DC was treated with a flux of ozone until the solution
went pale blue (approximately 5h). Oxygen was bubbled through the solution for
lOmin until the solution decolourised and triphenylphosphine (34.0g, 130mmol) was
then added in one portion. The solution was allowed to warm up to room temperature
over Ih and then stirred for 12h.The solution was then concentrated in vacuo to leave a
solid residue which was filtered through a short pad of silica, eluting with 20% ethyl
acetate in petroleum ether (b.p. 4O-60DC). The residue was then distilled under reduced
pressure to give the aldehyde (l5.6g, 74%) as a pale yellow oil, b.p. 94-96DCllmmHg;
'Umax (film) 2862, 2731, 1724, 1096cm-1; ~H (360MHz) 9.78 (t, J 1.8, IH,
CH2CHO), 7.37-7.33 (m, 5H, Ar), 4.54 (s, 2H, OCHzAr), 3.81 (t, J 6.1, 2H,
CH20Bn), 2.68 (td, J 6.1, 1.8, 2H, CH2CHO); ~e (90MHz) 200.9 (s), 137.7 (s),
128.2 (d), 127.5 (2x d), 73.0 (t), 63.6 (t), 43.6 (t); mlz (EI) Found: 164.0834 (M+
CU,li1202 requires 164.0837).
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(E)-6-Benzyloxy-hex-3-en-2-one (123)144
I-Triphenylphosphoranylidene-2-propanone (0.87g, 2.74mmol) was added in one
portion to a stirred solution of 3-benzyloxy-propionaldehyde (122) (0.45g, 2.74mmol)
in dichlorornethane (lOrnl) under a nitrogen atmosphere. The solution was stirred at
room temperature for 22h and then concentrated in vacuo to leave a yellow residue.The
residue was purified by chromatography on silica, eluting with 10% ethyl acetate in
petroleum ether (b.p. 40-60·C) to give the ketone (0.53g, 95%) as a colourless oil;
Umax (film) 3030, 2859, 1695, 1674, 1099cm·1; OH (400MHz) 7.35-7.23 (m, 5H,
Ar), 6.80 (dt, J 16.0, 6.8, IH, HC=CHCH2), 6.11 (dt, J 16.0, 1.0, IH,
OCCH=CH), 4.51 (s, 2H, OCH2Ar), 3.58 (t, J 6.3, 2H, CH20Bn), 2.51 (tdd, J 6.4,
6.4, 1.0, 2H, CH=CHCH2), 2.22 (s, 3H, CH3CO); Be (67.8MHz) 198.4 (s), 144.8
(d), 137.9 (s), 132.5 (d), 128.3 (d), 127.6 (2x d), 72.9 (t), 68.1 (t), 32.7 (t), 26.7 (q);
m/z (EI) Found: 204.1160 (M+ C13H1602 requires 204.1150); Found: C, 75.8; H,
7.9%, C13H1602 requires C, 76.4; H, 7.9%.
(E)-6- (Benzy loxy)- 2-(tert- bu tyldimethyl-silany loxy )hexa-t ,3-diene
(118)83
Triethylamine (0.27ml, 1.91mmol) was added to a solution of (E)-6-benzyloxy-hex-3-
en-Z-one (123) (0.30g, 1.47mmol) in dichloromethane (lOml) at O·C, under a nitrogen
atmosphere. The solution was stirred for lOmin and then tert-butyldimethylsilyl triflate
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(0.50ml, 2.2mrnol) was added dropwise over lmin. The solution was allowed to warm
to room temperature and stirred for 2h. Water (20ml) was added and the biphasic
mixture was extracted with dichloromethane (3 x 20ml), the combined extracts were
then dried (Na2S04) and concentrated in vacuo. The resulting oil was purified by
filtration through a short plug of silica, eluting with petroleum ether (b.p. 40-60·C) to
give the diene (0.47g, 100%) as a yellow oil; 'Umax (film) 2955, 2856, 1593, 1319,
1254, 1027cm-1; OH (400MHz) 7.36 (m, 5H, Ar), 6.04 (m, IH, HC=CHCHz), 5.97
(d, J 15.3, IH, HC=CHCH2), 4.54 (s, 2H, OCH2Ar), 4.25 (d, J 5.9, 2H,
CH2COTBSCH), 3.56 (t, J 6.8, 2H, CH20Bn), 2.45 (td, J 6.8, 6.7, 2H,
CH=CHCH2), 1.00 (s, 9H, SiC(CH3)3), 0.20 (s, 6H, Si(CH3h); Oc (67.8MHz) 154.9
(s), 138.0 (s), 129.6 (d), 128.3 (d), 128.2 (d), 127.7 (d), 127.6 (d), 94.4 (t), 72.9 (t),
69.7 (t), 32.6 (t), 25.8 (q), 18.3 (s), -4.7 (q); m/z (FAB) Found: 317.1948 ([M-H]+
C1Jl290ZSi requires 317.1937).
(2R*, 6R *)-4' -[6-(2" -Beozyloxy-ethyl)-4-(tert-butyl-dimethyl-
silanyloxy)-3,6.dihydro.2H·pyran.2-yl).2'·methyl.oxazole (124)
OTBS
OBn
Boron trifluoride diethyl etherate (44J.LI,0.36mmol) was added dropwise to a solution
of the diene (118) (l05mg, 0.33mmol) and the aldehyde (113) (40mg, 0.36mmol) in
diethyl ether (5ml) at -78°C, under an argon atmosphere. The solution was stirred at
-78°C for lh and then allowed to warm to room temperature over a further lh.
Triethylamine (2 drops) and water (lOml) were then added and the biphasic mixture
was extracted with ethyl acetate (3 x 15ml), the combined extracts were then dried
(NaZS04) and concentrated in vacuo to leave a yellow oil. The oil was purified by
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chromatography on silica, eluting with 20% ethyl acetate in petroleum ether (b.p. 40-
60·C), to give the dihydropyran (85mg, 60%) as a colourless oil; Umax (soln., CHCI3)
2930,2856, 1670, 1579, 1362, 1096, 893cm-i; OH (360MHz) 7.46 (d, J 1.0, 1H, Ox-
H), 7.33-7.28 (m, 5H, Ar), 4.86 (t, J 1.6, 1H,H-5), 4.60 (ddd, J 11.0, 3.5, 1.0,
1H, H-2), 4.51 (s, 2H, OCH2Ar), 4.50-4.47 (m, IH, H-6), 3.70-3.58 (m, 2H,
CHzOBn), 2.49-2.43 (m, IH, H-3), 2.45 (s, 3H, OX-CH3)'2.22 (dt, J 16.4, 2.9, 1H,
H-3), 1.90 (dd, J 6.7,6.4, 2H, CH2CH20Bn), 0.92 (s, 9H, SiC(CH3)3), 0.15 (s, 3H,
SiCH3), 0.14 (s, 3H, SiCH3); Oc (90MHz) 161.6 (s), 148.3 (s), 141.2 (s), 138.5 (s),
134.6 (d), 128.3 (d), 127.6 (d), 127.4 (d), 106.1 (d), 72.9 (t), 72.1 (d), 69.7 (d),
66.8 (t), 36.4 (t), 34.8 (t), 25.6 (q), 17.9 (s), 13.9 (q), -4.3 (q), -4.7 (q); m/z (EI)
Found: 430.2408 ([MH]+ C24H36N04Si requires 430.2414).
(2R *, 6R*)-6-(2' '-Benzyloxy-ethyl)-2-(2' -methyl-oxazol-4'-yl)-
tetrahydro- pyran-4-one (125)
o
OBn
Tetrabutylammonium fluoride hydrate (84mg, 0.27mmol) was added in one portion to
a solution of the dihydropyran (124) (76mg, 0.18mmol) in THF (5ml) at room
temperature. The solution was stirred for 5min and then a saturated solution of
ammonium chloride (10ml) was added and the solvent was removed in vacuo. The
residue was extracted with ethyl acetate (3 x 15ml), the combined extracts were then
dried (Na2S04)and concentrated in vacuo to leave a yellow oil. The oil was purified by
chromatography on silica, eluting with 20% ethyl acetate in petroleum ether (b.p. 40-
60·C), to give the ketone (39mg, 70%) as a colourless oil; umax (soln., CHCI3) 2926,
2864, 1715, 1584, 1355, 1099cm-1;~H (360MHz) 7.48 (s, ia, OX-H), 7.36-7.26 (m,
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5H, Ar), 4.62 (dd, J 11.8, 2.8, IH, H-2), 4.50 (app. q, J 12.0, 2H, OCH2Ar), 4.00-
3.93 (m, IH, H-6), 3.68-3.55 (m, 2H, CH20Bn), 2.81 (dd, J 14.7, 11.8, IH, H-
3ax), 2.59 (d app. t, J 14.7, 2.4, IH, H-3eq), 2.51-2.36 (obs. m, 5H, H-5, Ox-CH3),
2.09-2.00 (m, IH, CHHCH20Bn), 1.92-1.83 (m, IH, CHHCH20Bn); Be (90MHz)
206.1 (s), 162.1 (s), 139.8 (s), 138.2 (s), 135.0 (s), 128.4 (d), 127.6 (2x d), 74.5
(d), 73.0 (t), 71.6 (d), 66.0 (t), 47.6 (d), 46.2 (t), 36.3 (t), 14.0 (q); m/z (EI) Found:
315.1477 (M+ ClsH21N04requires 315.1471).
(E)-3-Hydroxy-2-(3'-phenyl-acryloylamino)-propionic acid methyl ester
(131)145
Triethylamine (l2.8m1, 92.1mmol) was added to a suspension of dl-serine methyl ester
hydrochloride (4.80g, 30.7mmol) in THF (200ml) at O°C, under a nitrogen
atmosphere. The suspension was stirred for 15min and then cinnamic acid (4.09g,
27.6mmol) was added in one portion. After a further 5min, I-hydroxybenzotriazole
(5.20g, 38.4mmol) was added, followed by 1,3-dicyclohexylcarbodiimide (8.90g,
43.0mmol) and the resulting suspension was stirred for ISh while warming to room
temperature. The suspension was filtered, and the filtrate was concentrated in vacuo.
The residue was taken up in ethyl acetate (lOOml)and washed with a saturated solution
of sodium bicarbonate (3 x 50ml). The organic phase was dried and concentrated in
vacuo to leave a brown residue. The residue was purified by chromatography on silica,
eluting with 40% ethyl acetate in petroleum ether (b.p. 40-60°C), increasing to 100%
ethyl acetate, to give the hydroxy-amide (5.35g, 78%) as a waxy solid; m.p. 96-97°C
(Tol.IDCM), [Lit. m.p. 94-95°C (EtOAc)]142;umax (soln., CHCI3) 3421,2956, 1741,
1668, 1629, 1503, 1356cm-1; BH (400MHz) 7.62 (d, J 15.7, IH, PhCH=CH), 7.46-
7.43 (m, 2H, Ar), 7.34-7.29 (m, 3H, Ar), 7.09 (d, J 8.6, IH, NH), 6.53 (d, J 15.7,
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IH, PhCH=CH), 4.83-4.79 (m, IH, CHC02CH3), 4.05 (dd, J 11.3, 3.8, IH,
CHHOH), 3.97 (dd, J 11.3, 3.3, IH, CHHOH), 3.75 (s, 3H, C02CH3); oe
(67.8MHz) 171.2 (s), 166.7 (s), 141.9 (d), 134.4 (s), 129.8 (d), 128.7 (d), 127.9
(d), 119.9 (d), 62.7 (t), 55.0 (d), 52.6 (q); m/z (EI) Found: 249.1013 (M+ C13H1SN04
requires 249.1001); Found: C, 62.8; H, 6.1; N, 5.7%, Calc. for CJ3H1SN04: C, 62.6;
H, 6.1; N, 5.6%.
(E)-2-Styryl-4,S-dihyro-oxazole-4-carboxylic acid methyl ester (132)
Diethylaminosulfur trifluoride (0.35ml, 2.65mmol) was added dropwise to a solution
of the hydroxy amide (131) (600mg, 2.41mmol) in dichloromethane (l Oml) at -78°C,
under a nitrogen atmosphere. The solution was stirred at -78°C for 2h and then an
aqueous solution of ammonium hydroxide (lOml, 4M) and ice (lOg) were added. The
biphasic mixture was allowed to warm to room temperature and then extracted with
dichloromethane (3 x 30ml), the combined extracts were then dried (Na2S04) and
concentrated in vacuo to leave a brown oil. The oil was purified by chromatography on
silica, eluting with 40% ethyl acetate in petroleum ether (b.p. 40-60°C), to give the
oxazoline (480mg, 86%) as a colourless oil; Umax (soln., CHCh) 2955, 2910, 1731,
1650, 1632, 1608, 1366, 1071,992, 973cm-1; OH (360MHz) 7.48-7.45 (m, 2H, Ar),
7.41 (d, J 16.3, IH, PhCH=CH), 7.39-7.33 (m, 3H, Ar), 6.65 (d, J 16.3, IH,
PhCH=CH), 4.88 (dd, J 10.5, 7.9, IH, CRC02CH3), 4.60 (dd, J 8.7, 7.9, IH,
CHHO), 4.50 (dd, J 10.5, 8.7, IH, CHHO), 3.80 (s, 3H, C02CR3); Be (67.8 MHz)
171.4 (s), 165.9 (s), 141.3 (d), 134.7 (s), 129.7 (d), 128.7 (d), 127.5 (d), 114.1 (d),
69.0 (t), 68.2 (d), 52.6 (q); m/z: (EI) Found: 231.0895 (M+ CI3HJ3N03 requires
231.0895).
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(1R, E)-N - [2-(tert- Buty l-dlmethyl-silany loxy)-1- hydroxy methy l-ethy 1-
3'-phenyl-acrylamide (138)
4-Methylmorpholine (21.2ml, 193rnmol)was added to a solution of the amine (137)87
(1l.4g, 55.5mmol) in THF (3ooml) at O°C,under a nitrogen atmosphere. The solution
was stirred for 15min and then cinnamic acid (9.50g, 64.3mmol) was added in one
portion. After a further 5min, l-hydroxybenzotriazole (lO.9g, SO.4mmol)was added,
followed by 1,3-dicyclohexylcarbodiimide (1S.6g, 90.0mmol) and the resultant
suspension was stirred for ISh while warming to room temperature. The suspension
was filtered, and the filtrate was concentrated in vacuo, the residue was taken up in
ethyl acetate (250ml). The organic phase was washed with a saturated solution of
sodium bicarbonate (2 x 250ml), citric acid (2 x 200ml) and brine (2 x 200ml). The
organic phase was dried and concentrated in vacuo to leave a solid residue..The residue
was purified by chromatography on silica, eluting with 20% ethyl acetate in petroleum
ether (b.p. 40-60°C), increasing gradually to 100% ethyl acetate, to give the hydroxy-
amide (l4.0g, 75%) as a yellow oil; [a]o = -25.6 (c = 1.6, CHCh); umax (soln.,
CHCIl) 3626, 3430, 2930, 285S, 1666, 1626, 1074cm-1; BH (360MHz) 7.64 (d, J
15.7, IH, PhCH=CH), 7.52-7.49 (m, 2H, AT), 7.3S-7.34 (m, 3H, Ar), 6.44 (d, J
15.7, IH, PhCH=CH», 6.40 (br d, J 7.7, IH, NH), 4.14-4.10 (m, IH, NHCH) ,
3.94 (dd, J 11.2,4.2, IH, CHHOTBS), 3.91-3.83 (m, 2H, CH20H) , 3.74 (dd, J
11.2,4.5, IH, CHHOTBS), 0.92 (s, 9H, SiC(CH3)l), 0.10 (s, 3H, SiCHl), 0.09 (s,
3H, SiCH3); Be (90MHz) 166.2 (s), 141.5 (d), 134.7 (s), 129.7 (d), 128.S (d), 127.S
(d), 120.3 (d), 63.9 (t), 63.S (t), 52.0 (d), 25.S (q), IS.2 (s), -5.5 (q), -5.6 (q); mlz
(EI) Found: 260.1108 ([M-tBu-H20]+ C14HlSN02Sirequires 260.1107).
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(4R, E) -4- (Iert- Buty l-dlmethy l-sllany loxymethyl)- 2-styry 1-4,5-dihyro-
oxazole (139)
Diethylaminosulfur trifluoride (3.0ml, 22.5rnmol) was added dropwise over 20min to a
solution of the hydroxy-amide (138) (5.8g, 17.3mmol) in dichloromethane (l00ml) at
-78°C, under a nitrogen atmosphere. The solution was stirred at -78°C for 2h and then
an aqueous solution of ammonium hydroxide (1Oml, 4M) and ice (20g) were added.
The biphasic mixture was allowed to warm to room temperature and then extracted with
dichloromethane (3 x 70ml), the combined extracts were then dried (Na2S04) and
concentrated in vacuo to leave a brown oil. The oil was purified by chromatography on
silica, eluting with 40% ethyl acetate in petroleum ether (b.p. 40-60°C), to give the
oxazoline (4.2g, 77%) as a yellow oil; [a]D = +56.9 (c = 2.2, CHCI3); umax (soln.,
CHCI3) 2930,2858, 1653, 1608, 1352, 1099,987, 973cm-1; OH (360MHz) 7.49-7.46
(m, 2H, Ar), 7.38-7.32 (m, 4H, Ar, PhCH=CH), 6.62 (d, J 16.3, IH, PhCH=CH),
4.36-4.28 (m, 3H, CH20TBS, H-4), 3.87-3.83 (m, IH, H-5), 3.63-3.59 (m, IH, H-
5), 0.88 (s, 9H, SiC(CH3)3), 0.07 (s, 3H, SiCH3), 0.06 (s, 3H, SiCH3); oe (90MHz)
164.4 (s), 139.9 (d), 135.2 (s), 129.3 (d), 128.7 (d), 127.4 (d), 115.5 (d), 69.9 (t),
68.0 (d), 64.9 (t), 25.7 (q), 18.1 (s), -5.4 (2x q); m/z (EI) Found: 317.1812 (M+
C18H27N02Si requires 317.1811); Found: C, 68.1; H, 8.7; N, 4.3%, CISH27N02Si
requires C, 68.1; H, 8.6; N, 4.4%.
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(4S, E)-(2-Styryl-4,S-dihyro-oxazol-4-yl)-methanol (140)
Tetrabutylammonium fluoride hydrate (4.40g, 16.8mmol) was added in one portion to
a solution of the oxazoline (139) (4.10g, 12.9mmol) in THF (lOOml) at room
temperature. The solution was stirred for 10min, then the solvent was removed in
vacuo and the residue purifiedby chromatography on silica, eluting with ethyl acetate to
give the alcohol (2.3g, 88%) which crystallised as a white solid; m.p. 88-90·C
(Et20lPet.); [a]D = -42.5 (c = 2.3, CHCh); '\)max (soln., CHCh) 3592, 3207, 2906,
1658, 1608, 1365, 1103, 1070, 994, 973cm-1; BH (360MHz) 7.33-7.29 (m, 5H, Ar),
7.21 (d, J 16.3, IH, PhCH=CH), 6.52 (d, J 16.3, IH, PhCH=CH), 4.42-4.31 (m,
3H, CH20H, H-4), 3.97 (dd, J 11.9,2.5, 1H, H-5), 3.63 (dd, J 11.9, 3.2, IH, H-
5); oe (90MHz) 165.3 (s), 140.5 (d), 134.8 (s), 129.5 (d), 128.6 (d), 127.5 (d),
114.3 (d), 68.9 (t), 67.8 (d), 63.3 (t): m/z (EI) Found: 203.0957 (M+ CI2H13N02
requires 203.0946).
(2R)-2-tert-Butoxycarbonylamino-3-hydroxy-propionic acid methyl ester
(143) 146
Acetyl chloride (100ml, 1.40mol) was added dropwise over 30min to methanol
(400ml) at O°C, under a nitrogen atmosphere. The solution was stirred for lOmin
before d-serine (SO.Og,0.47mol) was added in one portion and the solution was slowly
heated to reflux. The mixturewas heated under reflux for a further 2h, then cooled and
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the solvent was removed in vacuo to give the crude ester hydrochloride (74.0g, 100%)
as a white solid which was used without further purification.
Serine methyl ester hydrochloride (60.0g, 0.39mol) was suspended in THF (900ml)
and triethylamine (116ml, O.83mol)was added. The resulting white suspension was
cooled to ODC and a solution of di-tert-butyl dicarbonate (84.2g, 0.39mol) in THF
(300ml) was added dropwise over 2h. The mixture was allowed to warm up to room
temperature and stirred overnight. The solvent was removed in vacuo, and the residue
partitioned between diethyl ether (900ml) and water (600ml). The aqueous phase was
extracted with diethyl ether (2 x 450ml) and the combined organic phases washed with
hydrochloric acid (500ml, 1M), sodium bicarbonate (500ml, 10% aq.) and brine
(500ml). The combined organic phases were dried and concentrated in vacuo to give
the carbamate (80g, 95%) as a colourless oil; [a.]D = +17.9 (c = 5.0, MeOH), [Lit.
+17.5 (c = 5.0, MeOH)]l43; 'Umax (film) 3400, 1700cm-1; OH (500MHz) 5.63 (d, J
7.7, IH, NH), 4.30 (br s, IH, CHNHBOC), 3.91-3.85 (m, IH, CHHOH), 3.82-
3.75 (m, IH, CHHOH), 3.71 (s, 3H, OCH3), 3.43 (br s, IH, OH), 1.39 (s, 9H,
C(CH3)3); oe (67.8MHz) 171.4 (s), 155.7 (s), 80.1 (s), 62.9 (t), 55.6 (d), 52.4 (q),
28.1 (q).
(4R)-2,2-Dimethyoxazolidine-3,4-dicarboxylic acid-3-tert-butyl ester-4-
methyl ester (144)85
Boron triflouride diethyl etherate (3.0ml, 24mmol) was added to a solution of the
carbamate (143) (80g, 0.37mol) in a mixture of acetone (900ml) and 2,2-
dimethoxypropane (360ml) at room temperature. The resulting solution was stirred at
room temperature for 3h until all the starting material had been consumed, as
124
determined by TLC. The solvent was removed in vacuo, the residual oil taken up in
dichloromethane (900ml) and washed with a saturated solution of sodium bicarbonate
(2 x 800ml, 50% aq.), then brine (800ml). The organic phase was then dried and
concentrated in vacuo to give the oxazolidine as a yellow oil, which was purified by
distillation (72.0g, 77%); b.p. 1l0DC/2mmHg, [lit. b.p. 101-102DCl2mmHg]8S; [a]o =
+52.5 (c = 1.5, CHCI3), [lit [a]o = +53.0 (c = 1.3, CHCI3)]85; Umax (film) 1759,
1709cm-1; 8H (400MHz, C6D6, T=346K) 4.40 (br s, IH, CHNBOC), 3.91-3.82 (m,
2H, CH20), 3.41 (s, 3H, OCH3), 1.77 (br s, 3H, CCH3), 1.52 (br s, 3H, CCH3),
1.41 (s, 9H, C(CH3)3); mlz (EI) Found: 244.1183 ([M-Me]+ ClIH1SNOs requires
244.1185).
(4R)-4-Formyl-2,2-dimethyoxazolidine-3-carboxylic acid teTt-butyl ester
(145)85
The ester (144) (28.5g, 0.11mol) was dissolved in anhydrous toluene (250ml) and the
solution cooled to -78DC before dropwise addition of a solution of di-
isobutylaluminium hydride (125ml, 1.5M in toluene, 0.18mol). Stirring was continued
at _78°C for 3h before slow addition of anhydrous methanol (30ml) and warming to
room temperature. The mixture was then poured into a solution of potassium sodium
tartrate (90g) in water (250ml) and the biphasic mixture stirred for 2h, the phases were
separated and the aqueous layer extracted with diethyl ether (2 x 400ml). The organic
layers were combined, dried and concentrated in vacuo to leave the aldehyde as a
yellow oil, which was purified by distillation (l8.8g, 75%), b.p. l00°C/lmmHg, [lit.
b.p. 101-102°C/2mmHg]85; [a]o = +83.0 (c = 1.3, CHCI3), [lit [a]o = +95.0 (c=1.3,
CHCI3)]85; umax (film) 2979,2717, 1739, 1709cm-i; ~H (400MHz, C~6, T = 346K)
9.42 (br s, IH, CHCHO), 4.05-3.95 (br m, IH, CHNBOC), 3.75 (dd, J 9.3, 3.5,
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1H, CHCHHO), 3.66 (dd, J 9.3, 7.2, 1H, CHCHHO), 1.61 (s, 3H, CCH3), 1.48 (s,
3H, CCH3), 1.40 (s, 9H, C(CH3)3)'
(2R, 6S, 4'R)-4' -t 6-(2" -Benzyloxy-ethyl)-4-(tert- butyl-dimethyl-
silanyloxy)-3,6-dihydro-2H -pyran-2-yl]-2',2' -dimethyl-oxazolidine-3'-
carboxylic acid tert-butyl ester (150)
OTBDMS
Zinc chloride (7.40g, 54.1mrnol) was added in one portion to a stirred solution of the
aldehyde (145) (12.4g, 54.1mrnol) in hexane (250ml) at room temperature, under a
nitrogen atmosphere. After 10min a solution of the diene (118) (11.5g, 36.1mmol) in
hexane (50ml) was added and stirring continued at room temperature for 5 days until
the diene was completely consumed, as determined by TLC. The solution was then
added to saturated sodium bicarbonate (300ml) and extracted with ethyl acetate (3 x
4OOrnl). The organic layers were combined, dried (Na2S04) and the solvent removed in
vacuo to leave a yellow oil, which was purified by chromatography eluting with 10%
ethyl acetate in petroleum ether (b.p. 40-60°C), to give the cycloadduct (13.0g, 65%)
as a colourless oil; [a]o = +23.8 (c = 2.0, CHCI3); Umax (film) 2931, 1701, 1087cm-l;
OR (500MHz, DMSO, T = 373K) 7.38-7.22 (m, 5H, Ar), 4.92 (dd, J 3.3, 2.0, IH,
H-5), 4.50 (s, 2H, OCH2Ar), 4.42-4.38 (m, lH, H-2), 4.17-4.13 (m, IH, H-6),
4.04-3.90 (m, 3H, H-4', H-51, 3.66-3.54 (m, 2H, CH20Bn), 2.23-2.14 (m, IH, H-
3), 1.90-l.74 (m, 3H, H-3, CH2CH20Bn), l.55 (s, 3H, CCH3), l.48 (s, 3H, CCH3),
l.46 (s, 9H, C02C(CH3)3), 0.95 (s, 9H, SiC(CH3)3), 0.16 (s, 6H, Si(CH3)2); m/z
(FAB) Found: 546.3218 ([M-H]+ C3oH48N06Si requires 546.3251); Found: C, 65.4;
H, 9.1; N, 2.6%, C30H4~06Si requires C, 65.8; H, 9.0; N, 2.6%.
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(2R, 6S, 4'R)-4'-[6-(2"-Benzyloxy-ethyl)-4-oxo-tetrahydro-pyran-2-
yl]-2',2' -dimethyl-oxazolidine-3' -carboxylic acid tert-butyl ester (152)
o
OBn
Tetrabutylammonium fluoride hydrate (4.46g, 17.1mmol)was added in one portion to
a solution of the dihydropyran (150) (8.50g, 15.5mmol) in THF (200ml) at O°C.The
solution was stirred for 20min and then a saturated solution of ammonium chloride
(200ml) was added and the solvent was removed in vacuo. The residue was extracted
with ethyl acetate (3 x 250ml), the combined extracts were then dried (NaZS04) and
concentrated in vacuo to leave a yellow oil. The oil was purified by chromatography on
silica, eluting with 20% ethyl acetate in petroleum ether (b.p. 40-60°C), to give the
ketone (6.30g, 94%) as a yellow oil; [a]D = +0.7 (c = 2.0, CHzClz);Umax (film) 2978,
1699,1392, 1366cm-1; OH(500MHz, CJ>6, T = 348K) 7.35-7.19 (m, 5H, Ar), 4.49-
4.46 (m, IH, H-2), 4.42-4.36 (m, 3H, H-6, OCHzAr), 4.12-4.06 (m, 2H, H-4', H-
5'), 3.82 (dd, J 9.7, 6.7, IH, H-5'), 3.54-3.42 (m, 2H, CHzOBn), 2.46-2.39 (m,
3H), 2.15 (dd, J 14.8, 4.1, IH), 1.92-1.75 (m, 2H, CHzCHzOBn), 1.51 (s, 3H,
CCH3), 1.49 (s, 3H, CCH3), 1.47 (s, 9H, C02C(CH3)3); Oe (125MHz, C6D6, T =
348K) 205.3 (s), 153.2 (s), 139.9 (s), 129.1 (d), 128.4 (d), 128.2 (d), 95.1 (s), 80.0
(s), 73.9 (t), 72.1 (d), 70.3 (d), 67.3 (t), 64.3 ro, 60.4 (d), 46.5 (t), 42.9 (t), 34.2 (t),
29.1 (q), 27.3 (q), 24.2 (q); m/: (FAB) Found: 434.2547 ([MH]+ C24H3~06 requires
434.2543).
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(2R, 4R, 6S, 4'R)-4'-[6-(2"-Benzyloxy-ethyl)-4-hydroxy-tetrahydro-
pyran-2-yl]-2',2' -dimethyl-oxazolidine-3' -carboxyllc acid tert- buty I
ester (153)
OBn
K-Selectride® (50ml, 1M in THF, 50mmol) was added dropwise over Ih to a solution
of the ketone (152) (18.0g, 41.5mmol) in THF (300ml) at -78"C, under a nitrogen
atmosphere. The solution was stirred for 2h and then quenched by dropwise addition of
methanol (50m1) and allowing to warm to room temperature, The solvent was removed
in vacuo and a saturated solution of ammonium chloride (looml) was added. The
residue was extracted with ethyl acetate (3 x 250ml), the combined extracts were then
dried and concentrated in vacuo to leave colourless oil which was purified by
chromatography on silica, eluting with 20% ethyl acetate in petroleum ether (b.p. 40-
60·C) increasing to 50% ethyl acetate in petroleum ether (b.p. 4O-60"C), to give the
alcohol (14.5g, 80%) as a colourless oil; [a]o = -13.1 (c = 2.5, CHCI3); umax (film)
3476 (br), 1695, 1375, 1256, 1172, 1102, 1055cm-1; OR (500MHz, T = 334K) major
rotamer 7.33-7.25 (m, 5H, Ar), 4.50 (d, J 6.6, 2H, OCHzAr), 4.32-3.88 (m, 6H, H-
2, H-4, H-6, H-4', H-5'), 3.59-3.44 (m, 2H, CHzOBn), 2.42-2.35 (m, IH), 1.98-
1.62 (m, 3H, CHzCHzOBn), 1.60 (s, 3H, CCH3), 1.52 (s, 3H, CCH3), 1.49 (s, 9H,
COZC(CH3)3); 0.96-0.84 (m, 2H); m/z (FAB) Found: 435.2603 (M+ CZ4H37N06
requires 435.2621).
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(2R, 4R, 65, 4'R)-4'-[ 4-Acetoxy-6-(2' '-benzyloxy-ethyl)-tetrahydro-
pyran-2-yl]-2',2' -dimethyl-oxazolidine-3' -carboxylic acid tert-butyl
ester (154)
OBn
Triethylamine (1.73mI, 12.4mmol) and 4-dimethylaminopyridine (lOmg, cat.) were
added successively to a solution of the alcohol (153) (2.7g, 6.2mmol) in
dichloromethane (lOamI) at O·C,under a nitrogen atmosphere. The solution was stirred
for 5min before dropwise addition of acetic anhydride (2.34ml, 24.8mmol). The
solution was stirred for Lfih at ODCbefore allowing the solution to warm to room
temperature and stirring for a further 1h. A saturated solution of ammonium chloride
(lOamI) was added, the organic layer was separated and the aqueous phase extracted
with dichloromethane (3 x 100ml). The combined organic layers were dried and the
solvent removed in vacuo. The residue was purified by filtration through a short
column of silica, eluting with 30% ethyl acetate in petroleum ether (b.p. 40-60·C), to
give the ester (2.96g, 100%) as a yellow oil; [a]D = -11.5 (c = 6.9, CHC13); umax
(film) 1737, 1698, 1366, 1241cm-1;BH (sOOMHz,T = 334K) major rotamer 7.33-7.25
(m, sa, Ar), 5.19 (br s, 1H, H-4), 4.50 (s, 2H, OCHzAr), 4.27-4.26 (m, 1H, H-2),
4.16-4.15 (m, IH, H-6) 4.10-3.95 (m, 2H, H-4', H-51, 3.90 (dd, J 9.6,6.4, IH, H-
5'), 3.56 (app. t, J 6.5, 2H, CH20Bn), 2.21 (br s, IH), 2.05-1.97 (m, 2H), 2.02 (s,
3H, OCOCH3), 1.83-1.70 (m, 4H, CHHCHzOBn, CCH3), 1.61-1.51 (m, 4H,
CHHCHzOBn, CCH3)' 1.49 (s, 9H, COZC(CH3)3); m/z (FAB) Found: 478.2811
([MH]+ CZ6H4oN07 requires 478.2805); Found: C, 65.0; H, 8.2; N, 2.4%,
CZ6H3~07 requires C, 65.4; H, 8.2; N, 2.9%.
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(2R, 4R, 6S, 1 'R)-Acetic acid-6-(2"-benzyloxy-ethyl)-2-(1 '-tert-
butoxycar bony lamlno- 2' -hyd roxy -ethy I)-tetrahydro- pyran-s- yl] ester
(155)
NHBOC
OSn
p-Toluenesulfonic acid monohydrate (2.23g, 11.7mrnol)was added to a solution of the
acetonide (154) (2.80g, 5.9mmol) in methanol (150ml) at room temperature. The
solution was stirred for 1.5h, then a saturated solution of sodium bicarbonate (50ml)
was added and the solvent removed in vacuo. The aqueous phase was extracted with
ethyl acetate (3 x 150ml), the combined extracts were then dried and concentrated in
vacuo to leave a yellow oil. The oil was purified by chromatography on silica eluting
with 50% ethyl acetate in petroleum ether (b.p. 40-60°C), to give the alcohol (2.0g,
78%) as a pale yellow oil; [a]n = -27.0 (c = 5.4, CHCI3);umax (film) 3440, 2980,
1713, 1499, 1240cm-1; BH (360MHz) 7.36-7.25 (m, 5H, Ar), 5.19 (br s, IH, NH),
5.15-5.11 (m, IH, H-4), 4.50 (d, J 2.2, 2H, OCH2Ar), 4.13-4.10 (m, IH, H-2),
4.07-4.03 (m, IH, H-6), 3.74-3.58 (m, 3H, CH20H, CHNH) , 3.52 (t, J 6.1, 2H,
CH20Bn), 3.17 (br s, IH, OH), 2.30-2.22 (m, IH), 2.04 (s, 3H, OCOCH3), 2.00-
1.94 (m, IH), 1.89-1.82 (m, IH), 1.69-1.58 (m, 3H), 1.43 (s, 9H, C(CH3)3); Be
(90MHz) 170.2 (s), 156.4 (s), 138.1 (s), 128.4 (d), 127.8 (d), 127.7 (d), 79.6 (s),
73.1 (t), 69.3 (d), 67.6 (t), 67.1 (d), 66.6 (d), 64.1 (t), 53.8 (d), 33.4 (t), 33.2 (t),
31.7 (t), 28.4 (q), 21.5 (q); m/z (EI) Found: 437.2407, (M+ C23H3sN07requires
437.2414).
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(2R, 4R, 6S, 1'R, E)-Acetic acid-6-(2"'-benzyloxy-ethyl)-2-(1 "-but-
2"-enoylamino-2'-hydroxy-ethyl)-tetrahydro-pyran-4-yl ester (185)
OBn
Trifluoroacetic acid (lOml, 120mmol) was added dropwise to a solution of the
carbamate (155) (1.20g, 2.74mmol) in dichloromethane (50ml) at O·C, under a
nitrogen atmosphere. The solution was stirred for 2h, then the solvent was removed in
vacuo. A saturated solution of sodium bicarbonate (50ml) was added to the residue and
the organics were extracted with ethyl acetate (3 x50ml), the combined extracts were
then dried (Na2S04) and concentrated in vacuo to leave the crude amine which was
used immediately without purification.
Triethylamine (1.54ml, 11.0mmol) was added in one portion to a solution of the crude
amine in THF (70ml) at O·C under a nitrogen atmosphere and stirred for 15min.
Crotonic acid (0.33g, 3.8mmol) was then added, followed by sequential addition of 1-
(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (0.74g, 3.8mmol) and 1-
hydroxybenzotriazole (0.46g, 3.4mmol). The solution was stirred at O·C for lh before
allowing to warm to room temperature and stirring for a further 14h. Saturated
ammonium chloride solution (30ml) was added and the solvent was removed in vacuo.
The residue was extracted with ethyl acetate (4 x 50ml), the combined extracts were
then dried (Na2S04) and concentrated in vacuo to leave a yellow residue. The residue
was purified by chromatography on silica, eluting with 50% ethyl acetate in petroleum
ether (b.p. 40-60·C), increasing to 100% ethyl acetate, to give the hydroxy-amide
(0.75g, 68%) as a colourless oil; [a]o = -28.4 (c = 2.2, CHCI3); umax (soln., CHCh)
3658, 3428, 1731, 1681cm-1; 8H (500MHz) 7.37-7.30 (m, 5H, Ar), 6.85 (dq, J 15.1,
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6.9, 1H, CH3CH=CH), 6.15 (d, J 8.1, 1H, NH), 5.81 (dq, J 15.1, 1.5, 1H,
CH=CHCO), 5.11 (tt, J 5.0,4.1, 1H, H-4), 4.50 (d, J 1.3, 2H, OCH2Ar), 4.20-4.16
(m, 1H, H-2), 4.07-4.02 (m, 2H, H-6, CHNH), 3.75-3.65 (m, 2H, CH20H), 3.59-
3.51 (m, 2H, CH20Bn), 3.46 (br s, 1H, OH), 2.28-2.21 (m, IH), 2.05 (s, 3H,
OCOCH 3), 1.98-1.92 (m, IH), 1.87-1.79 (m, 1H), 1.84 (dd, J 6.9, 1.5, 3H,
CH3CH=CH), 1.73-1.58 (m, 3H); Oe (90MHz) 170.0 (s), 166.4 (s), 140.3 (d), 138.0
(s), 128.2 (d), 127.7 (d), 127.5 (d), 124.6 (d), 72.8 (t), 68.6 (d), 67.2 (t), 66.9 (d),
66.5 (d), 63.2 (t), 52.4 (d), 33.4 (2x t), 31.5 (t), 21.2 (q), 17.5 (q); m/z (EI) Found:
(2R, 4R, 6S, 4'R, E)-Acetic acid-6-(2"-benzyloxy-ethyl)-2-(2'-
propenyl-4' ,5' -dihydro-oxazol-4' -ylj-tetrahydro-pyran-d-yl ester (186)
OBn
Diethylaminosulfur trifluoride (391-11,0.30mmol) was added dropwise to a solution of
the hydroxy-amide (185)(80mg, 0.20mmol) in dichloromethane (5ml) at -78°C, under
a nitrogen atmosphere. The solution was stirred at -78°C for 2h and then an aqueous
solution of ammonium hydroxide (4ml, 4M) and ice (lOg) were added. The biphasic
mixture was allowed to warm to room temperature and then extracted with
dichloromethane (3 x 15ml), the combined extracts were then dried (Na2S04) and
concentrated in vacuo to leave a yellow oil. The oil was purified by chromatography on
silica, eluting with 80% ethyl acetate in petroleum ether (b.p. 40-60°C), to give the
oxazoline (64mg, 80%) as a colourless oil; [a]D = -114.0 (c = 2.5, CHCI3); Umax
(film) 1735, 1677cm-1; OH (360MHz) 7.37-7.28 (m, 5H, Ar), 6.58 (dq, J 15.8, 6.9,
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1H, CH3CH=CH), 5.99 (dq, J 15.8, 1.6, 1H, Ox-CH=CH), 5.30-5.22 (m, 1H, H-
4),4.50 (d, J 3.1, 2H, OCH2Ar), 4.30-4.13 (m, 3H, CH20, CHN), 4.12-4.05 (m,
1H, H-6), 3.98 (dt, J 8.2, 4.0, IH, H-2), 3.54 (dd, J 7.5, 5.9, 2H, CH20Bn), 2.23-
2.13 (m, 1H), 2.05-1.98 (m, 1H), 2.04 (s, 3H, OCOCH3), 1.90-1.67 (m, 3H), 1.84
(dd, J 6.9, 1.6, 3H, CH3CH=CH), 1.62-1.55 (m, 1H); oe (90MHz) 170.3 (s), 163.9
(s), 139.4 (d), 138.4 (s), 128.3 (d), 127.6 (d), 127.5 (d), 119.0 (d), 73.0 (t), 69.2 (t),
68.6 (d), 68.0 (t), 67.7 (d), 67.4 (d), 67.3 (t), 33.9 (t), 33.7 (t), 30.8 (t), 21.4 (q),
18.3 (q); m/z (FAB) Found: 388.2120, ([MH]+ C22H30NOsrequires 388.2124).
(2R, 4R, 6S, E)-Acetic acid-6-(2"-benzy)oxy-ethyl)-2-(2'-propeny)-
oxazo)-4'-yl)-tetrahydro-pyran-4-y) ester (187)
)~)1 0 OBn
Dess-Martin periodinane (2.50g, 5.93mmol) was added in one portion to a solution of
the alcohol (185) (0.80g, 1.98mmol) in dichloromethane (50ml) at room temperature,
under a nitrogen atmosphere. The mixture was stirred for 3h and then diethyl ether
(200ml) was added. The resulting suspension was then poured into a saturated solution
of sodium thiosulfate and sodium bicarbonate (1: 1, 200ml) and stirred vigourously for
30min. The organic layer was separated and the aqueous phase was extracted with
diethyl ether (2 x 200rnl) and the combined organic layers were dried. The solvent was
removed in vacuo to leave a yellow waxy oil, which was used immediately without
purification.
Triphenylphosphine (2.60g, 9.88mmol), followed by 2,6-di-tert-butylpyridine
(4.40m1, 19.8mmol) and dibromotetrachloroethane (3.21g, 9.88mmol) were added to a
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solution of the crude aldehyde in dichloromethane (50ml) at O·C, under a nitrogen
atmosphere. The solution was stirred for 1h and then a solution of 1,8-
diazabicyclo[5.4.0]undec-7-ene (7.40ml, 49.4mmol) in acetonitrile (20ml) was added
and the residual solution stirred for a further 1h. The solution was concentrated in
vacuo to leave a dark residue which was purified by chromatography on silica, eluting
with 20% ethyl acetate in petroleum ether (b.p. 40-60·C) increasing to 40% ethyl
acetate in petroleum ether (b.p. 40-60·C), to give the oxazole (0.45g, 58%) as a yellow
oil; [a]D = -54.0 (c = 0.3, CHC13); Amax (EtOH) 205 (11200), 208 (10800), 251
(9400),258 (11200)nm; umax (film) 1798, 1242cm-1; BH (500MHz) 7.50 (s, 1H,Ox-
H), 7.41-7.26 (m, 5H, Ar), 6.70 (dq, J 15.9,6.9, 1H, CH3CH=CH), 6.27 (dq, J
15.9, 1.7, 1H, Ox-CH=CH), 5.11-5.05 (m, 2H, H-2, H-4), 4.50 (app. q, J 11.9,
2H, OCH2Ar), 3.91-3.86 (m, IH, H-6), 3.67-3.63 (m, 1H, CHHOBn), 3.59-3.55
(m, 1H, CHHOBn), 2.44-2.40 (m, 1H, H-3ax), 2.05 (s, 3H, OCOCH3), 2.00-1.96
(m, 1H), 1.95-1.86 (m, 2H), 1.91 (dd, J 6.9, 1.7, 3H, CH3CH=CH), 1.81-1.75 (m,
1H), 1.44 (ddd, J 12.2, 12.2, 10.6, 1H, H-5ax); Be (125MHz) 170.5 (s), 161.4 (s),
140.6 (s), 138.4 (s), 135.4 (d), 135.0 (d), 128.3 (d), 127.6 (d), 127.5 (d), 117.8 (d),
73.0 (t), 68.1 (d), 67.7 (d), 67.1 (d), 66.5 (t), 37.1 (t), 35.8 (t), 32.9 (t), 21.3 (q),
18.4 (q); m/z (EI) Found: 385.1882, (M+ C2zH27NOsrequires 385.1889).
(2R, 4R, 6S)-Acetic acid-6-(2"-benzyloxy-ethyl)-2-(2'-formyl-oxazol-
4'-yl)-tetrahydro-pyran-4-yl ester (193)
OSn
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4-Methylmorpholine N-oxide (0.37g, 2.7mmol), followed by osmium tetroxide
(20mg, cat.) were added to a solution of the oxazole (187) (0.35g, 0.9Immol) in
acetone (30ml) and water (3ml). The solution was stirred at room temperature for 12h
and then a saturated solution of sodium thiosulfate (20ml) was added. The solvent was
removed in vacuo and the residue was taken up in ethyl acetate (50ml) and the organic
phase separated. The aqueous phase was extracted with ethyl acetate (3 x 50ml) and the
combined organic layers were dried (Na2S04). The solvent was removed in vacuo to
leave a yellow oil, which was used immediately without purification.
An aqueous solution of sodium periodate (0.28g, 0.65M, 1.3mmol) was added
dropwise over 5min to a vigourously stirred suspension of silica (2g) in
dichloromethane (20m}). The crude diol in dichloromethane (Sml) was then added
dropwise over 2min and the suspension stirred for 30min. The suspension was filtered
and the silica was washed with dichloromethane (2 x 75ml). The solvent was removed
in vacuo to leave a yellow oil which was purified by chromatography on silica, eluting
with 40% ethyl acetate in petroleum ether (b.p. 40-60·C), to give the aldehyde (0.30g,
88%) as a yellow oil; [a.]D = -54.3 (c = 1.1, CHCh); umax (film) 2861, 1736, 1707cm-
1; BH (360MHz) 9.67 (d, J 0.7, IH, CHO), 7.87 (d, J 0.7, IH, Ox-H), 7.36-7.25 (m,
5H, Ar), 5.19 (br d, J 5.2, IH, H-2), 5.01 (m, IH, H-4), 4.49 (s, 2H, OCH2Ar),
3.92-3.85 (m, IH, H-6), 3.70-3.64 (m, IH, CHHOBn), 3.57-3.49 (m, IH,
CHHOBn), 2.53-2.47 (m, IH, H-3ax), 2.05 (s, 3H, OCOCH3), 2.04-1.75 (m,4H,
H-3eq, H-5eq, CH2CHzOBn), 1.46 (ddd, J 12.3, 12.3, 10.5, IH, H-5ax); Be
(90MHz) 177.0 (d), 170.1 (s), 157.8 (s), 143.3 (s), 139.6 (d), 138.0 (s), 128.2 (d),
127.5 (d), 127.4 (d), 72.8 (t), 67.7 (d), 67.1 (2x d), 65.9 (t), 36.8 (t), 35.4 (t), 32.6
(t), 21.0 (q); m/z (FAB) Found: 374.1609, ([MH]+ C:zoHuN06requires 374.1604).
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(2R, 4R, 6S)-Acetic acid-6-(2"-benzyloxy-ethyl)-2-(2'-hydroxymethyl-
oxazol-4'-yl)-tetrahydro-pyran-4-yl ester (194)
OAe,
OBn
Sodium borohydride (BBmg,2.3mmol) was added in one portion to a solution of the
aldehyde (193) (0.29g, 0.7Bmmol) in methanol (20ml) at O°C, under a nitrogen
atmosphere. The solution was stirred for lh atO'C and then a solution of saturated
ammonium chloride (20ml) was added and the solvent removed in vacuo. The mixture
was extracted with ethyl acetate (3 x 150ml), the combined extracts were then dried
(Na2S04) and concentrated in vacuo to leave a yellow oil. The oil was purified by
chromatography on silica, eluting with BO%ethyl acetate in petroleum ether (b.p. 40-
60°C), to give the alcohol (0.26g, 89%) as a yellow oil; [a]D = -54.3 (c = 1.1. CHC13);
umax (film) 340B, 1737, 1098cm-1; ~H (360MHz) 7.60 (d, J 1.4, IH, Ox-H), 7.36-
7.26 (m, 5H, Ar), 5.09 (br d, J 5.5, IH, H-2), 5.06-5.02 (m, IH, H-4), 4.64 (d, J
5.4, 2H, CH20H), 4.49 (s, 2H, OCH2Ar), 4.36 (t, J 5.9, IH, OH), 3.88-3.84 (m,
IH, H-6), 3.68-3.53 (m, 2H, CH20Bn), 2.42 (dt, J 13.0, 2.2, IH, H-3ax), 2.05 (s,
3H, OCOCH3), 2.00-1.78 (m, 4H, H-3eq, H-5eq, CH2CH20Bn), 1.44 (ddd, J 12.3,
12.3, 10.6, IH, H-5ax); ~c (90MHz) 170.4 (s), 163.7 (s), 139.7 (s), 138.2 (s), 136.2
(d), 128.2 (d), 127.4 (2x d), 72.8 (t), 67.8 (d), 67.5 (d), 67.0 (d), 66.2 (t), 56.9 (t),
36.9 (t), 35.5 (t), 32.7 (0, 21.1 (q); m/z (EI) Found: 375.1684, (M+ C20H2,N06
requires 375.1682).
136
(2R, 4R, 6S)-Acetic acid-6-(2"-benzyloxy-ethyl)-2-(2'-bromomethyl-
oxazol-4'-yl)-tetrahydro-pyran-4-yl ester (195)
OBn
A solution of triphenylphosphine (118mg, 0.4Smmol) in dichloromethane (3ml) was
added dropwise to a solution of the alcohol (194) (130mg, 0.3Smmol) and carbon
tetrabromide (172mg, 0.S2mmol) in dichloromethane (7ml) at ODC,under a nitrogen
atmosphere. The solution was stirred for ISh while allowing to warm to room
temperature and then the solvent was removed in. vacuo. The residue was purified by
chromatography on silica, eluting with 50% ethyl acetate in petroleum ether (b.p. 40-
60·C), to give the bromide (122mg, 80%) as a colourless oil; [a]D = -42.7 (c = 5.5,
CHCh); 'Umax (film) 1736, 1242, 1098cm-1; BH (500MHz) 7.62 (d, J 1.4, tH, Ox-H),
7.37-7.28 (m, 5H, Ar), S.12 (br d, J 5.6, lH, H-2), 5.06-S.02.(m, lH, H-4), 4.S1
(d, J 2.2, 2H, OCH2Ar), 4.38 (s, 2H, CH2Br), 3.89-3.85 (m, IH, H-6), 3.65-3.55
(m, 2H, CH20Bn), 2.43-2.40 (m, IH, H-5), 2.05 (s, 3H, OeOCH3), 2.01-1.78 (m,
4H), 1.45 (ddd, J 12.3, 12.3, 10.5, IH, H-5); Be (90MHz) 170.3 (s), 159.4 (s),
141.0 (s), 138.3 (s), 137.3 (d), 128.3 (d), 127.5 (2x d), 72.9 (t), 67.9 (d), 67.5 (d),
67.1 (d), 66.2 (t), 37.0 (t), 3S.6 (t), 32.7 (t), 21.1 (q), 20.1 (t); m/z (FAB) Found:
438.0898, ([MH]+ CwHzsNOsBr79 requires 438.0916).
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(2R, 4R, 6S)-Acetic acid-6-(2"-benzyloxy-ethyl)-2-(2'-(diethoxy-
phosphorylmethyl)-oxazol-4' -ylj-tetrahydro-pyran-a-yl ester (196)
OBn
Triethyl phosphite (0.40ml, 2.3mmol) was added to a solution of the bromide (195)
(1lOmg, 0.25mmol) in toluene (O.Sml)under a nitrogen atmosphere. The solution was
refluxed for 3.5h, then cooled and the solvent was removed in vacuo. The residue was
purified by chromatography on silica, eluting with ethyl acetate, to give the
phosphonate (llSmg, 95%) as a colourless oil; [a]o = -54.3 (c = 1.1, CHCh); 'Umax
(film) 1737, 1244, 1097, 1027, 971cm-1; BH (360MHz) 7.58 (t, J 1.3, IH, Ox-H),
7.36-7.26 (m, 5H, Ar), 5.09 (br d, J 5.4, IH, H-2), 5.06-5.02 (m, IH, H-4), 4.49
(s, 2H, OCHzAr), 4.17-4.09 (m, 4H, P(OCHzCH3)z), 3.90-3.S4 (m, IH, H-6), 3.66-
3.52 (m, 2H, CHzOBn), 3.34 (d, J p_H21.4,2H, Ox-CH2P), 2.43-2.39 (m, IH, H-
3ax), 2.04 (s, 3H, OCOCH3), 2.00-1.73 (m, 4H, H-3eq, H-5eq, CHzCHzOBn), 1.42
(ddd, J 12.3, 12.3, 10.6, IH, H-5ax), 1.31 (t, J 7.1, 6H, P(OCH2CH3h); Be
(90MHz) 170.4 (s), 156.5 (sd, Jrc 10.4), 140.5 (sd, Jrc 1.6), 138.3 (8), 136.7 (dd,
Je-c 2.1), 12S.4 (d), 128.3 (d), 127.6 (d), 73.0 (t), 68.0 (d), 67.6 (d), 67.2 (d), 66.4
(t), 62.S (td, Jp-e 3.7), 62.7 (td, Ir-e 3.8), 37.0 (t), 35.7 (t), 32.9 (t), 27.5 (td, Ir-e
140.5), 21.3 (q), 16.3 (2x q); mlz (FAB) Found: 496.2106, ([MH]+ Cz4H3,N08P
requires 496.2100).
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(2R, 4R, 6S)-Acetic acid-6-(2 II "-benzyloxy-ethyl)-2-{2 '-[ 4"-( 4"'-
methoxy-benzyloxy)-but-l "-enyl]-oxazol-4'-yl)-tetrahydro-pyran-4-yl
ester (201)
OBn
PMBO
Lithium chloride (0.8mg, 19J1mol)followed by 1,8-diazabicyclo[5.4.0]undec-7-ene
(2.4J11,16J1mol)were added to a solution of the phosphonate (196) (8mg, 16J1mol)in
acetonitrile (Iml) at room temperature, under a nitrogen atmosphere. The solution was
stirred for 10min before addition of the 3-(p-methoxybenzyloxy)-propionaldehyde
(3.2mg, 16J1mol)in acetonitrile (0.5ml) and stirring was continued for a further 2h.
The solvent was removed in vacuo, and the residue was purified by chromatography on
silica, eluting with 50% ethyl acetate in petroleum ether (b.p. 40-60°C), to give the
olefin (6mg, 70%) as a colourless oil; OH (500MHz) 7.51 (d, J 0.9, IH, Ox-H), 7.35-
7.26 (m, 7H, Ar), 6.89 (d, J 8.6, 2H, Ar), 6.71 (dt, J 16.1, 7.0, IH, CH2CR=CH),
6.33 (d, J 16.1, IH, Ox-CR=CH), 5.12-5.05 (m, 2H, H-2, H-4), 4.50 (d, J 3.2, 2H,
OCH2Ar), 4.47 (s, 2H, OCHzAr), 3.91-3.87 (m, IH, H-6), 3.81 (s, 3H, OCR3),
3.67-3.55 (m, 4H, CH20Bn, CH20PMB), 2.53 (app. qd, J 6.7, 1.0, 2H,
CH=CHCRz), 2.43 (dt, J 12.9, 2.2, IH, R-3ax), 2.05 (s, 3H, OCOCH3), 2.01-1.78
(m, 4H, H-3eq, H-5eq, CH2CHzOBn), 1.44 (ddd, J 12.2, 12.2, 10.7, IH, R-5ax); Oc
(125MHz) 170.5 (s), 161.2 (s), 159.2 (s), 140.7 (s), 138.4 (s), 136.5 (d), 135.2 (d),
130.2 (s), 129.3 (d). 128.4 (d), 127.7 (d), 127.5 (d), 118.1 (d), 113.8 (d), 73.1 (t),
72.7 (t), 68.5 (t), 68.2 (d), 67.7 (d), 67.1 (d), 66.5 (t), 55.3 (q), 37.1 (t), 35.8 (t),
33.2 (t), 32.9 (t), 21.3 (q); m/z (FAB) Found: 536.2646, ([MH]+ C31H3SN07requires
536.2648).
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(E)-2-But-2'-enoylamino-3-hydroxy-propionic acid methyl ester (203)
Triethylamine (7.2ml, S1.4mmol)was added to a suspension of dl-serine methyl ester
hydrochloride (2.0g, 12.9mmol) in THF (50ml) at O·C,under a nitrogen atmosphere.
The suspension was stirred for 15min and then crotonic acid (LOg, 11.6mmol) was
added in one portion. After a further 5min, I-hydroxybenzotriazole (2.2g, 16.1mmol)
was added, followed by 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide (3.5g,
18.0mmol) and the resultant suspension was stirred for 36h at room temperature.
Saturated ammonium chloride solution (20ml) was added and the solvent was removed
in vacuo. The residue was extracted with ethyl acetate (3 x 75ml), the combined
extracts were then dried and concentrated in vacuo to leave a yellow oil. The oil was
purified by chromatography on silica, eluting with ethyl acetate, to give the amide
(1.74g, 80%) as a colourless oil; '\)max (soln., CHCh) 3356 (br), 1741, 1672cm-l; BH
(360MHz) 6.97 (d, J 7.8, IH, NH), 6.81 (dq, J 15.7, 6.8, IH, CH=CHCH3), 5.92
(dq, J 15.7, 1.6, IH, COCH=CH), 4.67-4.63 (m, IH, CHC02CH3), 4.05 (brs, IH,
OH), 3.94 (dd, J 11.2, 3.3, IH, CHHOH) , 3.83 (dd, J 11.2, 2.9, IH, CHHOH),
3.72 (s, 3H, C02CH3), 1.80 (dd, J 6.8, 1.6, 3H, CH=CHCH3); Be (90MHz) 172.0
(s), 166.4 (s), 141.2 (d), 124.3 (d), 62.8 (t), 54.6 (d), 52.5 (q), 17.7 (q); m/z. (EI)
Found: 188.0932 ([MH]+ CBH14N04 requires 118.0923); Found: C, 51.0; H, 7.2; N,
7.5%, CBH13N04 requires C, 51.3; H, 7.0; N, 7.5%.
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(E)-2-Propenyl-4,5-dihyro-oxazole-4-carboxylic acid methyl ester (204)
Diethylaminosulfur trifluoride (1.70ml, 12.5mmol) was added dropwise to a solution
of the hydroxy-amide (203) (1.80g, 9.6mmol) in dichloromethane (40ml) at -78°C,
under a nitrogen atmosphere. The solution was stirred at -78°C for 2h and then an
aqueous solution of ammonium hydroxide (20ml, 4M) and ice (40g) were added. The
biphasic mixture was allowed to warm to room temperature and then extracted with .
dichloromethane (3 x 50ml), the combined extracts were then dried and concentrated in
vacuo to leave a brown oil. The oil was purified by chromatography on silica, eluting
with 80% ethyl acetate in petroleum ether (b.p. 40-60·C), to give the oxazoline (1.25g,
77%) as a yellow oil; umax (film) 2954, 2914, 1742, 1675, 1609, 1208cm-l; 5H
(360MHz) 6.68 (dq, J 15.8, 7.0, IH, CH=CHCH3), 6.03 (dq, J 15.8, 1.7, IH, Ox-
CH=CH), 4.81 (dd, J 10.5, 7.9, IH, CHC01CH3), 4.52 (dd, J 8.5, 7.9, IH,
CHHO), 4.45 (dd, J 10.5, 8.7, IH, CHHO), 3.79 (s, 3H, C02CH3), 1.88 (dd, J 7.0,
1.7, 3H, CH=CHCH3); 5c (67.8MHz) 171.5 (8), 165.3 (s), 140.8 (d), 118.2 (d),
68.8 (t), 68.0 (d), 52.5 (q), 18.3 (q); m/z (EI) Found: 169.0744 (M+ CsHUN03
requires 169.0739).
(E)-2-Propenyl-oxazole-4-carboxylic acid methyl ester (205)
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1,8-Diazabicyclo[5.4.0]undec-7-ene (l.2ml, 7.8mmol) was added in one portion to a
solution of the oxazoline (204) (l.lg, 6.5mmol) in dichloromethane (20ml) at O·C,
under a nitrogen atmosphere. Bromotrichloromethane (0.77ml, 7.8mmol) was then
added dropwise and the solution was stirred for 3h whilst allowing to warm to room
temperature. A solution of saturated ammonium chloride (30ml) was added and the
organics were extracted with dichloromethane (3 x 50ml), the combined extracts were
then dried and concentrated in vacuo to leave a yellow residue. The residue was
purified by chromatography on silica, eluting with 40% ethyl acetate in petroleum ether
(b.p. 40-60·C), to give the oxazole (1.02g, 94%) which crystallised as a white solid;
mp 42-44·C (Ben.lHex.); umax (soln., CHCI3)2992, 2953, 2849, 1730, 1668, 1580,
1322, 1117, 965cm-1; OH (360MHz) 8.09 (s, IH, H-5), 6.80 (dq, J 15.9, 6.9, IH,
CH=CHCH3), 6.28 (dq, J 15.9, 1.7, IH, Ox-CH=CH), 3.86 (s, 3H, C02CH]), 1.90
(dd, J 6.9, 1.7, 3H, CH=CHCH3); Oc (90MHz) 161.6 (s), 142.9 (s, d), 137.5 (d),
133.7 (8), 117.0 (d), 52.0 (q), 18.4 (q); m/z (EI) Found: 167.0586 (M+ CsHgN03
requires 167.0582); Found: C, 57.4; H, 5.4; N, 8.3%, CSHgN03 requires C, 57.5; H,
5.4; N, 8.4%.
(E)-(2-Propenyl-oxazol-4-yl)-methanol (206)
A solution of di-isobutylaluminium hydride (22.8ml, l.5M in toluene, 34.3mmol) was
added dropwise over 20min to a solution of the ester (205) (2.2g, 13.2mmol) in
toluene (80ml) and dichloromethane (10ml) at -78°C,under a nitrogen atmosphere. The
solution was stirred at -78·C for 2h and then at O°Cfor a further 2h, before careful
addition of methanol (50ml). The resultant suspension was then poured into a slurry of
ethyl acetate (300ml) and magnesium sulfate and stirred vigourously for 2h. The slurry
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was then filtered through a pad of Celite and washed with ethyl acetate (11) and
concentrated in vacuo to leave the alcohol (1.22g, 67%) which crystallised as a white
solid; m.p. 59-61°C (Hex.lEtzO); Umax (soln., CHeI3) 3262 (br), 2974, 2878, 1667,
1350cm-i; BH (360MHz) 7.44 (s, IH, H-5), 6.70 (dq, J 15.9, 6.9, IH,
CH=CHCH3), 6.24 (dq, J 15.9, 1.7, 1H, Ox-CH=CH), 5.11 (br s, 1H, OH), 4.53
(s, 2H, CHzOH), 1.89 (dd, J 6.9, 1.7, 3H, CH=CHCH3); Be (67.8MHz) 161.6 (s),
140.9 (s), 136.1 (d), 134.2 (d), 117.3 (d), 55.7 (t), 20.2 (q); m/z (EI) Found:
139.0635 (M+ C7HgN02 requires 139.0633); Found: C, 60.1; H, 6.6; N, 9.9%,
C7HgNOz requires e, 60.4; H, 6.5; N, 10.1%.
(E)-2-Propenyl-oxazole-4-carbaldehyde (207)
Activated manganese dioxide (1.82g, 21.0mmol) was added in one portion to a
solution of the oxazole alcohol (206) (O.3Sg,2.Smmol) in dichloromethane (40ml).
The solution was stirred at room temperature for 16h until all of the starting material
had been consumed. The mixture was then filtered through Celite and concentrated in
vacuo to leave the aldehyde (0.28g, 80%) which crystallised as a white solid; m.p.
82°e (Hex.lEt20); Umax (soln., CHeI3) 2762, 1698cm-1; BH (360MHz) 9.89 (s, IH,
CHO), 8.16 (s, 1H, H-5), 6.85 (dq, J 16.0, 6.9, IH, CH=CHCH3), 6.31 (dq, J 16.0,
1.8, IH, Ox-CH=CH), 1.94 (dd, J 6.9, 1.8, 3H, CH=CHCH3); Be (90MHz) 161.6
(s), 140.9 (s), 136.1 (d), 134.2 (d), 117.3 (d), 55.7 (t), 20.2 (q); m/z (EI) Found:
137.0471 (M+ C7H7N02 requires 137.0471); Found: C, 61.3; H, 5.2; N, 10.2%,
C7H7N02 requires C, 61.1; H, 5.2; N, 10.0%.
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(+/- )-(2R*, 6R*, E)-4 '-[6-(2' '-Benzyloxy-ethyl)-4-(tert-butyl-dimethyl-
silanyloxy )-3,6-dihydro-2 H -pyran-2-yl]-2' -propenyl-oxazole (208)
OTBS
)~)1 0 OBn
Boron trifluoride diethyl etherate (53J.LI,0.43mmol) was added dropwise to a solution
of the diene (118) (125mg, 0.39mmol) and the aldehyde (207) (59mg, 0.43mmol) in
diethyl ether (5ml) at -78°C, under an argon atmosphere. The solution was stirred at
-78°C for 2h and then a saturated solution of sodium bicarbonate (5ml) was added. The
biphasic mixture was extracted with ethyl acetate (3 x 15ml), the combined extracts
were then dried (Na2S04) and concentrated in vacuo to leave a colourless oil. The oil
was purified by chromatography on silica, eluting with 10% ethyl acetate in petroleum
ether (b.p. 40-60°C), to give the dihydropyran (97mg, 54%) as a colourless oil; OH
(360MHz) 7.45 (s, IH, Ox-H), 7.34-7.25 (m, 5H, Ar), 6.72 (dq, J 15.9, 6.9, IH,
CH=CHCH3), 6.31 (d br q, J 15.9, 1.6, IH, Ox-CH=CH), 4.86 (t, J 1.4, IH, H-5),
4.63 (ddd, J 10.8, 3.5, 0.9, IH, H-2), 4.51 (s, 2H, OCH2Ar), 4.51-4.49 (m, IH, H-
6), 3.71-3.59 (m, 2H, CH20Bn), 2.51-2.42 (m, IH, H-3), 2.27 (d app. t, J 16.5,
2.9, IH, H-3) 1.93-1.88 (m, 5H, CH=CHCH3, CHlCH20Bn), 0.93 (s, 9H,
SiC(CH3)3), 0.16 (s, 3H, SiCH3), 0.15 (s, 3H, SieH3). This compound was used
immediatelywithout further characterisation.
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(+/- )-(2R*, 6R*, E)-6-(2" -Benzy)oxy-ethyl)-2-(2' -propenyl-oxazol-a"-
ylj-tetrahydro-pyran-a-one (209)
o
OBn
Tetrabutylammonium fluoride hydrate (8Smg, 0.27mmol) was added in one portion to
a solution of the dihydropyran (208) (9Smg, 0.21mmol) in THF (Sml) at room
temperature. The solution was stirred for 5min and then a saturated solution of
ammonium chloride (Sml) was added and the solvent was removed in vacuo. The
residue was extracted with ethyl acetate (3 x l Sml), and the combined extracts were
then dried (NaZS04) and concentrated in vacuo to leave a yellow oil. The oil was
purified by chromatography on silica, eluting with SO%ethyl acetate in petroleum ether
(b.p. 40-60°C), to give the ketone (60mg, 84%) as a colourless oil; \)max (film) 171S,
166Scm-1; OH (360MHz) 7.47 (s, IH, Ox-H), 7.36-7.26 (m, 5H, Ar), 6.7S (dq, J
15.9, 6.9, IH, CH=CHCH3), 6.30 (dq, J 15.9, 1.6, IH, Ox-CH=CH), 4.64 (ddd, J
11.8, 2.8, 0.3, IH, H-2), 4.S0 (d, J 3.5, 2H, OCHzAr), 4.01-3.93 (m, IH, H-6),
3.69-3.55 (m, 2H, CH20Bn), 2.80 (ddd, J 14.7, 11.8,0.7, IH, H-3ax), 2.63 (ddd, J
14.7, 2.8, 1.9, IH, H-3eq), 2.51-2.37 (rn, 2H, H-5), 2.09-1.85 (m, 5H,
CH=CHCH3, CH2CH20Bn); Oc (90MHz) 206.1(s), 161.6 (s), 140.7 (s), 138.3 (s),
l35.8 (s), 134.2 (d), 128.4 (d), 127.6 (2x d), 117.7 (d), 74.S (d), 73.0 (t), 71.8 (d),
66.0 (t), 47.6 (t), 46.3 (t), 36.4 (t), 18.4 (q); m/z (EI) Found: 341.1634, (M+
C:wHz3N04requires341.1627).
14S
(+ /-)-(2R*, 4R*, 6R*, E)-6-(2"-Benzyloxy-ethyl)-2-(2'-propenyl-
oxazol-4'-yl)-tetrahydro-pyran-4-o1 (210)
OH
f
OBn
L-Selectride® (0.21ml, 1M in THF, 0.21mmol) was added dropwise to a solution of
the ketone (209) (50mg, 0.15mmol) in THF (4ml) at ...;78°C,under a nitrogen
atmosphere. The solution was stirred for 30min and then a saturated solution of
ammonium chloride (5ml) was added and the solvent was removed in vacuo. The
residue was extracted with ethyl acetate (3 x 15ml), the combined extracts were then
dried (Na2S04) and concentrated in vacuo to leave a solid residue. The residue was
purified by chromatography on silica, eluting with 70% ethyl acetate in petroleum ether
(b.p. 40-60°C), to give the alcohol (41mg, 82%) as a colourless oil; 'Umax (film) 3613,
3376 (br), 1665, 1093cm-1; ~H (360MHz) 7.40 (s, IH, Ox;..H), 7.34-7.26 (m, 5H,
Ar), 6.69 (dq, J 15.9, 6.9, IH, CH=CHCH3), 6.29 (dq, J 15.9, 1.6, IH, Ox-
CH=CH), 4.86 (dd, J 11.2, 2.6, IH, H-2), 4.51 (s, 2H, OCHzAr), 4.33 (br s, IH,
H-4), 4.16-4.11 (m, IH, H-6), 3.65-3.58 (m, 2H, CH20Bn), 2.00-1.71 (m, 8H),
1.60 (ddd, J 14.2, 11.6, 2.8, IH, H-5ax); ~c (90MHz) 161.2 (s), 142.7 (s), 138.5
(s), 135.1 (d), 133.9 (d), 128.3 (d), 127.6 (d), 127.4 (d), 117.9 (d), 72.8 (t), 69.4
(d), 67.3 (d), 66.8 (t), 64.2 (d), 38.3 (t), 37.7 (t), 36.2 (t), 18.4 (q); m/: (FAB)
Found: 344.1872, ([MH]+ CwHuN04requires 344.1862).
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(+1-)-(2R*, 4R*, 6R*, E)-Acetic acid-6-(2"-benzyloxy-ethyl)-2-(2'-
propenyl-oxazol-4 '-yl)-tetrahydro-pyran-4-yl ester (211)
OBn
Triethylamine (16J.lI,0.12mrnol) and 4-dimethylaminopyridine (1 crystal, cat.) were
added successively to a solution of the alcohol (210)(20mg, 58J.lmol)at O°C,under a
nitrogen atmosphere. The solution was stirred for 5min before addition of acetic
anhydride (22J.lI,0.23mrnol) dropwise. The solution was stirred for a further 30min at
O°Cand then pipetted onto a short column of silica and eluted with 50% ethyl acetate in
petroleum ether (b.p. 40-60°C) to give the ester (21mg, 100%) as a colourless oil; Umax
(film) 1731, 1372, 1078cm-1; BH (500MHz) 7.41 (s, IH, Ox-H), 7.34-7.26 (m, 5H,
Ar), 6.70 (dq, J 15.9, 6.9, lH, CH=CHCH3), 6.29 (dq, J 15.9, 1.6, IH, Ox-
CH=CH), 5.28 (t, J 2.8, IH, H-4), 4.75 (d, J 11.8, IH, H-2), 4.51 (s, 2H,
OCH2Ar), 4.04-4.00 (m, lH, H-6), 3.67-3.55 (m, 2H, CH20Bn), 2.11-2.08 (m,
IH), 2.10 (s, 3H, OCOCH3) 1.93 (dd, J 6.9, 1.6, 3H, CH=CHCH3), 1.91-1.75 (m,
4H), 1.62-1.58 (m, IH); Be (90MHz) 170.3 (8), 161.3 (s), 142.4 (s), 138.5 (8),
135.3 (d), 133.9 (d), 128.3 (d), 127.6 (d), 127.5 (d), 117.9 (d), 72.9 (t), 70.0 (d),
68.2 (d), 67.4 (d), 66.4 (t), 36.1 (t), 35.4 (t), 34.8 (t), 21.3 (q), 18.4 (q); m/z (EI)
Found: 385.1890, (M+ C22H27NOsrequires385.1889).
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3.2 Methodology Towards trans- Tetrahydropyrans
But-3-enyloxy-tert-butyl-diphenyl-silane (230)147
TBDPSO~
Triethylamine (l9.9ml, 142mmol) and 4-dimethylaminopyridine (0.80g, 7.1mmol)
were added successively in one portion to a solution of 3-buten-l-01 (5.10g,
71.1mmol) in dichloromethane (l50ml) at room temperature, under a nitrogen
atmosphere. The solution was stirred for 10min before dropwise addition of tert-
butyldiphenylsilyl chloride (14.1ml, 85.3rnrnol) over 15min. The solution was stirred
for 3h and then a saturated solution of ammonium chloride (150ml) was added. The
organic phase was separated and the aqueous layer extracted with dichloromethane (3 x
lOOm1).The organic extracts were combined, dried and concentrated in vacuo to leave a
yellow oil. The oil was purified by chromatography on silica, eluting with 10% ethyl
acetate in petroleum ether (b.p. 40-60°C), to give the silyl ether (19.0g, 86%) as a pale
yellow oil; \}max (film) 3070, 2930, 1427, 1111cm-1;SH (360MHz) 7.76-7.72 (m, 4H,
Ar), 7.50-7.41(m, 6H, Ar), 5.96-5.84 (m, 1H, CH=CHz), 5.15-5.05 (m, 2H,
CH=CHz), 3.78 (t, J 6.7, 2H, TBDPSOCHz), 2.41-2.35 (m, 2H, CHzCH=CHz),
1.12 (s, 9H, SiC(CH3)3); Sc (90MHz) 135.6 (d), 135.4 (d), 133.9 (s), 129.5 (d),
127.6 (d), 116.4 (t), 63.5 (t), 38.0 (t), 26.8 (q), 19.2 (s); m/z (EI) Found: 309.1672,
([M-H]+ CzoHzsOSi requires 309.1675); Found: C, 77.7; H, 8.6%, C2oHz60Si
requires C, 77.4; H, 8.4%.
3-(tert-Butyl-diphenyl-silanyloxy)-propionaldebyde (231)147
H
TBDPSO~O
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Ozone was bubbled through a solution of but-3-enyloxy-tert-butyl-diphenyl-silane
(230) (18.7g, 60mmol) in dichloromethane (500ml) at -78·C for 2h until the solution
turned blue. Oxygen was then allowed to bubble through for lOmin until the solution
went colourless. Triphenylphosphine (19.0g, 72.5mmol) was then added in one
portion and the solution was allowed to warm to room temperature over lh. The
solution was then stirred at room temperature for 12h and concentrated in vacuo to
leave a solid residue. The residue was adsorbed onto silica gel and purified by
chromatography on silica, eluting with 10% ethyl acetate in petroleum ether (b.p. 40-
60·C), to give the aldehyde (17.2g, 91%) as a colourless oil; umax (film) 2728,
1727cm-1; BH (360MHz) 9.85 (t, J 2.1, IH, CHO), 7.72-7.69 (m,4H, Ar), 7.47-7.40
(m, 6H, Ar), 4.06 (t, J 6.0, 2H, TBDPSOCH2), 2.64 (td, J 6.0,2.1, 2H, CH2CHO),
1.08 (s, 9H, SiC(CH3)3); Be (90MHz) 201.8 (d), 135.5 (d), 133.2 (s), 129.8 (d),
127.7 (d), 58.2 (t), 46.3 (t), 26.7 (q), 19.1 (s); m/z (EI) Found: 255.0840, ([M-tBu]+
C1,H1S02Si requires 255.0841); Found: C, 72.8; H, 7.9%, C,Jf2S02Si requires C,
73.0; H, 7.7%.
f3-Methoxy-bis-(2-isocarnyl)borane (237)116b
Following the literature procedure described by Brown et al. (+}-2-carene (25.0g,
183.3mmol) (235) was added dropwise over 15min to a stirred solution of borane-
methyl sulfide (8.6ml, 1O.OM, 86.0mmol) in THF (170ml) at -10·C, under a nitrogen
atmosphere. Following complete addition, stirring was discontinued and the flask
containing the reaction mixture was stored at O·C for 24h, after which time white
crystalline needles of bis-(2-isocaranyl)borane (236) had separated out. The
supernatant liquid was then decanted by double-ended needle, and the crystals were
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washed with cooled (O°C) anhydrous diethyl ether (2 x 1OOml), under a nitrogen
atmosphere. The solid was then dried in vacuo at room temperature. bis-(2-
Isocaranyl)borane (236) was then suspended in THF (25ml) and methanol (6.6ml)
was added dropwise over 20min, at O°Cwith stirring. After the evolution of hydrogen
had ceased (O°C, 4h), a clear solution had formed indicating complete methanolysis.
The solvent was removed in vacuo (15mm, Ih; 1mm, 2h) to obtain J3-methoxy-bis-(2-
isocamyl)borane (19.1g, 73%) as a colourless oil.
(3R)-1-(tert-Butyl-diphenyl-silanyloxy)-hex-S-en-3-o1 (232) 148
OH,
TBDPSO~
I3-Methoxy-bis-(2-isocarnyl)borane (237) (17.1g, 54mmol) was dissolved in
anhydrous diethyl ether (80ml) and cooled to -78°C, under an argon atmosphere.
Allylmagnesium bromide (51.8ml, 1.0M in Et20, 51.8romol) was added dropwise over
15min to this solution at -78°C and then warmed to room temperature and stirred for
lh. The suspension was then recooled to -78°C and the aldehyde (231) (17.0g,
54mmol) was added dropwise over 30min. The suspension was then stirred at -78°C
for 5h before addition of 3M sodium hydroxide (20ml) and hydrogen peroxide (40ml),
and the biphasic mixture was then refluxed for 10h. The mixture was cooled and the
organic layer was separated and washed with a saturated brine solution (lOOml), the
organic layer was dried (Na2S04), and concentrated in vacuo to leave a colourless oil.
The oil was then purified by chromatography on silica, eluting with 10% ethyl acetate
in petroleum ether (b.p. 40-60DC), to give the alcohol (13.7g, 70%) as a colourless oil;
[a]o = +4.4 (c = 1.5, CHCI3); 'Umax (film) 3477 (br) cm+; OH (360MHz) 7.71-7.68
(m, 4H, Ar), 7.48-7.39 (m, 6H, Ar), 5.92-5.81 (m, IH, CH=CH2), 5.15-5.10 (m,
2B, CH=CH2) 4.01-3.92 (m, IB, CHOH), 3.91-3.82 (m, 2H, TBDPSOCH2), 3.26
(d, J 2.4, IH, OH), 2.29-2.05 (m, 2H, CH2CH=CH2), 1.78-1.66 (m, 2H,
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TBDPSOCH2CH2), 1.07 (s, 9H, SiC(CH3h); Oe (90MHz) 135.5 (d), 134.9 (d),
133.0 (s), 129.8 (d), 127.8 (d), 117.4 (t), 70.9 (d), 63.3 (t), 41.9 (t), 37.8 (t), 26.8
(q), 19.0 (s); m/z (EI) Found: 297.1310, ([M-tBu]+ ClsH2102Sirequires 297.1311);
Found: C, 74.6; H, 8.6%, C22H3002Sirequires C, 74.5; H, 8.5%.
(4R)-6-(tert-Butyl-diphenyl-silanyloxy)-4-(triethyl-silanyloxy)-hex-l-
ene (233)
OTES,
TBDPSO~
Triethylamine (1.75ml, 8.94mmol) and 4-dimethylaminopyridine (50mg, 0.45mmol)
were added successively in one portion to a solution of the alcohol (232) (1.60g,
4.47mmol) in dichloromethane (50ml) at O°C, under a nitrogen atmosphere. The
solution was stirred for 10min before dropwise addition of triethylsilyl chloride
(0.93ml, 5.36mmol) over 2min. The solution was stirred for 2h before addition of a
saturated solution of ammonium chloride (50ml). The organic phase was separated and
the aqueous layer extracted with dichloromethane (2 x 50ml). The combined organic
extracts were then dried and concentrated in vacuo to leave a colourless oil. The oil was
purified by chromatography on silica, eluting with 5% ethyl acetate in petroleum ether
(b.p. 40-60°C), to give the silyl ether (1.83g, 88%) as a colourless oil; [a]o = -7.2 (c =
1.55, CHCI3); Umax (film) 3071, 2955, 2876, 1428, l l l Icm+; OH (360MHz) 7.70-
7.66 (m, 4H, Ar), 7.46-7.36 (m, 6H, Ar), 5.88-5.77 (m, IH, CH=CH2), 5.06-5.01
(m, 2H, CH=CH2), 3.98 (app.. tt, J 6.1, 5.8, IH, CHOTES), 3.80-3.68 (m, 2H,
TBDPSOCH2), 2.30-2.17 (m, 2H, CH2CH=CH1), 1.79-1.64 (m, 2H,
TBDPSOCH2CH2), 1.07 (s, 9H, SiC(CH3)3), 0.95 (t, J 7.7, 9H, Si(CH2CH3)3), 0.59
(q, J 7.7, 6H, Si(CH2CH3)3); oe (90MHz) 135.6 (d), 135.1 (d), 133.9 (s), 129.5 (d),
127.6 (d), 116.8 (t), 68.8 (d), 60.7 (t), 42.1 (t), 39.7 (t), 26.8 (q), 19.2 (s), 6.9 (q),
5.0 (t); m/z (EI) Found: 411.2181, ([M-tBu]+ CuH3s02Si2 requires 411.2176); Found:
C, 71.9; H, 9.5%, C28H4401Si2 requires C, 71.7; H, 9.5%.
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(3S)-5-(tert-Butyl-diphenyl-silanyloxy)-3-(triethyl-silanyloxy)-pentanal
(234)
OTES H
TBDPSO~O
Sodium bicarbonate (3.95g, 47.0mmol) was added in one portion to a solution of the
olefin (233) (l1.0g, 23.5mmol) in dichloromethane (170ml). The solution was cooled
to -78°C and ozone was bubbled through for 1h until the solution turned blue. Oxygen
was then bubbled through for 10min until the solution went colourless.
Triphenylphosphine (6.1g, 23.5mmol) was then added in one portion and the solution
was allowed to warm to room temperature over 1h, stirred at room temperature for 12h
and then a saturated solution of sodium bicarbonate (50ml) was added. The organic
layer was separated, and the aqueous layer was extracted with dichloromethane (2 x
75ml). The combined organic extracts were then dried (N~S04) and concentrated in
vacuo to leave a solid residue, which was adsorbed onto silica gel and purified by
chromatography on silica, eluting with 5% ethyl acetate in hexane, to give the aldehyde
(9.3g, 84%) as a colourless oil; [a.]D = -2.6 (c = 2.4, CH2CI2); umax (film) 2730,
173Ocm-1;~H (300MHz) 9.90 (t, J 2.2, 1H, CHO), 7.70-7.66 (m,4H, Ar), 7.45-7.36
(m, 6H, Ar), 4.40 (app. quin., J 5.9, 1H, CHOTES), 3.80-3.72 (m, 2H,
TBDPSOCH2), 2.58-2.48 (m, 2H, CH2CHO), 1.95-1.70 (m, 2H,
TBDPSOCH2CH2), 1.08 (s, 9H, SiC(CH3)3), 0.95 (t, J 8.1, 9H, Si(CH2CH3)3), 0.59
(q, J 8.1, 6H, Si(CH2CH3)3); ~c (75MHz) 201.7 (d), 135.5 (d), 133.6 (s), 129.6 (d),
127.6 (d), 65.5 (d), 60.3 (t), 51.0 (t), 40.5 (t), 26.9 (q), 19.1 (s), 6.7 (q), 5.0 (t); m/;
(FAB) Found: 471.2711. ([MH]+ C27H4303Si2requires 471.2750).
(4R, 6S)-8-(tert-Butyl-diphenyl-silanyloxy)-6-(triethyl-silanyloxy)-oct-
l-en-4-ol (239)
OTES OH, ,
TBDPSO~
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(+)-f3-Methoxydiisopinocampheylborane (6.12g, 19.4mmol) was dissolved in
anhydrous diethyl ether (200ml) and cooled to -78"C, under an argon atmosphere.
Allylmagnesium bromide (18.6ml, 1.0M in Et20, 18.6mmol) was then added dropwise
to this solution over lSmin at -78"C and then warmed to room temperature and stirred
for lh. The suspension was then recooled to -78"C and a solution of the aldehyde
(234) (9.10g, 19.4mmol) in diethyl ether (50ml) was added dropwise over 15mins.
The suspension was then stirred at -78"C for 3h and then allowed to warm up to room
temperature and stirred for a further 2h. The suspension was quenched with methanol
and a solution of 3M sodium hydroxide (20ml) and hydrogen peroxide (30ml) were
added and the biphasic mixture refluxed for 4h. The mixture was then cooled and the
organic layer was separated and washed with a saturated brine solution (lOOml), the
organic layer was then dried (Na1S04) and concentrated in vacuo to leave a colourless
oil. The oil was then purified by chromatography on silica, eluting with 5% ethyl
acetate in hexane, to give the alcohol (7.0g, 71%) as a colourless oil; [a]D = +14.1 (c =
0.9, CH1CI1); Umax (film) 3500 (br) cm+; aH (400MHz) 7.65-7.61 (m, 4H, Ar), 7.43-
7.33 (m, 6H, Ar), 5.86-5.75 (m, IH, CH=CH2), 5.10-5.05 (m, 2H, CH=CHz), 4.16-
4.10 (m, IH, CHOTES), 3.81-3.73 (m, IH, CHOH), 3.72-3.62 (m, 2H,
TBDPSOCHz), 3.28 (d, J 1.2, IH, OH), 2.17 (app. t, J 6.1, 2H, CH1CH=CH1),
1.92-1.78 (m, IH, CH1CHOH), 1.72-1.60 (m, 2H, TBDPSOCH1CH1, CH1CHOH),
1.50-1.40 (m, IH, TBDPSOCH1CH1), 1.03 (s, 9H, SiC(CH3)3), 0.93 (t, J 8.0, 9H,
Si(CH1CH3)3), 0.60 (q, J 8.0, 6H, Si(CH1CH3)3); ac (90MHz) 135.5 (d), 134.9 (d),
133.6 (s), 129.6 (d), 127.6 (d), 117.3 (t), 70.8 (d), 70.4 (d), 60.4 (t), 42.4 (t), 42.2
(t), 40.8 (t), 26.8 (q), 19.1 (s), 6.8 (q), 5.1 (t); m/z (FAB) Found: 513.3209, ([MH]+
C3oH4903Sil requires 513.3220); Found: C, 70.3~ H,9.5%, C~4803Sil requires C,
70.3; H, 9.4%.
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(4S, 6R)- [2'- (6-Allyl-2,2-dimethy 1-[1,3]-dioxan-4-y I)-ethoxy ]-tert-
butyl-dlphenyl-sllane (244)
p-Toluenesulfonic acid monohydrate (4mg, 20~mol) was added to a solution of the
alcohol (239) (108mg, 0.21mmol) in 2,2-dimethoxypropane (5ml) at O°C. under a
nitrogen atmosphere. The solution was stirred for lh and the solvent was then removed
in vacuo. The residue was purified by chromatographyon silica, eluting with 5% ethyl
acetate in hexane, to give the acetonide (70mg. 76%) as a pale yellow oil; [a]o = -1.2
(c = 2.7, CHCI3); umax (film) 3071, 2991. 2932, 2857, 1428, 1112cm-1; OH
(400MHz) 7.68-7.63 (m, 4H. Ar), 7.42-7.33 (m, 6H, Ar), 5.84-5.73 (m, IH,
CR=CHz), 5.09-5.02 (m, 2H, CH=CHz), 4.12-4.06 (m, IH, CRO), 3.88-3.79 (m,
2H, CHO, TBDPSOCHH). 3.71-3.65 (m, IH. TBDPSOCHH), 2.32-2.25 (m, IH.
CR2CH=CH2), 2.15-2.08 (m, IH, CHzCH=CH2), 1.70-1.63 (m, 2H,
TBDPSOCH2CHz), 1.47 (ddd, J 12.9, 2.4,2.4, IH, CHOCHHCHO), 1.42 (s, 3H.
CCH3), 1.37 (s, 3H. CCH3), 1.13 (ddd, J 12.7, 11.7, 11.7, IH, CHOCHHCHO),
1.03 (s, 9H, SiC(CH3)3); Oc (90MHz) 135.5 (d), 134.2 (d). 133.9 (s), 129.5 (d),
127.6 (d). 117.0 (t), 98.4 (s), 68.7 (d), 65.6 (d). 59.6 (t), 40.9 (t). 39.3 ro, 36.7 (t).
30.3 (q), 26.8 (q), 19.9 (s), 19.2 (q); mtz (FAB) Found: 439.2625. ([MH]+
CZ7H3903Sirequires 439.2668).
(4R, 6S)-4-(tert-Butyl-dimethyl-silanyloxy)-8-(tert-butyl-diphenyl-
silanyloxy)-6-(triethyl-silanyloxy)-oct.l-ene (240)
orss ores, ,
TBDPSO~
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Triethylamine (1.65ml, 11.7mmol) was added in one portion to a solution of the
alcohol (239) (2.00g, 3.20mmol) in dichloromethane (50ml) at O°C,under a nitrogen
atmosphere. The solution was stirred for 5min before tert-butyldimethylsilyl triflate
(1.17ml, 5.lOmmol) was added dropwise over lmin. The solution was strirred for a
further 90min at O°C,and then a saturated solution of ammonium chloride (50ml) was
added and the organic layer was separated. The aqueous fraction was then extracted
with dichloromethane (2 x lOOml),the combined organic layers were then dried and
concentrated in vacuo to leave a yellow oil. The oil was purified by chromatography on
silica eluting with 5% ethyl acetate in hexane, to give the silyl ether (1.94g, 79%) as a
colourless oil; [o.]D = -6.2 (c = 1.6, CH2C12);Umax (soln., CHCI3) 2953, 2858, 1462,
1389, 1362, 1206, 1066cm-1; OR (500MHz) 7.70-7.67 (m, 4H, Ar), 7.45-7.37 (m,
6H, Ar), 5.86-5.78 (m, IH, CH=CH2), 5.05-5.02 (m, 2H, CH=CH2), 3.99-3.94 (m,
IH, CHOTES), 3.89-3.81 (m, IH, CHOTBS), 3.78-3.70 (m, 2H, TBDPSOCH2),
2.32-2.27 (m, IH, CHHCH=CH2), 2.22-2.15 (m, IH, CHHCH=CH2), 1.82-1.70
(m, 2H, TBDPSOCH2CH2), 1.63 (app. t, J 6.3, 2H, CH2CHOTBS), 1.07 (s, 9H,
SiC(CH3)3), 0.93 (m, 9H, Si(CH2CH3)3), 0.90 (s, 9H, C(CH3)3), 0.61-0.54 (m, 6H,
Si(CH2CH3)3), 0.07 (s, 3H, SiCH3), 0.05 (s, 3H, SiCH3); Oc (125MHz) 135.5 (d),
135.0 (d), 133.9 (s), 129.5 (d), 127.6 (d), 116.9 ro, 69.1 (d), 66.8 (d), 60.9 (t), 44.9
(t), 41.9 (t), 40.2 (t), 26.9 (q), 25.9 (q), 19.1 (s), 18.0 (s), 6.8 (q), 5.1 (t), -4.3 (q),
-4.5 (q); m/z (EI) Found: 569.3318, ([M-tBu)+ C32H'303Shrequires 569.3303).
(3S, SS)-3-(tert-Butyl-dimethyl-silanyloxy )-7 -(tert· butyl-dipheny I·
silanyloxy).S.(triethyl·silanyloxy)·heptanal (241)
OTES OTBSO
TBDPSO~H
Sodium bicarbonate (0.52g, 6.2Ommol)was added in one portion to a solution of the
olefin (240) (1.94g, 3.IOmmol) in dichloromethane (50ml). The solution was cooled
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to -78°C and ozone was bubbled through for lh until the solution turned blue. Oxygen
was then bubbled through the solution for 10min until the solution went colourless.
Triphenylphosphine (0.89g, 3.41mmol) was then added in one portion and the solution
was allowed to warm to room temperature over lh, stirred at room temperature for 3h
and then filtered through a pad of celite. The solvent was removed in vacuo to leave a
solid residue which was purified by chromatography on silica, eluting with 5% ethyl
acetate in hexane, to give the aldehyde (1.70g, 89%) as a colourless oil; [a]o = +4.8 (c
= 1.2, CH2CI2); 'Umax (film) 2713, 1727cm-1; OH (360MHz) 9.82 (dd, J 2.9,2.0, 1H,
CHO), 7.71-7.68 (m, 4H, Ar), 7.47-7.35 (m, 6H, Ar), 4.39-4.35 (m, IH,
CHOTES), 4.01-3.96 (m, IH, CHOTBS), 3.75 (t, J 6.6, 2H, TBDPSOCH2), 2.65-
2.59 (m, lH, CHHCHO), 2.53-2.47 (m, IH, CHHCHO), 1.83-1.70 (m, 4H,
TBDPSOCH2CH2, CH2CHOTBS), 1.09 (s, 9H, SiC(CH3)3), 0.96 (t, J 8.0, 9H,
Si(CH2CH3)3), 0.89 (s, 9H, SiC(CH3)3), 0.59 (q, J 8.0, 6H, Si(CH2CH3)3), 0.09 (s,
6H, Si(CH3)2); Oc (l25MHz) 202.1 (d), 135.5 (d), 133.7 (s), 129.6 (d), 127.6 (d),
66.6 (d), 65.6 (d), 60.6 (t), 50.7 (t), 45.2 (t), 40.2 (t), 26.8 (q), 25.7 (q), 19.1 (s),
17.9 (s), 6.9 (q), 5.1 (t), -4.4 (q), -4.7 (q).
(SR, 7S, E)-S-(tert-Butyl-dimethyl-silanyloxy)-9-(tert-butyl-diphenyl-
silanyloxy)-,-(triethyl-silanyloxy)-non-2-enoic acid methyl ester (242)
TBDPSO
OTES OTBS, ,
Methyl (triphenylphosphoranylidene)acetate (0.96g, 2.86mmol) was added in one
portion to a stirred solution of the aldehyde (241) (1.50g, 2.39mmol) in
dichloromethane (30ml) at room temperature, under a nitrogen atmosphere. The
solution was stirred at room temperature for 64h and then concentrated in vacuo to
leave a yellow residue. The residue was purified by chromatography on silica, eluting
with 10% ethyl acetate in hexane, to give the ester (1.56g, 95%) as a colourless oil;
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[a]D = -4.4 (c = 1.2, CHlCIl); '\)max (film) 1728cm-I; OH (360MHz) 7.70-7.67 (m,
4H, Ar), 7.46-7.37 (rn, 6H, Ar), 7.00 (dt, J 15.6, 7.3, IH, H-3), 5.86 (d, J 15.6,
IH, H-2), 3.98-3.93 (m, 2H, H-5, H-7), 3.75 (s, 3H, COlCH3), 3.74-3.69 (m, 2H,
H-9), 2.47-2.42 (m, IH, H-4), 2.31-2.28 (m, IH, H-4), 1.76 (app. q, J 6.3, 2H,
CHz), 1.70-1.62 (m, 2H, CH2), 1.08 (s, 9H, SiC(CH3h), 0.94 (t, J 8.0, 9H,
Si(CHzCH3)3), 0.89 (s, 9H, SiC(CH3)3), 0.61-0.55 (m, 6H, Si(CH2CH3)3), 0.06 (s,
3H, SiCH3), 0.05 (s, 3H, SiCH3); Oe (90MHz) 166.7 (s), 146.1 (d), 135.5 (d), 133.8
(s), 129.6 (d), 127.6 (d), 123.0 (d), 68.4 (d), 66.6 (d), 60.7 (t), 51.3 (q), 45.1 (t),
40.3 (t), 40.1 (t), 26.8 (q), 25.8 (q), 19.1 (s), 18.0 (s), 6.9 (q), 5.1 (t), -4.5 (2x q);
m/z (FAB) Found: 627.3345, ([M-tBu]+ C34H"O,Sh requires 627.3357); Found: C,
66.7; H, 9.5%, C38H640sSi3requiresC, 66.6; H, 9.4%.
(SR, 7S, E)-S-(tert-Butyl-dimethyl-silanyloxy)-9-(tert-butyl-diphenyl-
silanyloxy)-'-hydroxy-non-2-enoic acid methyl ester (243)
OH OTBS, ,
TBDPSO
Trifluoroacetic acid (0.3Sml, 4.56mmol) was added to a solution of the ester (242)
(1.20g, 1.75mmol) in THF (25ml) and water (4ml) at room temperature. The solution
was stirred at room temperature for 2h before being neutralised with a saturated
solution of sodium bicarbonate (20ml).The mixture was extracted with ethyl acetate (3
x 50m1),the combined extracts were then dried (Na2S0,,)and concentrated in vacuo to
leave a colourless oil. The oil was purified by chromatography on silica, eluting with
10% ethyl acetate in hexane, to give the alcohol (0.57g, 81% based on recovered
starting material) as a colourless oil; [a]D = -3.8 (c = 1.3, CH2CI2);'\)max (film) 3526
(br) cm+; OH (360MHz) 7.70-7.67 (m, 4H, Ar), 7.47-7.38 (m, 6H, Ar), 6.99 (dt, J
15.7, 7.7, IH, H-3), 5.87 (d, J 15.7, IH, H-2), 4.10-3.97 (m, 2H, H-5, H-7), 3.91-
3.78 (m, 2H, H-9), 3.74 (s, 3H, C02CH]), 3.43 (d, J 1.7, IH, OH), 2.49-2.35 (m,
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2H, H-4), 1.76-1.65 (m, 3H, H-6, H-8), 1.57 (ddd, J 14.0,6.0, 3.5, IH, H-6), 1.06
(8, 9H, SiC(CH3)3), 0.91 (8, 9H, SiC(CH3)3), 0.10 (8, 6H, Si(CH3)2); Oc (90MHz)
166.7 (8), 145.5 (d), 135.5 (d), 133.2 (8), 129.8 (d), 127.7 (d), 123.3 (d), 70.0 (d),
68.7 (d), 62.5 (t), 51.4 (q), 44.0 (t), 40.1 (t), 39.1 (t), 26.8 (q), 25.8 (q), 19.0 (s),
18.9 (s), -4.4 (q), -4.6 (q); m/z (FAB) Found: 571.3342, ([MH]+ C32HslOSSiz
requires 517.3275); Found: C, 67.6; H, 9.1%, C32HsoOsSi2 requires C, 67.3; H,
8.8%.
(2SIR, 4S, 6S)·{4·(tert.Butyl.dimethyl·silanyloxy)·6·[2'-(tert·butyl-
diphenyl-silanyloxy)-ethyl]-tetrahydro-pyran-2-yl}.acetic acid methyl
ester (247/249)
OTBS, OTBS,
TBDPSO
A solution of lithium bis(trimethylsilyl)amide (81~1, 1M in THF, 81J.Lmol)was added
dropwise to a solution of the alcohol (243) (31mg, 54J.Lmol)in THF (2ml) at -78°C,
under a nitrogen atmosphere. The solution was stirred at _78GC for 3h before addition
of a saturated solution of ammonium chloride (2ml) and allowing to warm to room
temperature. The mixture was then extracted with ethyl acetate (3 x 15ml), the
combined extracts were then dried (Na2S04) and the solvent removed in vacuo to leave
a yellow oil. The oil was purified by chromatography on silica, eluting with 5% ethyl
acetate in hexane, to give the pyran (21mg, 68%, 8:1 cis:trans) as a colourless oil; cis
isomer (247): [OlD = -3.9 (c = 1.8, CH3CI); umax (soln., CHCI3) 2928, 2856, 1732,
1106, 1062cm-1; OH (360MHz) 7.70-7.66 (m, 4H, Ar), 7.45-7.35 (m, 6H, Ar), 4.25-
4.18 (m, 2H, H-2, H-4), 4.12-4.06 (m, IH, H-6), 3.83-3.70 (m, 2H, CH20TBDPS),
3.60 (s, 3H, C02CH3), 2.49 (dd, J 14.6, 7.4, IH, CHHC02Me), 2.34 (dd, J 14.6,
6.4, IH, CHHC02Me), 1.74-1.54 (m, 4H, 2x CH2), 1.44-1.37 (01, 2H, CH2), 1.05
158
(s, 9H, SiC(CH 3)3), 0.91 (s, 9H, SiC(CH 3)3), 0.06 (2x s, 6H, Si(CH 3h); Oc
(90MHz) 171.6 (s), 135.6 (d), 134.1 (s), 129.4 (d), 127.6 (d), 68.6 (2x d), 64.9 (d),
60.3 (t), 51.4 (q), 41.4 (t), 39.4 (t), 39.1 (t), 29.7 (t), 26.8 (q), 25.8 (q), 19.2 (s),
18.0 (s), -4.4 (q); m/: (FAB) Found: 513.2523, ([M-tBu]+ C2sH4JOsSi2 requires
513.2493).
(SR, 7S, E)-9-(tert-Butyl-diphenyl-silanyloxy)-5,7-dihydroxy-noD-2-
enoie acid methyl ester (245)
OH OH, ,
TBDPSO
Trifluoroacetic acid (36~1, 0.48mmol) was added dropwise to a solution of the silyl
ether (243) (89mg, 0.16mmol) in THF (lOml) and water (2ml) at O°C. The solution
was stirred at this temperature for lh before allowing to warm to room temperature and
stirring for 8h. A solution of saturated sodium bicarbonate (lOml) was then added and
the solvent was removed in vacuo. The residue was extracted with ethyl acetate (3 x
20ml), the combined extracts were then dried (Na2S04) and concentrated in vacuo to
leave a colourless oil. The oil was purified by chromatography on silica, eluting with
50% ethyl acetate in petroleum ether (b.p. 40-60°C), to give the diol (50mg, 70%) as a
colourless oil; [a]o = +7.0 (c = 2.2, CHC13); umax (soln., CHCh) 3472 (br), 1715,
1660, 1l06cm-1; OH (360MHz) 7.69-7.66 (m, 4H, Ar), 7.49-7.39 (m, 6H, Ar), 7.02
(dt, J 15.7, 7.4, IH, H-3), 5.92 (dt, J 15.7, 1.4, IH, H-2), 4.21-4.05 (m, 4H, H-5.
H-7, 2x OH), 3.89-3.86 (m, 2H, H-9), 3.73 (s, 3H, C02CH3), 2.46-2.35 (m, 2B, H-
4), 1.82-1.51 (m, 4H, H-6. H-8), 1.06 (s, 9H, SiC(CH3)3); Oc (90MHz) 166.8 (s),
145.5 (d), 135.5 (d), 132.6 (s), 130.0 (d), 127.8 (d), 123.2 (d), 73.3 (d), 71.0 (d),
63.4 (t), 51.4 (q), 42.5 (t), 40.3 (t), 38.5 (t), 26.7 (q), 19.0 (8); m/z (FAB) Found:
457.2448, ([MH]+ C:zJI370sSi requires 457.2410).
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(2S, 4S, 6S)-{ 6-[2 '-(tert- butyl-diphenyl-silanyloxy)-ethyl]-4-bydroxy-
tetrahydro-pyran-2-yl}-acetic acid methyl ester (248)
OH,
TBDPSO
Sodium hydride (l2.3mg, 60% in oil, 0.31mmol) was added in one portion to a
solution of the diol (245) (70mg, 0.15mmol) in THF (5ml) at room temperature, under
a nitrogen atmosphere. The solution was stirred for lh and then a saturated solution of
ammonium chloride (5ml) was added. The mixture was then extracted with ethyl acetate
(3 x 15ml), the combined extracts were then dried (Na2S04), and the solvent removed
in vacuo to leave a colourless oil. The oil was purified by chromatography on silica
eluting with 50% ethyl acetate in hexane, to give the tetrahydropyran (31mg, 44%) as a
colourless oil; [0.]0 = -3.9 (c = 0.5, CHC13); umax (film) 3612, 3470 (br), 1731,
Ll l lcm+; 8H (400MHz) 7.69-7.66 (m, 4H, Ar), 7.44-7.36 (m, 6H, Ar), 4.24-4.17
(m, 2H, H-2, H-4), 4.02-3.97 (m, IH, H-6), 3.81-3.74 (m, 2H, CH20TBDPS), 3.61
(s, 3H, C02CH3), 2.51 (dd, J 14.9, 12.3, IH, CHHCOtMe), 2.36 (dd, J 14.9, 6.3,
IH, CHHC02Me), 1.79-1.43 (m, 6H, 3x CHt), 1.06 (s, 9H, SiC(CH3)3); Be
(75MHz) 171.5 (s), 135.5 (d), 134.0 (s), 129.4 (d), 127.5 (d), 68.7 (d), 68.4 (d),
64.4 (d), 60.4 (t), 51.1 (q), 41.2 (t), 39.0 (t), 38.4 (t), 38.2 (t), 26.6 (q), 19.2 (s);
m/z (FAB) Found: 457.2444, ([MH]+ C26H370!lSi requires 457.2410).
(2S, 4S, 6S)-Benzoic acid 2-[2'-(/erl-butyl-diphenyl-silanyloxy)-ethyl]-
6-methoxycarbonylmethyl-tetrahydro-pyran-4-yl ester (250)
OBz,
TBDPSO
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Benzoyl chloride (12,.11,O.llmmol) and 4-dimethylaminopyridine (lmg, cat.) were
added succesively to a solution of the alcohol (248) (30mg, 66J.1mol) in
dichloromethane (2ml) at O°C,under a nitrogen atmosphere. The solution was stirred
for 10min before dropwise addition of triethylamine (18J.11,O.13mmol)and the solution
stirred for a further 17h. The solvent was then removed in vacuo and the residue was
purified by chromatography on silica, eluting with 20% ethyl acetate in hexane, to give
the ester (37mg, 100%) as a colourless oil; [a]D = -9.3 (c = 1.2, CHCh); umax (film)
3070, 1739, 1716cm-1;5H (360MHz) 8.14-8.12 (m, 2H, Ar), 7.72-7.67 (m, 4H, Ar),
7.64-7.60 (m, IH, Ar), 7.50-7.31 (m, 8H, Ar), 5.52 (app. t, J 3.0, IH, H-4), 4.32-
4.27 (m, IH, H-2), 4.20-4.16 (m, IH, H-6), 3.88-3.76 (m, 2H, CH20TBDPS), 3.66
(s, 3H, C02CH3), 2.58 (dd, J 15.0, 7.8, IH, CHHC02Me), 2.45 (dd, J 15.0, 5.5,
IH, CHHC02Me), 2.04 (br. d, J 14.1, IH, H-3), 1.97 (br d, J 14.2, IH, H-5), 1.85-
1.61 (m, 4H, 2x CH2), 1.07 (s, 9H, SiC(CH3)3); 5c (90MHz) 171.4 (s), 165.6 (s),
135.5 (d), 133.9 (s), 133.0 (d), 130.4 (s), 129.6 (d), 129.5 (d), 128.4 (d), 127.6 (d),
69.5 (d), 69.4 (d), 68.2 (d), 60.0 (t), 51.6 (q), 41.2 (t), 38.8 (t), 35.5 (t), 35.4 (t),
26.8 (q), 19.2 (s); m/z (FAB) Found: 561.2707, ([MH]+ CnH4106Si requires
561.2672).
(35, 5R)-1-(tert-Butyl-diphenyl-silanyloxy)-oct-7 -ene-3,5-diol (256)
(35, 5R)-5-(tert-Butyl-dimethyl-silanyloxy)-1-(tert-butyl-diphenyl-
silanyloxy )-oct-7 -ene-3,5-diol (255)
OH OH, ,
TBDPSO~
256
OH orss, ,
rBDPSO~
2S5
Trifluoroacetic acid (0.10ml, 1.3mmol) was added dropwise to a solution of the tria-
silyl ether (240) (0.32g, 0.51mmol) in THF (I5ml) and water (3m!) at oDe. The
solution was stirred at this temperature for 2h before addition of a saturated solution of
sodium bicarbonate (10ml). The biphasic mixture was extracted with ethyl acetate (3 x
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40ml), the combined extracts were then dried (Na2S04) and concentrated in vacuo to
leave a colourless oil. The oil was purified by chromatography on silica, eluting with
10% ethyl acetate in petroleum ether (b.p. 40-60°C), to give the diol (256) (86mg,
42%) as a colourless oil, and the alcohol (255) (149mg, 57%) as a colourless oil. Diol
(256); [a]D = +3.8 (c = 0.9, CHCI3); Umax (soln., CHCI3) 3475cm-1; OH (360MHz)
7.71-7.67 (m, 4H, Ar), 7.49-7.39 (m, 6H, Ar), 5.92-5.80 (m, IH, CH=CH2), 5.16-
5.10 (m, 2H, CH=CH2), 4.20-4.14 (m, IH, H-3), 4.00-3.83 (m, 4H, n.t, H-5,
OH), 3.67 (br s, IH, OH), 2.31-2.22 (m, 2H, H-6), 1.84-1.61 (m, 4H, H-2, H-4) ,
1.07 (s, 9H, SiC(CH3)3); oe (125MHz) 135.5 (d), 134.8 (d), 132.9 (s), 127.8 (d),
124.9 (d), 117.6 (t), 72.8 (d), 71.5 (d), 63.1 (t), 42.6 (t), 42.2 (t), 38.8 (t), 26.8 (q),
19.0 (s); m/z (EI) Found: 341.1575, ([M-tBu]+CwH2.S03Sirequires 341.1573).
Alcohol (255); [a]D = -10.9 (c = 5.1, CH3CI); Umax (soln., CHCI3) 3501cm-1; OH
(360MHz) 7.72-7.68 (m, 4H, Ar), 7.47-7.38 (m, 6H, Ar), 5.87-5.76 (m, IH,
CH=CH2), 5.09-5.05 (m, 2H, CH=CH2), 4.07-3.94 (m, 2H, H-3, H-5), 3.91-3.78
(m, 2H, H-1), 3.51 (d, J 1.8, IH, OH), 2.37-2.23 (m, 2H, H-6), 1.78-1.58 (m,4H,
H-2, H-4), 1.06 (s, 9H, SiC(CH 3)3), 0.92 (s, 9H, SiC(CH 3)3), 0.11 (s, 6H,
Si(CH3)2); oe (90MHz) 135.5 (d), 134.4 (d), 133.4 (s), 129.7 (d), 127.7 (d), 117.3
(t), 71.4 (d), 68.8 (d), 62.1 (t), 43.3 (t), 42.2 (t), 39.3 (t), 26.8 (q), 25.8 (q), 19.1
(s), 17.9 (s), -4.1 (q), -4.7 (q); m/z (EI) Found: 455.2455, ([M-tBu]+C2JI3903SiZ
requires 455.2448). The alcohol (255) could be converted to the diol (256) by
prolonged exposure to a more concentrated solutionof trifluoroacetic acid.
Trifluoroacetic acid (O.20m1,2.6mmol) was added dropwise to a solution of the alcohol
(255) (l35mg, 0.26mmol) in THF (5ml) and water (Iml) at room temperature. The
solution was stirred for 8h before addition of a saturated solution of sodium bicarbonate
(10ml) and removal of the solvent in vacuo. The residue was extracted with ethyl
acetate (4 x 20ml), the combined extracts were then dried (Na2S0,,)and concentrated in
vacuo to leave a colourless oil. The oil was purified by chromatography on silica,
eluting with 30% ethyl acetate in petroleum ether (b.p. 40-60°C), to give the diol
(64mg, 61%) as a colourless oil.
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(2R, 4S, 6S)-6-[2'-(tert-Butyl-diphenyl-silanyloxy)-ethyl]-tetrahydro-
pyran-2,4-diol (257)
OH,
TBDPSO~
OH
Ozone was bubbled through a solution of the diol (256) (SOmg, 0.20mmol) in
dichloromethane (lOml) at -7SoCfor 30min until the solution turned blue. Oxygen was
then bubbled through for lOmin until the solution went colourless. Triphenylphosphine
(5Smg, 0.22mmol) was then added in one portion and the solution was allowed to
warm to room temperature over lh, The solution was then stirred at room temperature
for 12h and concentrated in vacuo to leave a solid residue. The residue was purified by
chromatography on silica, eluting with 50% ethyl acetate in petroleum ether (b.p. 40-
60°C), to give a 3:1 ratio of hemi-acetal anomers (57mg, 95%) as a colourless oil;
\)max (soln., CHCI3) 3597, 3532cm-1; BH (360MHz) 7.72-7.66 (m, 4H, Ar), 7.47-
7.37 (m, 6H, Ar), 5.24 (t, J 4.4, IH, H-2), 4.49-4.41 (m, IH, H-4), 4.17-4.10 (m,
IH, H-6), 3.90-3.77 (m, 2H, CH20TBDPS). 3.72 (d, J 5.S, IH, OH), 3.0S (d, J
6.9, IH, OH), 1.97-1.90 (m, IH), I.S7-1.70 (m, 4H), 1.60-1.49 (m, IH), 1.07 (s,
9H, SiC(CH3)3); Be (90MHz) 135.6 (d), 133.9 (s), 129.6 (d), 127.6 (d), 92.7 (d),
64.S (d), 60.3 (t), 59.7 (d). 3S.6 (t), 38.3 (t), 35.1 (t). 26.8 (q), 19.2 (s); mil. (FAB)
Found: 423.1927. ([M+Na]+C2)Hn04SiNa requires 423.1968).
(2S, 4S, 6S)-Acetic acid 2-acetoxy-6-[2'-(tert-butyl-diphenyl-
silanyloxy)-ethyl]-tetrahydro-pyran-4-yl ester (258)
OAe,
TBDPSO~
OAe
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Triethylamine (O.lOml, 0.71mmol) and 4-dimethylaminopyridine (3mg, 29""mol) were
added successively to a solution of the hemi-acetal (257) (57mg, 0.14mmol) in
dichloromethane (5ml) at O°C, under a nitrogen atmosphere. The solution was stirred
for 5min before dropwise addition of acetic anhydride (54",,1,0.57mmol). The solution
was allowed to warm up to room temperature and stirred for 1h before addition of 1M
hydrochloric acid (0.2ml) and a saturated solution of sodium chloride (15ml). The
organic residue was extracted with ethyl acetate (4 x 15ml), the combined extracts were
then dried (Na2S04) and concentrated in vacuo to leave a colourless oil. The oil was
purified by chromatography on silica, eluting with 20% ethyl acetate in petroleum ether
(b.p. 40-60'C), to give a 3:1 ratio of bis-acetate anomers (59mg, 86%) as a colourless
oil; umax (soln., CDCl3) 1730cm-1; ~H (360MHz) 7.70-7.65 (m, 4H, Ar), 7.46-7.37
(m, 6H, Ar), 6.19 (d, J 3.9, 1H, H-2), 5.14 (app. t, J 3.1, 1H, H-4), 4.60-4.53 (m,
IH, H-6), 3.89-3.69 (m, 2H, CH20TBDPS), 2.10 (s, 3H, OCOCH3), 2.04 (s, 3H,
OeOCH3), 2.01-1.50 (m, 6H, 3x CH2), 1.07 (s, 9H, SiC(CH3)3); ~c (90MHz) 170.4
(s), 169.6 (s), 135.5 (d), 133.8 (s), 129;6 (d), 127.6 (d), 91.3 (d), 65.7 (d), 62.6 (d),
59.5 (t), 38.1 (t), 34.4 (t), 31.5 (t). 26.7 (q), 21.2 (2x q), 19.2 (s); m/z (FAB) Found:
507.2191, ([M+Na]+C27H3606SiNa requires 507.2179).
(2S, 4S, 6S)-Acetic acid 2-allyl-6-[2'-(tert-butyl-diphenyl-sllanyloxy)-
ethyl]-tetrahydro-pyran-4-yl ester (260)
OAe,
Allyltrimethylsilane (20J,l1,0.13mmol) was added to a solution oftbe bis-acetate (258)
(31mg, 64""mmol) in dichloromethane (lml) and acetonitrile (lml) at _78°C, under a
nitrogen atmosphere. Boron trifluoride diethyl etherate (16J,l1, 0.13mmol) and
trimetbylsilyl trifluoromethanesulfonate (2.5 ......13J1mol) were then added successively
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and the solution stirred at _78°Cfor 30min. A saturated solution of sodium bicarbonate
(lml) and then added and the mixture allowed to warm to room temperature. The
biphasic mixture was extracted with ethyl acetate (3 x 15ml), the combined extracts
were then dried (Na2S04) and concentrated in vacuo to leave a colourless oil. The oil
was purified by chromatography on silica, eluting with 10%ethyl acetate in petroleum
ether (b.p. 40-60°C), to give the trans-tetrahydropyran (28mg, 94%) as a colourless
oil; [a]o = -38.5 (c = 1.3, CHCI3); \)max (soln., CHCI3) 2931, 2859, 1725, 1367,
1111cm-1; OH (360MHz) 7.70-7.66 (m, 4H, Ar), 7.46-7.37 (m, 6H, Ar), 5.78-5.66
(m, IH, CH=CH2), 5.09-4.98 (m, 3H, CH=CH2, H-4), 4.31 (dddd, J 9.4, 4.6, 4.6,
4.6, IH, H-6), 3.81-3.67 (m, 2H, CHzOTBDPS), 3.57 (dddd, J 9.6, 6.3, 6.3, 2.8,
IH, H-2), 2.36-2.28 (m, IH, CHHCH=CH2), 2.23-2.14 (m, IH, CHHCH=CH2),
2.05 (s, 3H, OCOCH3), 2.04-1.94 (m, 2H, H-5, H-1'), 1.80-1.76 (m, 2H, H-5, H-
1'), 1.75-1.64 (m, IH, H-3), 1.34 (ddd, J 12.6, 9.9, 9.9, IH, H-3), 1.06 (s, 9H,
SiC(CH3)3); oe (90MHz) 170.4 (s), 135.6 (d), 134.5 (d), 133.8 (s), 129.6 (d), 127.6
(d), 117.0 (t), 68.4 (d), 68.3 (d), 67.7 (d), 60.6 (t), 40.0 (t), 36.2 (t), 34.5 (t), 34.4
(t), 26.8 (q), 21.3 (q), 19.2 (s); mil. (FAB) Found: 467.2610, ([MH]+ C28H3904Si
requires 467.2618); Found: C, 72.2; H, 8.7%, C28H3804Si requires C, 72.1; H, 8.2%.
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3.3 Synthetic Studies Towards the Side Chain
2,3:4,S-Di-D-isopropylidene-D-xylose diethyl dithioacetal (266)149
Ethanethiol (50.0ml, 0.676mol) was added dropwise over lOmin to a stirred solution
of (D)-xylose (50.0g, 0.333mol) in 6M hydrochloric acid (400ml) at room temperature.
The mixture was stirred for 2h and then neutralised with calcium carbonate (120g) until
pH 7 was attained. The precipitated inorganic residue was removed by filtration and
washed with toluene (500ml). The biphasic filtrate was concentrated in vacuo to leave
the crude dithioacetal as an orange residue. The residue was taken up in acetone (IL),
cooled to O°C and then concentrated sulfuric acid (15ml) was added. The resulting
solution was stirred for 16h and then neutralised by the addition of calcium hydroxide
(50g). The precipitated solid was removed by filtration and washed with acetone
(500ml). The filtrate was then concentrated in vacuo to leave a brown oil which was
taken up in diethyl ether and washed with a saturated solution of sodium bicarbonate
(600ml), a saturated solution of brine (600m1). The organic layer was then dried and
the solvent removed in vacuo to leave the crude bis-acetonide (-70g) as a yellow oil.
An analytical sample was purified by chromatography on silica, eluting with 10% ethyl
acetate in petroleum ether (b.p. 4O-60°C), to give the bis-acetonide as a pale yellow oil;
[a]n = -70.1 (c = 2.6, acetone), [lit. -67.0 (c = 2.8, acetone)]144; Umax (soln., CHCI3)
2982, 2931, 1381, 1372, 1070cm-1; aH (360MHz) 4.34 (m, 2H, H-2. B-3), 4.12 (dd,
J 7.4, 3.1, IH, H-4), 4.04 (dd, J 8.1, 6.7, 1H, H-5), 3.92 (t, J 7.6, 1H, H-5), 3.89
(d, J 5.2, 1H, R-1), 2.79-2.68 (m, 4H, S(CR2CH3h), 1.45 (s, 3H, CCB3), 1.41 (s,
6H, 2x CCH3), 1.36 (s, 3H, CCH3), 1.26 (t, J 7.4, 3H, SCH2CR3), 1.25 (t, J 7.4,
3H, SCH1CH3); ac (90MHz) 110.0 (s), 109.4 (8), 80.0 (d), 78.6 (d), 75.2 (d), 65.8
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(t), 53.0 (d), 27.3 (q), 27.1 (q), 26.1 (q), 25.5 (q), 25.3 (t), 24.9 (t). 14.3 (q), 14.2
(q); mlz (EI) Found: 336.1445, (M+ ClSH2S04S2requires 336.1429).
2-Deoxy.4,5-0·isopropylidene.D-threo-pent-t·enose diethyl dithioacetal
(267)123
OH SEt
O~J 3 ~1 SEt
~o '
A solution of the bis-acetonide (266) (-70g. O.21mol) in THF (300ml) was added
dropwise over 1h to a solution of potassium r-butoxide (30.4g. 0.271mol) in THF
(750ml) and dimethylsulfoxide (300ml) at room temperature. under a nitrogen
atmosphere. The solution was stirred for 1h and then poured onto ice (500g). The
mixture was extracted with dichloromethane (3 x 400ml) and the combined organic
extracts were washed with water (500ml) and dried (Na2S04)' The solution was
concentrated in vacuo to leave a brown oil. which was purified by chromatography on
silica. eluting with 20% ethyl acetate in petroleum ether (b.p. 40-60°C), to give the
allylic alcohol (32.8g, 35%. 3 steps) as a yellow oil; [a]o = -54.4 (c = 2.4, CHCI3),
[lit. -48.5 (c = 2.4. CHCh)]123; umax(soln., CHCh) 3566 (br), 1374, 1065cm-1; aH
(360MHz) 5.85 (d, J 8.6, 1H, H-2), 4.75-4.70 (m, 1H, H-3), 4.03 (app. q, J 6.4,
1H, H-4), 3.91 (dd, J 8.4, 6.4, 1H, H-5), 3.73 (dd, J 8.4, 6.4. IH, H-5), 2.86-2.66
(m, 5H. S(CH2CH3b OH), 1.42 (s, 3H, CCH3), 1.32 (s, 3H, CCH3), 1.21 o, J 7.4,
3H, SCH2CH3), 1.20 (t, J 7.4, 3H, SCH2CH3); ac (90MHz) 135.8 (s), 132.6 (d),
109.6 (8), 78.7 (d), 70.5 (d), 65.6 (t), 27.4 (t), 26.8 (t), 26.5 (q), 25.2 (q), 14.9 (q),
13.7 (q); m/z (EI) Found: 260.0908, ([M-H20]+ Cl2H2002S2 requires 260.0905);
Found: C, 52.0; H, 8.1%. calc. for C12H2203S2:C, 51.8; H, 8.0%.
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2.Deoxy.4,S·O·isopropylidene.D.threo·pentose diethyl dithioacetal
(268)123
OH SEt
~o ; 3 2 1 SEt
~O
A solution of the allylic alcohol (267) (32.0g, 0.115mol) in THF (300ml) was added
dropwise over 2h to a suspension of lithium aluminium hydride (IO.Og, 0.264mol) in
THF (800ml) at room temperature, under a nitrogen atmosphere. After the addition was
complete the mixture was stirred for 3h. Residual lithium aluminium hydride was
quenched by sequential addition of water (lOml), 2M sodium hydroxide (lOml) and
water (20ml) over a lh period. The resulting mixture was filtered through Celite, and
the residual solid washed with diethyl ether (500ml). The filtrate was washed with
brine (500ml), dried (Na2S04) and concentrated in vacuo to give the alcohol (29.1g,
90%) as a colourless oil; [a]o = +26.3 (c = 3.9, CHCI3), [lit. +25.6 (c = 5.0,
CHCI3)]l23; Umax (soln., CHCh) 3471(br), 1372, 1067cm-1; BH (360MHz) 4.05 (dd,
J 10.4, 4.2, IH, H-l), 4.01-3.95 (m, 2H, H-4, H-5), 3.87 (ddd, J 10.0, 4.5, 2.5,
ur, H-3), 3.73 (dd, J 10.9, 9.5, IH, H-5), 3.07 (br s, IH, OH), 2.72-2.51 (m, 4H,
S(CHzCH3h), 1.98 (ddd, J 14.2, 7.8, 4.2, IH, H-2), 1.67 (ddd, J 14.2, 10.4, 2.5,
IH, H· 2), 1.40 (s, 3H, CCH 3), 1.33 (s, 3H, CCH 3), 1.23 (t, J 7.4, 6H,
S(CHzCH3)z); Be (90MHz) 109.4 (s), 78.5 (d), 69.5 (d), 65.8 (t), 47.5 (d), 40.1 (t),
26.4 (q), 25.1 (q), 24.2 (t), 23.9 (q), 14.4 (q), 14.3 (q); m/: (EI) Found: 280.1160,
(M+ClzHz403Sz requires 280.1167); Found: C, 51.4; H, 8.9; S, 23.0%, calc. for
ClzH2403SZ: C, 51.4; H, 8.6; S, 22.8%.
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3-0-(4'-Methoxy-benzyl)-2-deoxy-4,S-O-isopropylidene-D-threo-
pentose diethyl dithioacetal (269)
OPMBSEt
~o ; 3 2 1 SEt
~O
Potassium t-butoxide (2.2Ig, 19.7mmol)was added in one portion to a stirred solution
of the alcohol (268) (4.60g, 16.4mmol) in THF (100ml) at -20°C, under a nitrogen
atmosphere. The solution was stirred at -20°C for Ih, then tetrabutylammonium iodide
(0.61g, 1.6mmol) and a solution of 4-methoxybenzyl bromide (4.62g, 23.0mmol) in
THF (20ml) were added. The suspension was allowed to warm to room temperature
and stirring was continued for 15h. Saturated ammonium chloride solution (50ml) was
added and the solvent was removed in vacuo. The residue was extracted with ethyl
acetate (3 x 75ml), the combined extracts were then dried and concentrated in vacuo to
leave a yellow oil. The oil was purified by chromatography on silica, eluting with 10%
ethyl acetate in petroleum ether (b.p. 40-60°C), to give the 4-methoxybenzyl ether
(6.4lg, 98%) as a colourless oil; [a]D = +34.0 (c = 2.4, CHCI3); umax (film) 1612,
854, 822cm-1; OH (360MHz) 7.29 (d, J 8.8, 2H, Ar), 6.89 (d, J 8.8, 2H, Ar), 4.75
(d, J 11.2, IH, OCHHAr), 4.69 (d, J 11.2, IH, OCHHAr), 4.25 (dd, J 13.2, 6.6,
IH, H-4), 4.00 (dd, J 8.3, 6.6, IH, H-5), 3.94 (dd, J 10.6,4.1, IH, H-1), 3.94-3.88
(m, IH, H-3), 3.82 (s, 3H, ArDCH3), 3.74 (dd, J 8.3, 7.1, IH, H-5), 2.71-2.52 (m,
4H, S(CH1CH3h), 2.00 (ddd, J 14.2, 9.6, 4.1, IH, H-2), 1.75 (ddd, J 14.2, 10.6,
1.9, IH, H-2), 1.47 (s, 3H, CCH3), 1.38 (s, 3H, CCH3) 1.24 (t, J 7.4, 6H,
S(CH1CH3)2); Oc (90MHz) 159.2 (s), 130.7 (s), 129.5 (d), 113.7 (d), 109.4 (s), 77.7
(d), 76.9 (d), 72.9 (t), 65.6 (t), 55.2 (q), 47.5 (d), 37.3 (t), 26.4 (q), 25.1 (q), 24.3
(t), 23.4 (t), 14.4 (q), 14.3 (q); m/; (EI) Found: 400.1751, (M+C:wH320,Sl requires
400.1742).
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(3R, 4'R)·3·(2' ,2'·Dimethyl·[1' ,3']·dioxolan·4 '·yl)·3·(4' "-methexy-
benzyloxy)·propionaldehyde (270)
PMBO 0
"O~H
~03'
Calcium carbonate (O.28g, 2.85mmol) and a solution of mercury (II) perchlorate
hydrate (0.76g, 1.90mmol) in water (4ml) were added successively in one portion to a
solution of the dithioacetal (269) (0.38g, 0.95mmol) in THF (25ml). The resulting
solution was stirred for 3h at room temperature, diethyl ether (50ml) was added and the
suspension stirred for 15min. The suspension was filtered through a short pad of silica
and the resulting solution was then dried (NaZS04)' The solvent removed in vacuo to
leave a colourless oil, which was purified by chromatography on silica eluting with
50% ethyl acetate in petroleum ether (b.p. 4O-60°C),to give the aldehyde (0.25g, 91%)
as a colourless oil; [o.]D = +28.5 (c = 3.7, CHeI3); 'Umax (film) 2729, 1725cm-1; 8H
(360MHz) 9.73 (t, J 1.7, IH, H-l), 7.24 (d, J 8.7, 2H, Ar), 6.88 (d, J 8.7, 2H, Ar),
4.59 (app. q, J 11.3, 2H, CH2Ar), 4.32-4.27 (m, IH, H-5'), 4.14-4.09 (m, IH, H-
3),4.00 (dd, J 8.6, 6.8, 1H, H-41, 3.83-3.79 (m, IH. H-51. 3.80 (s, 3H. ArOCH3),
2.61 (ddd, J 7.0. 1.7. 1.7. 2H. H-2). 1.44 (s, 3H. CCH3), 1.36 (s, 3H. CCH3); 8c
(90MHz) 200.7 (d). 159.3 (s), 129.9 (s), 129.6 (d). 113.8 (d). 109.7 (s), 76.3 (d),
73.6 (d), 72.4 (t), 65.2 (0. 55.2 (q), 44.4 ro, 26.2 (q), 24.9 (q); m/z (EI) Found:
294.1460, (M+C,JizzOs requires 294.1467).
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(lR, 3S, 4'R)-I-(2',2' -Dimethyl-[1' ,3']-dioxolan-4' -yl)-I-( 4 "_
methoxy-benzyloxy)-hex-5-en-3-ol (271)
PMBO OH
1'O~6
, 2
~03'
(- )-J3-Methoxydiisopinocampheylborane (7.00g, 22.2mmol) was dissolved in
anhydrous diethyl ether (250ml) and cooled to -78°C, under an argon atmosphere.
Allylmagnesium bromide (20.5ml, l.OM in Et20, 20.5mmol) was added dropwise over
15min, at -78°C and then warmed to room temperature and stirred for 1h. The
suspension was then recooled to -78°C and a solution of the aldehyde (270) (5.lOg,
17.1mmol) in diethyl ether (60ml) was added dropwise over 15min. The suspension
was stirred at -78°C for 3h and then quenched with methanol (4ml). A solution of 2M
sodium hydroxide (lOOml) and hydrogen peroxide (lOOml) were added and the
biphasic mixture refluxed for 2h. The mixture was then cooled and the organic layer
was separated. The aqueous layer was then extracted with ethyl acetate (3 x 100ml),
dried (Na2S04) and the combined organic extracts were concentrated in vacuo to leave a
colourless oil. The oil was then purified by chromatography on silica, eluting with 20%
ethyl acetate in petroleum ether (b.p. 40-60°C), to give the alcohol (4.69g, 82%) as a
colourless oil; '\)max (film) 3474 (br), 1612cm-1; OH (360MHz) 7.30 (d, J 8.6, 2H, Ar),
6.90 (d, J 8.6, 2H, Ar), 5.85-5.73 (m, IH, H-5), 5.13-5.08 (m, 2H, H-6), 4.76 (d, J
11.3, IH, OCHHAr), 4.61 (d, J 11.3, IH, OCHHAr), 4.26 (ddd, J 7.2, 6.6, 6.6,
IH, H-4'), 4.07-3.97 (m, 2H, H-5'), 3.93-3.86 (m, IH, H-3), 3.82 (s, 3H,
ArOCH3), 3.67 (dd, J 8.1, 7.6, IH, H-1), 2.23-2.19 (m, 2H, H-4), 1.65-1.45 (m,
2H, H-2) 1.46 (s, 3H, CCH3), 1.40 (s, 3R, CCH3); Oe (90MHz) 159.3 (s), 134.4
(d), 130.3 (s), 129.8 (d), 118.0 (t), 113.9 (d), 109.6 (s), 78.4 (d), 76.5 (d), 72.8 (t),
68.0 (d), 65.9 (t), 55.3 (q), 42.0 (t), 37.0 (t), 26.5 (q), 25.4 (q); mlz (EI) Found:
336.1931, (M+ C1Ji280S requires 336.1937).
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(lR, 3S, 4'R)-1-(2',2' -Dimethyl-[l' ,3')-dioxolan-4'-yl)-hexan-l,3-diol
(273)
Palladium on carbon (30mg. 10%) was added in one portion to a solution of the alcohol
(271) (90mg, 0.27mmol) in methanol (Sml). The flask was purged with hydrogen and
stirred under a hydrogen atmosphere for 24h. The suspension was filtered through
Celite and the solid residue was then washed with dichloromethane (SOml). The filtrate
was concentrated in vacuo to leave a yellow oil which was purified by chromatography
on silica, eluting with 40% ethyl acetate in petroleum ether (b.p. 40-60°C), to give the
diol (47mg, 81%) as a colourless oil; [a]o = +18.9 (c = 1.6, CHCh); Umax (film) 3426
(br) cm+; OH (360MHz) 4.06-3.91 (m, 3H, H-1, H-4', H-5'), 3.87-3.83 (m, IH,
H-3), 3.76-3.70 (m, IH, H-5'), 1.67-1.S9 (m, IH), I.S4-1.30 (m, 5H), 1.43 (s, 3H,
CCH3), 1.37 (s, 3H, CCH3), 0.92 (t, J 7.0, 3H, H-6); Oc (90MHz) 109.S (s), 79.1
(d), 69.S (d), 68.4 (d), 66.0 (t), 39.6 (2x o. 26.6 (q), 2S.2 (q), 18.8 (t), 14.0 (q); m/z
(EI) Found: 203.1278, ([M-Me)+C1oHI904requires 203.1283).
(lR, 3S, 4'R)-I-(2' ,2'-Dimethyl-[1' ,3']-dioxolan-4'-yl)-1,3-0-
isopropylidene-hexan-l,3-diol (274)
p-Toluenesulfonic acid monohydrate (4mg, 20J.LlIlol)was added to a solution of the diol
(273) (25mg, O.11mmol) in 2,2-dimethoxypropane (5ml) at O°C, under a nitrogen
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atmosphere. The solution was stirred for lOmin and the solvent was then removed in
vacuo. The residue was purified by chromatography on silica, eluting with 20% ethyl
acetate in petroleum ether (b.p. 40-60·C), to give the bis-acetonide (30mg, 100%) as a
colourless oil; [a]D = +42.5 (c = 0.6, CHCI3); 'Omax (film) 2985, 1456, 1378, 1224,
1071cm-1; OH (360MHz) 4.13 (dd, J 13.3,6.6, IH, H-5'), 4.03 (dd, J 8.3, 6.6, IH,
H-5'), 3.86 (ddd, J 9.6, 6.6, 6.6, IH, H-l), 3.81-3.77 (m, IH, H-3), 3.72 (dd, J
8.3, 6.9, IH, H-4'), 1.67-1.61 (m, IH), 1.55-1.28 (m, 5H), 1.43 (s, 3H, CCH3) ,
1.38 (s, 3H, CCH3), 1.37 (s, 3H, CCH3), 1.37 (s, 3H, CCH3), 0.92 (t, J 7.0, 3H,
H-6); Oc (90MHz) 109.8 (s), 100.6 (s), 77.8 (d), 67.9 (d), 66.2 (d), 65.4 (t), 37.9 (t),
34.0 (t), 26.5 (q), 25.3 (q), 24.5 (2x q), 18.5 (t), 13.9 (q); m/z (EI) Found: 243.1599,
([M-Me]+CJ3H2304requires243.1596).
(lR, 3S, 4'R)-I-(2' ,2'-Dimethyl-[I' ,3']-dioxolan-4'-yl)-3-methoxy-l-
(4"- methoxy- benzyloxy)- hex-s-ene (272)
Potassium t-butoxide (2.27g, 20.2mmol) was added in one portion to a stirred solution
of the alcohol (271) (3.40g, 10.lmmol) in THF (lOOmI)at -20·C, under a nitrogen
atmosphere. The solution was stirred at -20·C for 30min and then methyl iodide
(6.30ml, 10lmmol) was added dropwise over lOmin. The solution was allowed to
warm up to room temperature and then stirred for 6h. Saturated ammonium chloride
solution (50mI) was added and the solvent was removed in vacuo. The residue was
extracted with ethyl acetate (4 x 100ml), the combined extracts were then dried and
concentrated in vacuo to leave a yellow oil which was purified by chromatography on
silica, eluting with 20% ethyl acetate in petroleum ether (b.p. 40-60·C), to give the
methyl ether (3.43g, 97%) as a colourless oil; [a]o = +63.7 (c = 2.3, CHCh); 'Omax
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(soln., CHCI3) 1612cm-1; BH (360MHz) 7.30 (d, J 8.6, 2H, Ar), 6.88 (d, J 8.6, 2H,
Ar), 5.82-5.70 (m, 1H, H-5), 5.11-5.05 (m, 2H, H-6), 4.76 (d, JILl, 1H,
OCHHAr), 4.55 (d, JILl, IH, OCHHAr), 4.19 (dd, J 13.9, 6.7, 1H, H-5'), 3.98
(dd, J 8.2, 6.7, 1H, H-4'), 3.81 (s, 3H, ArDCH3), 3.73-3.66 (m, 2H, H-5', H-1),
3.48-3.42 (m, IH, H-3), 3.26 (s, 3H, OCH3), 2.30-2.26 (m, 2H, H-4), 1.58-1.50
(m, 1H, H-2), 1.46 (s, 3H, CCH3), 1.44-1.34 (m, IH, H-2), 1.38 (s, 3H, CCH3); oe
(90MHz) 159.1 (s), 134.1 (d), 130.9 (s), 129.6 (d), 117.3 (t), 113.7 (d), 109.2 (s),
78.8 (d), 76.2 (d), 76.1 (d), 72.8 (t), 65.9 (t), 56.3 (q), 55.1 (q), 37.5 (t), 36.1 (t),
26.5 (q), 25.3 (q); m/z (EI) Found: 350.2102, (M+ C2oH300S requires 350.2093);
Found: C, 68.7; H, 8.8%, C20H300s requires C, 68.6; H, 8.6%.
(3S, SR, 4'R)-5-(2' ,2'-Dimethyl-[1' ,3']-dioxolan-4'-yl)-3-methoxy-5-
(4"-methoxy benzyloxy)-pentanal (275)
4-Methylmorpholine N-oxide (O.23g, 1.7mmol), followed by osmium tetroxide
(20mg, cat.) were added to a solution of the methyl ether (272) (0.20g, O.57mmol) in
acetone (20ml) and water (2ml). The solution was stirred at room temperature for 12h
and then a saturated solution of sodium thiosulfate (20ml) was added. The solvent was
removed in vacuo and the residue was taken up in ethyl acetate (50ml) and the organic
layer separated. The aqueous phase was extracted with ethyl acetate (3 x 50ml) and the
combined organic layers were dried (Na2S04) and the solvent removed in vacuo to
leave a colourless oil, which was used immediately without purification.
An aqueous solution of sodium periodate (O.18g, 0.82mmol, O.65M) was added
dropwise over 5min to a vigourously stirred suspension of silica (1.5g) in
dichloromethane (20ml). The crude diol in dichloromethane (5ml) was then added
174
dropwise over 2min and the suspension stirred for Ih. The suspensionwas filtered and
the silica was washed with dichloromethane (200ml). The solvent was removed in
vacuo to leave a colourless oil which was purified by chromatography on silica, eluting
with 50% ethyl acetate in petroleum ether (b.p. 40-60·C), to give the aldehyde (0.199,
96%) as a colourless oil; [a]o = +60.7 (c = 1.8, CHCh); umax (film) 2727, 1723cm-1;
BH (360MHz) 9.78 (t, J 2.2, 1H, H-1), 7.30 (d, J 8.6, 2H, Ar), 6.89 (d, J 8.6, 2H,
Ar), 4.76 (d, J 11.2, IH, OCHHAr), 4.54 (d, J 11.2, IH, OCHHAr), 4.22 (ddd, J
6.7, 6.7, 6.6, 1H, H-4'), 3.99 (dd, J 8.2, 6.7, IH, H-5'), 3.91-3.82 (m, IH, H-5),
3.81 (s, 3H, ArOCH3), 3.78-3.65 (m, 2H, H-5', H-3), 3.25 (s, 3H, OCH3), 2.61
(dd, J 5.6, 2.2, 2H, H-2), 1.64-1.53 (m, 2H, H-4), 1.46 (s, 3H, CCH3), 1.38 (s,
3H, CCH3); Be (90MHz) 201.0 (s), 159.2 (s), 130.5 (s), 129.7 (d), 113.8 (d), 109.4
(s), 78.1 (d), 75.8 (d), 72.8 (d), 72.7 (t), 65.7 (t), 56.7 (q), 55.2 (q), 48.0 (t), 36.4
(t), 26.4 (q), 25.2 (q); m/z (EI) Found: 351.1854, ([M-H]+CJ9H2706requires
351.1867).
(4R, 1'R, 3'S)-4-[4'-[1" ,3"]-Dithian-2"-yl-3'-methoxy-l '-(4"'-
methoxy-benzyloxy)-butyl]-2,2-dimethyl-[l,3]-dioxolane (276)
PMBO OM. S:=J
10~S J 2'
~03
Zinc iodide (7mg, 23J.Ullol)was added to a solution of the aldehyde (275) (80mg.
O.23mmol) in diethyl ether (3ml) at room temperature. under a nitrogen atmosphere.
1,3-bis-(Trimethylsilylthio)propane (64mg. 0.25mmol) was added dropwise over lmin
and the cloudy suspension was stirred at room temperature for 1h. The reaction was
quenched with water (Sml), and extracted with ethyl acetate (3 x 15m1).the combined
extracts were then dried (Na2S04) and concentrated in vacuo to leave a colourless oil.
The oil was purified by chromatography on silica eluting with 20% ethyl acetate in
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petroleum ether (b.p. 40-60°C), to give the dithiane (15mg, 15%) as a colourless oil;
'Umax (soln., CHCI3) 2984, 2935, 2836, 1612, 1372, 1074cm-1; OH (360MHz) 7.31
(d, J 8.6, 2H, Ar), 6.88 (d, J 8.6, 2H, Ar), 4.74 (d, JILl, 1H, OCHHAr), 4.56 (d,
JILl, 1H, OCHHAr), 4.23-4.18 (m, 1H, H-5), 4.11 (t, J 7.1, 1H, H-1'), 3.97 (dd,
J 8.3, 6.6, 1H, H-4), 3.81 (s, 3H, ArDCH3), 3.74-3.65 (m, 3H, H-3', H-5, CHS2),
3.28 (s, 3H, OCH3), 2.99-2.75 (m, 4H, 2x CH2S), 2.15-1.76 (m, 4H), 1.64-1.50
(m, 2H), 1.46 (s, 3H, CCH3), 1.38 (s, 3H, CCH3); Oe (90MHz) 159.2 (s), 130.8 (s),
129.7 (d), 113.8 (d), 109.4 (s), 78.3 (d), 76.1 (d), 74.1 (d), 72.7 (t), 65.8. (t), 56.6
(q), 55.3 (q), 43.S (d), 40.0 (t), 36.3 (t), 30.4 (2x t), 26.6 (q), 25.9 (t), 25.3 (q); m/z
(EI) Found: 427.1609, ([M-Me]+ C21H310sS2requires 427.1613).
(2R, 3R, SS)-5-Methoxy-3-(4'-methoxy-benzyloxy)-oct-7-ene-l,2-diol
(277)
PMBO OMs
HO~8
i 4
OH
10Camphorsulfonic acid (37mg, 0.16mmol) was added to a solution of the acetonide
(272) (55mg, 0.16mmol) in methanol (Sml) at O·C. The solution was stirred for 4h,
whilst allowing to warm to room temperature. Saturated sodium bicarbonate solution
(lOml) was added and the solvent removed in vacuo. The aqueous phase was then
extracted with ethyl acetate (3 x 20ml), the combined extracts were then dried (NazS04)
and concentrated in vacuo to leave a yellow oil. The oil was purified by
chromatography on silica eluting with SO% ethyl acetate in petroleum ether (b.p. 40-
60°C), to give the dial (0.31g, 88%) as a colourless oil; [a]o = +3.7 (c = 1.4, CHCI3);
'Umax (film) 3574 (br), 1613cm-1; BH (360MHz) 7.29 (d, J 8.7, 2H, Ar), 6.91 (d, J
8.7, 2H, Ar), 5.84-5.74 (m, IH, H-7), S.14-5.10 (m, 2H, H-8), 4.S5 (app. q, J 11.1,
2H, OCH2Ar), 3.82 (s, 3H, ArDeH), 3.72-3.62 (m, 4H, H-1. H-2. H-3), 3.46-3.39
(m, IH, H-5), 3.35 (s, 3H, OCH), 3.05 (d, J 3.9, IH, CHOH), 2.77 (br s, 1H,
CH20H), 2.36-2.29 (m, 2H, H-6), 1.75-1.71 (m, 2H, H-4); Be (90MHz) 159.3 (s),
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133.8 (d), 130.2 (s), 129.5 (d), 117.6 (t), 113.8 (d), 76.9 (d), 76.6 (d), 73.7 (d),
72.7 (t), 63.8 (t), 56.0 (q), 55.2 (q), 37.3 (t), 35.9 (t); m/z (EI) Found: 310.1780,
(M+ C17H260s requires 310.1780).
(2R, 3R, 5S)-2' ,2'-Dimethyl-propionic acid 2-hydroxy-5-methoxy-3-
(4"-methoxy-benzyloxy)-oct-7-enyl ester (278)
PMBO OMe
1 , , 7
PIVO~8 I 4
OH
Trimethylacetyl chloride (8.7J.LI,80J.Lmol)and 4-dimethylaminopyridine (Img) were
added to a solution of the diol (277) (20mg, 60J.Lmol)in pyridine (Iml) at O°C,under a
nitrogen atmosphere. The solution was allowed to warm to room temperature over
30min and stirred for a further 12h. Hydrochloric acid (lOml, 2M) and ethyl acetate
(I5ml) were added and the organic layer was separated. The aqueous fraction was
extracted with ethyl acetate (2 x 15ml) and the combined organic layers were then dried
(Na2S04) and concentrated in vacuo to leave a yellow oil. The oil was purified by
chromatography on silica eluting with 50% ethyl acetate in petroleum ether (b.p. 40-
60°C), to give the ester (23mg, 92%) as a colourless oil; [alo = +10.3 (c = 2.9,
CHCI3); umax (film) 3468 (br), 1728cm-1; BH (360MHz) 7.27 (d, J 8.6, 2H, Ar), 6.99
(d, J 8.6, 2H, Ar), 5.84-5.73 (m, IH, H-7), 5.12-5.04 (m, 2H, H-8), 4.53 (app. q, J
11.0, 2H, OCH2Ar), 4.15 (d, J 5.8, 2H, H-1), 3.81 (s, 3H, ArOCH), 3.80 (obs. m,
IH, H-2), 3.72-3.68 (m, IH, H-3), 3.45-3.37 (m, IH, H-5), 3.33 (s, 3H, OCH),
2.51 (br s, IH, CHOH), 2.34-2.27 (m, 2H, H-6), 1.80-1.67 (m, 2H, H-4), 1.22 (s,
9H, COC(CH3)3); Be (90MHz) 178.6 (s), 159.4 (s), 133.9 (d), 130.2 (s), 129.6 (d),
117.7 (t), 113.9 (d), 76.8 (d), 75.7 (d), 73.0 (t), 71.7 (d), 65.4 (t), 56.0 (q), 55.3 (q),
38.8 (s), 37.4 (t), 35.9 (t), 27.2 (q); mlz (EI) Found: 394.2358, (M+ C22H)..06
requires 394.2355).
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(2R, 3R, 5S)-2',2'-Dimethyl-propionic acid 2-(tert-butyl-dimethyl-
silanyloxy )-S-methoxy-3-( 4" -methoxy- benzyloxy)-oct-7 -enyl ester
(279)
PMBO OMs
PIVO~8 i 4
OTBS
Triethylamine (0.20ml, 1.42mmol) was added in one portion to a solution of the
alcohol (278) (0.28g, O.71mmol)in dichloromethane (lOml) at O·C,under a nitrogen
atmosphere. The solution was stirred for 5min before tert-butyldimethylsilyl triflate
(0.20ml, 0.85mmol) was added dropwise over lmin. The solution was strirred for a
further 2h while allowing to warm to room temperature. A saturated solution of
ammonium chloride (20ml) was added and the organic layer was separated. The
aqueous phase was extracted with dichloromethane (3 x 25ml) and the combined
organic layers were then dried and concentrated in vacuo to leave a yellow oil. The oil
was purified by chromatography on silica eluting with 20% ethyl acetate in petroleum
ether (b.p. 40-60°C), to give the silyl ether (0.36g, 100%) as a colourless oil; [a]o =
+43.4 (c = 2.5, CHCI3); umax (film), 1729, 1612cm-i;OR(360MHz) 7.27 (d, J 8.7,
2H, Ar), 6.88 (d, J 8.7, 2H, Ar), 5.82-5.73 (m, IH, H-7), 5.09-5.03 (m, 2H, H-8),
4.59 (d, J 11.4, IH, OCHHAr), 4.49 (d, J 11.4, IH, OCHHAr), 4.30 (ddd, J 10.5,
6.1, 6.1, IH, H-2), 4.01-3.95 (m, 2H, H-1), 3.80 (s, 3H, ArDCH3), 3.68 (ddd, J
10.5, 3.7, 1.9, IH, H-3), 3.42-3.36 (m, IH, H-5), 3.25 (s, 3H, OCH3), 2.31-2.22
(m, 2H, H-6), 1.79-1.72 (m, IH, H-4), 1.53-1.45 (m, IH, H-4), 1.21 (s, 9H,
COC(CH3)3)' 0.89 (s, 9H, SiC(CH3)3), 0.07 (s, 3H, SiCHl), 0.06 (s, 3H, SiCHl); Be
(90MHz) 178.5 (s), 159.2 (s), 134.5 (d), 130.8 (s), 129.4 (d), 117.1 (t), 113.8 (d),
76.7 (d), 76.6 (d), 72.4 (t), 70.6 (d), 65.7 (t), 56.0 (q), 55.2 (q), 38.7 (8), 37.9 (t),
34.3 (t), 27.3 (q), 25.7 (q), 18.0 (s), -4.7 (2x q); m/; (EI) Found: 451.2510, ([M-
tBu]+ C24H3906Si requires 451.2516).
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(3S, 5R, 6R)-2',2'-Dimethyl-propionic acid 2-(tert-butyl-dimethyl-
silanyloxy)-S-methoxy-3-(4"-methoxy-benzyloxy)-7-oxo-heptyl ester
(280)
PMBO OMe 0
PIVO~H
:
OTBS
4-Methylmorpholine N-oxide (0.29g, 2.1mmol), followed by osmium tetroxide
(20mg, cat.) were added to a solution of the silyl ether (279) (0.36g, O.7Immol) in
acetone (15ml) and water (1.5ml). The solution was stirred at room temperature for 12h
and then a saturated solution of sodium thiosulfate (20ml) was added. The solvent was
removed in vacuo and the residue was taken up in ethyl acetate (50ml) and the organic
phase separated.The aqueous phase was extracted with ethyl acetate (3 x 50ml) and the
combined organic layers were dried (NaZS04). The solvent was removed in vacuo to
leave a colourless oil, which was used immediately without purification.
An aqueous solution of sodium periodate (0.22g, l Dmmol, 0.65M) was added
dropwise over 5min to a vigourously stirred suspension of silica (2g) in
dichloromethane (20ml). The crude diol in dichloromethane (5ml) was then added
dropwise over 2min and the suspension stirred for lh. The suspension was filtered and
the silica was washed with dichloromethane (200ml). The solvent was removed in
vacuo to leave a colourless oil which was purified by chromatography on silica, eluting
with 20% ethyl acetate in petroleum ether (b.p. 40-60·C), to give the aldehyde (0.34g,
93%) as a colourless oil; [a]o = +45.0 (c = 3.0, CHCI3); Umax (film) 2723, 1727cm-1;
5H (360MHz) 9.74 (dd, J 2.2, 1.8, IH, B-7), 7.24 (d, J 8.5, 2H, Ar), 6.85 (d, J 8.5,
2H, Ar), 4.57 (d, J 11.4, IH, OCHHAr), 4.44 (d, J 11.4, IH, OCHHAr), 4.30 (dd, J
11.2, 11.7, IH, H-1), 4.02-3.98 (m, IH, H-2), 3.92, (dd, J 11.2, 6.9, IH, H-1),
3.81-3.76 (m, IH, H-3), 3.76 (s, 3H, ArOCH3), 3.62 (ddd, J 10.3, 4.1, 1.3, IH, H·
5), 3.22 (s, 3H, OCH3), 2.56 (dd, J 3.8, 2.2, 2H, H-6), 1.96 (ddd, J 14.3, 8.9, 1.6,
IH, H-4), 1.46 (ddd, J 14.3, 10.6, 3.8, IH, H-4), 1.18 (s, 9H, COC(CH3)3)' 0.86
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(s, 9H, SiC(CH3h), 0.05 (s, 3H, SiCH3), 0.04 (s, 3H, SiCH3); Oc (90MHz) 201.0
(d), 178.3 (s), 159.2 (s), 130.3 (s), 129.4 (d), 113.7 (d), 76.7 (d), 73.3 (d), 72.1 (t),
69.9 (d), 65.4 (t), 56.4 (q), 55.1 (q), 48.2 (t), 38.6 (s), 34.5 (t), 27.1 (q), 25.6 (q),
17.8 (s), -4.8 (2x q); m/z (EI) Found: 421.2031, ([M-tBu-MeOH]+ C22H3406Si
requires 421.2047).
(3S, SR, 6R)-2',2'-Dimethyl-propionic acid 2-(tert-butyl-dimethyl-
silanyloxy)-6-[1" ,3"]-dithian-2' '-yl-S-methoxy-3-(4" '-methoxy-
benzyloxy)-hexyl ester (281)
PMBO OMe S~
~-)PIVO i 3 4 5 6 S
i
OTBS
Zinc iodide (17mg, 0.055mmol) was added to a solution of the aldehyde (280) (0.28g,
0.23mmol) in diethyl ether (IOml) at room temperature, under a nitrogen atmosphere.
1,3-bis-(Trimethylsilylthio)propane (0.15g, 0.60mmol) was added dropwise and the
cloudy suspension was then stirred at room temperature for 8h. The reaction was
quenched with water (10ml), extracted with ethyl acetate (3 x 30ml) and the combined
extracts were then dried (NaZS04)' The organic extracts were concentrated in vacuo to
leave a colourless oil, which was purified by chromatography eluting with 10% ethyl
acetate in petroleum ether (b.p. 40-60°C), to give the dithiane (0.20g, 73% based on
recovered starting material); [o.]D = +21.0 (c = 2.1, CHCh); '\)max (soln., CHCI3)
1721, 1612cm-1; OH (360MHz) 7.29 (d, J 8.6, 2H, Ar), 6.87 (d, J 8.6, 2H, Ar), 4.57
(d, J 11.2, IH, OCHHAr), 4.52 (d, J 11.2, IH, OCHHAr), 4.31 (d, J 8.5, IH, H-1),
4.12 (dd, J 7.9, 6.4, IH, CHSz), 4.01-3.93 (m, 2H, H-1, H-2), 3.80 (s, 3H,
ArOCH3), 3.66-3.59 (m, 2H, H-3, H-5), 3.27 (s, 3H, OCH3), 2.93-2.78 (m, 4H, 2x
CHzS), 2.15-1.78 (m, 5H), 1.50 (ddd, J 14.1, 10.4, 3.6, IH, H-4), 1.21 (s, 9H,
COC(CH3)3)' 0.88 (s, 9H, SiC(CH3)3), 0.07 (s, 3H, SiCH3), 0.06 (s, 3H, SiCH3); Oc
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(90MHz) 178.4 (s), 159.1 (s), 130.5 (s), 129.4 (d), 113.7 (d), 77.0 (d), 74.5 (d),
72.1 (t), 70.2 (d), 65.5 (t), 56.1 (q), 55.1 (q), 43.5 (d), 40.2 (t), 38.6 (s), 34.2 (t),
30.3 (t), 30.1 (t), 27.2 (q), 25.8 (t), 25.6 (q), 17.8 (8), -4.7 (q), -4.8 (q); m/z (FAB)
Found: 601.3024, ([MH]+ C3oH5306S2Sirequires 601.3053).
(E)-4-(tert-Butyl-diphenyl-silanyloxymethyl}-2-propenyl-oxazole (282)
Triethylamine (1. 15ml, 8.3mmol) was added in one portion to a solution of the oxazole
alcohol (206) (0.69g, 4.1mmol) in dichloromethane (20ml) at O°C under a nitrogen
atmosphere. The solution was stirred for 15min before addition of 4-
dimethylaminopyridine (30mg, 0.25mmol) followed by dropwise addition of tert-
butyldiphenylsilyl chloride (1.4ml, 5.4mmol). The solution was stirred for 16h whilst
warming to room temperature. A saturated solution of ammonium chloride (20ml) was
then added and the organic phase was separated and the aqueous layer extracted with
dichloromethane (3 x 40ml). The organic extracts were combined, dried and
concentrated in vacuo to leave a colourless oil. The oil was purified by chromatography
on silica, eluting with 10% ethyl acetate in petroleum ether (b.p. 40-60°C), to give the
silyl ether (1.56g, 100%) as a colourless oil; 'Umax (film) 3070, 3049, 2958, 2930,
2856, 1428, 1112, 702cm-1; 8H (360MHz) 7.76-7.73 (m, 4H, Ar), 7.48-7.35 (m,
7H, Ar, H-5), 6.71 (dq, J 15.9, 6.9, IH, CH=CHCH3), 6.28 (dq, J 15.9, 1.7, IH,
Ox-CH=CH), 4.70 (d, J 1.3, 2H, CH20TBDPS), 1.92 (dd, J 6.9, 1.7, 3H,
CH=CHCH3), 1.11 (8, 9H, SiC(CH3)3); 8c (125MHz) 161.2 (8), 141.5 (8), 134.8
(d), 134.1 (d), 133.1 (8), 129.7 (d), 127.7 (d), 127.5 (d), 117.8 (d), 59.4 (t), 26.7
(q), 19.2 (8), 18.3 (q); m/z (EI) Found: 320.1097 ([M-tBuJ+ C19H1SNOzSi requires
320.1107).
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4-(tert-Butyl-dipbenyl-silanyloxymethyl)-oxazole-2-carbaIdebyde (283)
4-Methylmorpholine N-oxide (1.51g, 11.1mmol), followed by osmium tetroxide
(20mg, cat.) were added to a solution of the oxazole (282) (l.4g, 3.7mmol) in acetone
(30ml) and water (3ml). The solution was stirred at room temperature for 12h and then
a saturated solution of sodium thiosulfate (40ml) was added. The solvent was removed
in vacuo and the residue was taken up in ethyl acetate (50ml) and the organic phase
separated. The aqueous phase was extracted with ethyl acetate (3 x 50ml) and the
combined organic layers were dried (Na2S04)' The solvent was removed in vacuo to
leave a colourless oil, which was used immediately withoutpurification.
An aqueous solution of sodium periodate (0.82g, 3.8mmol, 0.65M) was added
dropwise over 5min to a vigourously stirred suspension of silica (5g) in
dichloromethane (50ml). The crude diol in dichloromethane (lOml) was then added
dropwise over 2min and the suspension stirred for 2h. The suspension was filtered and
the silica was washed with dichloromethane (200ml), the solvent was removed in
vacuo to give the aldehyde (0.94g, 69%) as a colourless oil; \)max (film) 2857,
1708cm-1; OH (360MHz) 9.73 (s, IH, CHO), 7.77 (s, IH, H-5), 7.75-7.71 (m,4H,
Ar), 7.48-7.40 (m, 6H, Ar), 5.29 (s, 2H, CH20TBDPS), 1.12 (s, 9H, SiC(CH3)3);
Oc (90MHz) 177.3 (d), 157.8 (s), 144.2 (s), 138.9 (d), 135.4 (d), 132.7 (s), 130.0
(d), 127.8 (d), 59.0 (t), 29.7 (q), 19.2 (8); m/z (EI) Found: 308.0745 ([M-tBu]+
182
[4.(tert.Butyl.diphenyl·silanyloxymethyl)·oxazyl·2·yl] methanol (284)
(),OTBDPS
OH
Sodium borohydride (0.28g, 7.4mmol) was added in one portion to a solution of the
aldehyde (283) (0.90g, 2.5mmol) in methanol (30ml) at ODC,under a nitrogen
atmosphere. The solution was stirred for 90min at ODCand then a saturated solution of
ammonium chloride (20ml) was added and the solvent removed in vacuo. A saturated
solution of brine (l00ml) was added and the mixture was extracted with ethyl acetate (3
x 50ml), the combined extracts were then dried (Na2S04) and concentrated in vacuo to
give the alcohol (0.9g, 100%) as a colourless oil, which was used without further
purification; Umax (film) 3296 (br), 1576, 1112cm-1; OH (360MHz) 7.70-7.68 (m,4H,
Ar), 7.48 (t, J 1.3, IH, H-5), 7.47-7.36 (m, 6H, Ar), 4.68 (d, J 6.6, 2H, CH20H),
4.67 (d, J 1.3, 2H, CH20TBDPS), 3.77 (t, J 6.6, IH, OH), 1.08 (s, 9H, SiC(CH3)3);
Oc (90MHz) 163.6 (s), 140.9 (s), 140.8 (d), 135.5 (d), 133.1 (s), 129.8 (d), 127.8
(d), 59.1 (t), 57.2 (t), 29.8 (q), 19.2 (s); m/z (EI) Found: 310.0896 ([M-tBu]+
C17H16N03Si requires 310.0899); Found: C, 68.2; H, 7.0; N, 4.0%, C21H2!1N03Si
requires C, 68.3; H, 7.4; N, 3.8%.
2.Bromomethyl.4.(tert.Butyl.diphenyl.silanyloxymethyl).oxazole (285)
(),OTBDPS
Br
A solution of triphenylphosphine (O.I8g, 0.70mmol) in dichloromethane (3ml) was
added dropwise to a solution of the alcohol (284) (O.20g, 0.54mmol) and carbon
tetrabromide (O.27g, 0.8Immol) in dichloromethane (lOml) at O°C, under a nitrogen
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atmosphere. The solution was stirred for ISh while allowing to warm to room
temperature, the solvent was removed in vacuo and the residue was purified by
chromatography on silica, eluting with 10% ethyl acetate in petroleum ether (b.p. 40-
60·C), to give the bromide (0. 17g, 75%) as a pale yellow oil; umax (film) 3070,3047,
2957,2930,2857,1427,1112,824, 702cm-1; OH (360MHz) 7.74-7.71 (m, 4H, Ar),
7.56 o, J 1.0, IH, H-5), 7.49-7.39 (m, 6H, Ar), 4.71 (d, J 1.0, 2H, CH20TBDPS),
4.44 (s, 2H, CH2Br), 1.12 (s, 9H, SiC(CH3h); Oc (90MHz) 159.0 (s), 142.0 (s),
136.4 (d), 135.5 (d), 133.0 (s), 129.8 (d), 127.8 (d), 59.2 (t), 26.7 (q), 20.4 (t), 19.2
(s); m/z (FAB) Found: 428.0687 ([M-H]+ C21H23N02Br79Sirequires 428.0681).
(4S, 6R, 7R)-7 ,8-bis-(tert-Butyl-dimethyl-silanyloxy).4-methoxy-6-(4 '-
methoxy- benzyloxy j-ect-f-eue (298)
PMBO OMs
8 , , 2
rBso~1 ! 5
OrBS
Triethylamine (1.81ml, 12.9mmol) was added in one portion to a solution of the diol
(277) (1.00g, 3.22mmol) in dichloromethane (20ml) at O·C, under a nitrogen
atmosphere. The solution was stirred for 5min before tert-butyldimethylsilyl triflate
(1.78ml, 7.73mmol) was added dropwise over lrnin. The solution was strirred for a
further Ih whilst allowing to warm to room temperature. Saturated ammonium chloride
solution (40ml) was added and the organic layer was separated. The aqueous phase
was extracted with dichloromethane (3 x 50ml) and the combined organic layers were
dried and then concentrated in vacuo to leave a yellow oil. The oil was purified by
chromatography on silica eluting with 10% ethyl acetate in petroleum ether (b.p. 40-
60°C), to give the silyl ether (1.74g, 100%) as a colourless oil; [a]o = +33.8 (c = 3.0,
CHCI3); Umax (soln., CHCI3) 1612, 1086cm-1; OH (360MHz) 7.28 (d, J 8.7, 2H, Ar),
6.89 (d, J 8.7, 2H, Ar), 5.86-5.74 (m, IH, H-2), 5.10-5.02 (m, 2H, H-1), 4.61 (d, J
11.3, IH, OCHHAr), 4.48 (d, J 11.3, IH, OCHHAr), 3.84-3.77 (m, 2H, H-7, H-8),
184
3.81 (s, 3H, ArOCH3), 3.69 (ddd, J lO.5, 3.8, 2.2, 1H, H-6), 3.52 (dd, JILl, 7.9,
1H, H-8), 3.42-3.35 (m, 1H, H-4), 3.26 (s, 3H, OCH3), 2.30-2.23 (m, 2H, H-3),
1.72 (ddd, J 14.4, 9.8, 2.2, 1H, H-5), 1.49 (ddd, J 14.4, 10.5, 3.0, 1H, H-5), 0.91
(s, 9H, SiC(CH3)3), 0.90 (s, 9H, SiC(CH3h), 0.08 (s, 3H, SiCH3), 0.06 (3x s, 9H,
SiCH3); Oc (90MHz) 159.1 (8), 134.7 (d), 131.1 (8), 129.5 (d), 116.9 (t), 113.7 (d),
76.9 (d), 76.8 (d), 74.6 (d), 72.3 (t), 64.4 (t), 56.0 (q), 55.3 (q), 38.0 (t), 34.7 (t),
26.0 (q), 25.9 (q), 18.4 (s), 18.1 (s), -4.3 (q), -4.8 (q), -5.3 (q), -5.4 (q); m/z (EI)
Found: 481.2794, ([M-tBu]+ C2sH4s0sSi2 requires 481.2816); Found: C, 64.9; H,
10.3%, C29Hs40sSi2 requires C, 64.6; H, 10.1%.
(3R, SR, 6R)-6,7-bis-(tert-Butyl-dimethyl-silanyloxy)-3-methoxy-5-
(4' -methoxy-bensyloxyj-heptanal (299)
PMBO OMs 0
7 f , II
rBSO~H
'"OrBS
4-Methylmorpholine N-oxide (O.l1g, 0.84mmol), followed by osmium tetroxide
(20mg, cat.) were added to a solution of the silyl ether (298) (0.15g, 0.28mmol) in
acetone (lOml) and water (lml). The solution was stirred at room temperature for 12h
and then a saturated solution of sodium thiosulfate (20ml) was added. The solvent was
removed in vacuo and the residue was taken up in ethyl acetate (30ml) and the organic
phase separated. The aqueous phase was extracted with ethyl acetate (3 x 30ml) and the
combined organic layers were dried (Na2S04)' The solvent was removed in vacuo to
leave a colourless oil, which was used immediately without purification.
An aqueous solution of sodium periodate (85mg, 0.40mmol, O.65M) was added
dropwise over 5min to a vigourously stirred suspension of silica (lg) in
dichloromethane (lOml). The crude diol in dichloromethane (5ml) was then added
dropwise over 2min and the suspension stirred for 1h. The suspension was filtered and
the silica was washed with dichloromethane (50ml). The solvent was removed in
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vacuo to leave a colourless oil which was purified by chromatographyon silica, eluting
with 20% ethyl acetate in petroleum ether (b.p. 40-60·C), to give the aldehyde
(142mg, 94%) as a colourless oil; [a]o = +37.7 (c = 2.5, CHCI3); 'Umax (soln.,
CHCI3) 2737, 1723cm-1; OH (360MHz) 9.77 (t, J 2.4, IH, H-l), 7.26 (d, J 8.6, 2H,
Ar), 6.88 (d, J 8.6, 2H, Ar), 4.61 (d, J 11.2, 1H, OCHHAr), 4.44 (d, J 11.2, 1H,
OCHHAr), 3.88-3.84 (m, IH, H-3), 3.81 (s, 3H, ArOCH3), 3.82-3.77 (m, 2H, H-6,
H-7), 3.63 (ddd, J 10.4, 4.2, 1.8, 1H, H-5), 3.51 (dd, J 10.3, 7.1, 1H, R-7), 3.25
(s, 3H, OCH3), 2.58 (dd, J 5.7, 2.4, 2H, H-2), 1.97 (ddd, J 14.4, 8.7, 1.8, 1H, H-
4), 1.46 (ddd, J 14.4, 10.4, 4.2, 1H, H-4), 0.91 (s, 9H, SiC(CH3)3), 0.90 (s, 9H,
SiC(CH3)3), 0.09 (s, 3H, SiCH3), 0.07 (s, 3H, SiCH3), 0.06 (2x s, 6H, SiCH3); Oe
(90MHz) 201.4 (d), 159.2 (s), 130.6 (s), 129.5 (d), 113.8 (d), 77.0 (d), 73.8 (d),
73.7 (d), 72.1 (t), 64.2 (t), 56.4 (q), 55.2 (q), 48.4 (t), 34.7 (t), 26.0 (q), 25.8 (q),
18.3 (s), 18.1 (s), -4.3 (q), -4.9 (q), -5.3 (q), -5.4 (q).
(2R, 3R, 5R)-2-(tert-Butyl-dimethyl-silanyloxy)-S,7, 7-trimethoxy-3-
(4'-methoxy-benzyloxy)-heptan-t-ol (300)
PMBO OMs OMs
1 , , I
HO~OMS
II
OTBS
10-Camphorsulfonic acid (20mg, 90J.l.mol)was added in one portion to a solution of
the aldehyde (299) (95mg, 0.18mmol) in methanol (3ml) and dichloromethane (3ml)
under a nitrogen atmosphere. The solution was stirred at room temperature for I.Sh,
then a saturated sodium bicarbonate solution (5ml) was added and the solvent was
removed in vacuo. The residue was taken up in ethyl acetate (20ml) and the organic
phase separated. The aqueous phase was extracted with ethyl acetate (3 x 20ml) and the
combined organic layers were dried (Na2S04). The solvent was removed in vacuo to
leave a colourless oil, which was purified by chromatography on silica eluting with
30% ethyl acetate in petroleum ether (b.p. 40-60°C), to give the alcohol (74mg, 89%)
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as a colourless oil; [a]D = +26.0 (c = 2.1, CHCI3); 'Umax (soln., CHCI) 3494, 2930,
1612, 1082cm-1; BH (500MHz) 7.27 (d, J 8.6, 2H, Ar), 6.88 (d, J 8.6, 2H, Ar), 4.60-
4.49 (m, 3H, OCH2Ar, H-7), 3.94 (ddd, J 5.5, 5.5, 4.9, IH, H-2), 3.81 (s, 3H,
ArOCH3), 3.79-3.68 (m, 2H, H-l, H-3), 3.60-3.55 (m, IH, H-l), 3.49-3.45 (m, IH,
H-5), 3.33 (s, 3H, OCH3), 3.32 (s, 3H, OCH3), 3.26 (s, 3H, OCH3), 2.25 (t, J 6.2,
IH, OH), 1.89-1.82 (m, 2H, H-4, H-6), 1.77-1.71 (m, IH, H-6), 1.55 (ddd, J 14.1,
10.3, 3.5, IH, H-4), 0.90 (s, 9H, SiC(CH3)3), 0.08 (2x s, 6H, SiCH3); Be (125MHz)
159.3 (s), 130.5 (s), 129.6 (d), 113.8 (d), 102.1 (d), 77.8 (d), 74.6 (d), 72.3 (t),
71.2 (d), 63.5 (t), 59.2 (q), 55.3 (q), 52.8 (2x q), 37.5 (t), 34.3 (t), 25.8 (q), 18.0
(s), -4.7 (q), -4.8 (q); mlz (EI) Found: 351.1615. ([M-tBu-2xMeOH]+ C18H270sSi
requires 351.1628); Found: C, 61.0; H, 9.7%, C24H4407Si requires C, 61.0; H, 9.4%.
(2S, 3R, 5R).2·(tert-Butyl·dimethyl-silanyloxy).5,7, 7·trimethoxy-3-
(4'-methoxy-benzyloxy)-heptanal (301)
PMBO OMs OMs
OH'" , , I
~OMs1 4 6
OTBS
2,6-Di-tert-butylpyridine (1.1ml, 4.8mmol) was added in one portion followed by
Dess-Martin periodinane (0.68g, 1.6mmol) in one portion to a solution of the alcohol
(300) (0.38g, 0.8mmol) in dichloromethane (lOml) at room temperature, under a
nitrogen atmosphere. The mixture was stirred for Ih and then diethyl ether (30ml) was
added and the resulting suspension poured into a saturated solution of sodium
thiosulfate and sodium bicarbonate (1:1, 30ml) and stirred vigourously for 30min. The
organic layer was separated and the aqueous phase was extracted with ethyl acetate (3 x
30ml) and the combined organic layers were dried (N~S04)' The solvent was removed
in vacuo to leave a colourless oil, which was purified by chromatography on silica
eluting with 20% ethyl acetate in petroleum ether (b.p. 40-60°C), to give the aldehyde
(O.35g, 93%) as a colourless oil; [a]D = +35.0 (c = 2.4, CHCI3); 'Umax (soln., CHCh)
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1732cm-1; OH (360MHz) 9.71 (d, J 1.3, IH, H-1), 7.26 (d, J 8.7, 2H, Ar), 6.88 (d, J
8.7, 2H, Ar), 4.59-4.46 (m, 3H, OCH2Ar, H-7), 4.10 (dd, J 4.6, 1.3, IH, H-2),
3.93-3.86 (m, IH, H-3), 3.81 (s, 3H, ArDCH3), 3.50-3.45 (m, IH, H-5), 3.31 (2x
s, 6H, OCH3), 3.26 (s, 3H, OCH3), 1.90-1.60 (m, 4H, H-4, H-6), 0.92 (s, 9H,
SiC(CH3)3), 0.07 (s, 3H, SiCH3), 0.04 (s, 3H, SiCH3); oe (90MHz) 202.9 (d),
159.3 (s), 130.3 (s), 129.5 (d), 113.8 (d), 102.0 (d), 79.0 (d), 76.8 (d), 74.1 (d),
72.3 (t), 56.2 (q), 55.2 (q), 52.8 (q), 52.7 (q), 37.1 (t), 35.8 (t), 25.7 (q), 18.2 (s),
-4.7 (q), -5.2 (q); m/z (EI) Found: 381.1740, ([M-tBu-MeOH]+ C1Jl2906Si requires
381.1733).
(4R, SR, 7R)-4-(tert-Butyl-dimethyl-silanyloxy)-7,9,9-trimethoxy-5-
(4'-methoxy-benzyloxy)-2-methyl-non-(2E)-enoic acid ethyl ester (303)
OMs OMs
i 5 6
OTBS
8
(Carbethoxyethylidene)triphenylphosphorane (0.74g, 2.0mmol) was added in one
portion to a solution of the aldehyde (301) (0.32g, 0.7mmol) in benzene (lOml) under
a nitrogen atmosphere. The solution was heated at reflux for 50h, and then allowed to
cool and concentrated in vacuo. The residue was purified by chromatography on silica
eluting with 20% ethyl acetate in petroleum ether (b.p. 40-60°C), to give the ester
(0.34g, 91%) as a colourless oil; [a]D = +45.0 (c = 3.3, CHCI3); Umax (soln., CHCh)
1704, 1613cm-1; OH (360MHz) 7.26 (d, J 8.7, 2H, Ar), 6.86 (d, J 8.7, 2H, Ar), 6.65
(d br q, J 9.1, 1.4, IH, H-3), 4.70 (d, J 11.0, IH, OCHHAr), 4.56-4.45 (m, 3H,
OCHHAr, H-4, H-9), 4.23-4.13 (m, 2H, CH3CH20CO), 3.78 (s, 3H, ArDCH3),
3.65 (ddd, J 10.2, 5.4, 2.2, IH, H-5), 3.50-3.44 (m, IH, H-7), 3.29 (2x s, 6H,
OCH3), 3.22 (s, 3H, OCH3), 1.85 (d, J 1.4, 3H, CH3C=CH), 1.85-1.80 (m, IH, H-
8), 1.76-1.66 (m, 2H, H-6. H-8), 1.51 (ddd, J 13.8, 10.2, 3.3, IH, H-6), 1.28 (t, J
7.1, 3H, CH3CH20CO), 0.88 (s, 9H, SiC(CH3)3), 0.04 (s, 3H, SiCHl), 0.00 (s, 3H,
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SiCH3); ~c (90MHz) 167.6, (s), 159.1 (s), 140.8 (d), 130.7 (s), 129.5 (d), 128.6 (s),
113.7 (d), 101.9 (d), 79.2 (d), 74.2 (d), 73.1 (t), 71.5 (d), 60.6 (t), 55.9 (q), 55.1
(q), 52.7 (q), 52.5 (q), 37.1 (t), 35.5 (t), 25.7 (q), 18.0 (s), 14.1 (q), 13.3 (q), -4.6
(q), -4.9 (q); m/z (EI) Found: 433.2029, ([M-tBu-2xMeOH]+ CZ3H3306Sirequires
433.2046); Found: C, 62.8; H, 9.4%, C2.)IsoOsSirequires C, 62.8; H, 9.1%.
(4R, 5R, 7R)-4-(tert-Butyl-dimethyl-silanyloxy)-7 ,9,9-trimethoxy-S-
(4'-methoxy-benzyloxy)-2-methyl-non-(2E)-en-t-ol (304)
OMe OMe
HO
orBS
A solution of di-isobutylaluminium hydride (O.SOml, 1M in CH2Clz, 5.1mmol) was
added dropwise over 5min to a stirred solution of the ester (303) (loomg, 1.81mmol)
in dichloromethane at -78°C, under a nitrogen atmosphere. The solution was stirred at
this temperature for 1h, and then allowed to warm to room temperature and stirred for a
further 3h. The solution was quenched by dropwise addition of methanol (lml) and
poured into an aqueous solution of saturated potassium sodium tartrate (20ml) and
stirred vigourously for 2h. The biphasic mixture was then extracted with ethyl acetate
(3 x 20ml) and the combined organic extracts were dried (NazS04)' The solvent was
removed in vacuo to leave a colourless oil, which was purified by chromatography on
silica eluting with ethyl acetate, to give the alcohol (82mg, 89%) as a colourless oil;
[a]o = +33.5 (c = 1.9, CHCh); umax (soln., CHCh) 3613, 3455(br) cm+; ~H
(360MHz) 7.31 (d, J 8.5, 2H, Ar), 6.89 (d, J 8.5, 2H, Ar), 5.44 (d br q, J 9.2, 1.2,
IH, H-3), 4.76 (d, J 11.0, 1H, OCHHAr), 4.55-4.48 (m, 3H, OCHHAr, H-4, H-9),
4.00 (s, 2H, H-1), 3.82 (s, 3H, ArOCH3), 3.59 (ddd, J 9.7, 5.7, 1.9, IH, H-5),
3.53-3.46 (m, 1H, H-7), 3.33 (s, 3H, OCH3), 3.32 (s, 3H, OCH), 3.25 (s, 3H,
OCH3)' 1.97 (br s, IH, OH), 1.89-1.82 (m, 1H, H-8), 1.76-1.69 (m, 2H, H-6, H-8),
1.72 (d, J 1.0, 3H, CH3C=CH), 1.51 (ddd, J 13.6, 10.0,3.3, 1H, H-6), 0.91 (s,9H,
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SiC(CH3)3), 0.08 (s, 3H, SiCH3), 0.04 (s, 3H, SiCH3); Oc (90MHz) 159.1 (s), 136.9
(s), 131.0 (s), 129.5 (d), 125.7 (d), 113.7 (d), 101.9 (d), 79.6 (d), 74.5 (d), 73.0 (t),
71.3 (d), 68.2 (t), 56.1 (q), 55.2 (q), 52.7 (q), 52.5 (q), 37.2 (t), 35.7 (t), 25.8 (q),
18.1 (s), 14.5 (q), -4.3 (q), -4.7 (q); m/z (EI) Found: 391.1946, ([M-tBu-2xMeOH]+
C21H310SSirequires 391.1941).
(4R, 5R, 7R)-4-(tert-Butyl-dimetbyl-silanyloxy)-7 ,9,9-trimetboxy-5-
(4'-methoxy-benzyloxy)-2-metbyl-non-(2E)-enal (305)
H OMe OMe
o
orBS
2,6-Lutidine (0.16ml, 1.4mmol) was added in one portion followed by Dess-Martin
periodinane (0.20g, O.47mmol) in one portion to a solution of the alcohol (304)
(80mg, 0.16mmol) in dichloromethane (5ml) at room temperature, under a nitrogen
atmosphere. The mixture was stirred for Ih and then diethyl ether (20ml) was added
and the resulting suspension poured into a saturated solution of sodium thiosulfate and
sodium bicarbonate (1:1, 20ml) and stirred vigourously for 30min. The organic layer
was separated and the aqueous phase was extracted with ethyl acetate (3 x 25m1)and
the combined organic layers were dried (Na2S04). The solvent was removed in vacuo
to leave a colourless oil, which was purified by chromatography on silica eluting with
20% ethyl acetate in petroleum ether (b.p. 40-60°C), to give the aldehyde (75mg, 94%)
as a colourless oil; [a]o = +60.7 (c = 1.3, CHell); Amax (BtOH) 203 (8500), 217
(10100), 226 (9000), 232 (9000)nm; \)max (soln., CHCI3) 1688cm-1; 8H (360MHz)
9.42 (s, IH, H-l), 7.26 (d, J 8.7, 2H, Ar), 6.87 (d, J 8.7, 2H, Ar), 6.38 (d br q, J
8.6, 2.3, IH, H-3), 4.71 (dd, J 8.6, 5.2, IH, H-4), 4.67 (d, JILl, IH, OCHHAr),
4.53 (d, JILl, IH, OCHHAr), 4.48 (t, J 5.6, IH, H-9), 3.80 (s, 3H, ArOCH3),
3.72 (ddd, J 10.2,5.2, 2.2, IH, H-5), 3.51-3.45 (m, IH, H-7), 3.31 (s, 3H, OCH3),
3.30 (s, 3H, OCH3), 3.24 (s, 3H, OCH3), 1.86 (ddd, J 14.2, 6.1, 5.6, IH, H-8),
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1.76-1.68 (m, 2H, H-6, H-8), 1.77 (d, J 2.3, 3H, CH3C=CH), 1.54 (ddd, J 13.6,
10.2, 3.2, 1H, H-6), 0.90 (s, 9H, SiC(CH3)3), 0.07 (s, 3H, SiCH3), 0.00 (s, 3H,
SiCH3); ~c (90MHz) 195.1 (d), 159.3 (s), 152.5 (d), 139.2 (s), 130.5 (s), 129.6 (d),
113.8 (d), 101.9 (d), 79.0 (d), 74.2 (d), 73.1 (t), 71.0 (d), 56.1 (q), 55.3 (q), 52.8
(q), 52.6 (q), 37.1 (t), 35.6 (t), 25.8 (q), 18.1 (s), 10.1 (q), -4.6 (q), -4.8 (q); m/z
(FAB) Found: 533.2911, ([M+Na]+ C27H4607NaSi requires 533.2911).
(4R, 9R, lOR, l2R)-9-(tert-Butyl-dimethyl-silanyloxy)-4,12,14,14-
tetramethoxy-lO-( 4'-methoxy benzyl) -7-methyl-l-(trimethyl-silanyl)-
tetradeca-di-(5E, 7E)-en-l-yne (313)
OMs OMs OMs
A solution of sodium bis(trimethylsilyl)amide (78,...1,1M in THF, 78J.1mol)was added
dropwise to a solution of the sulfone (312) (25mg, 70,...rnol) and the aldehyde (305)
(25mg, 50J.1mol) in THF (3ml) at -78°C, under a nitrogen atmosphere. The solution
was stirred at -78°C for 3h and then allowed to warm up to room temperature over 1
hour. A solution of saturated ammonium chloride (5rnl) was added and the organic
layer was extracted with ethyl acetate (4 x 1Oml). The combined organic layers were
dried (Na2S04) and then concentrated in vacuo to leave a yellow oil. The oil was
purified by chromatography on silica eluting with 10% ethyl acetate in petroleum ether
(b.p. 40-60°C), to give the diene (24mg, 74%) as a colourless oil; [a]D = +41.3 (c =
1.2, CHC13); Amax (BtOH) 221 (39700), 274 (4900)nm; umax (soln., CHCI3) 2931,
2857, 2176, 1613, 1088cm-1; OR (360MHz) 7.29 (d, J 8.6, 2H, Ar), 6.88 (d, J 8.6,
2H, Ar), 6.25 (d, J 15.7, IH, H-6), 5.54 (dd, J 15.7, 7.8, IH, H-5), 5.46 (d, J 9.2,
IH, H-8), 4.76 (d, J 11.0, IH, OCHHAr), 4.57 (dd, J 9.2, 5.8, IH, H-9), 4.51 (d, J
11.0, IH, OCHHAr), 4.48 (t, J 5.6, IH, H-14), 3.81 (s, 3H, ArOCH3), 3.77 (ddd, J
10.0, 5.8, 1.8, IH, H-4), 3.63-3.58 (m, IH, H-10), 3.50-3.46 (m, 1H, H-12), 3.30
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(2x s, 6H, OCH3), 3.29 (s, 3H, OCH3), 3.23 (s, 3H, OCH3), 2.59 (dd, J 16.7, 5.6,
IH, H-3), 2.44 (dd, J 16.7, 7.1, IH, H-3), 1.87-1.68 (m, 3H, H-ll, H-13), 1.79 (s,
3H, CH3C=), 1.48 (ddd, J 13.8, 10.4, 3.3, IH, H-11), 0.89 (s, 9H, SiC(CH3)3),
0.14 (s, 9H, Si(CH3)3), 0.05 (s, 3H, SiCH3), 0.00 (s, 3H, SiCH3); Be (90MHz)
159.1 (s), 137.6 (d), 133.9 (s), 133.0 (d), 131.1 (s), 129.5 (d), 127.5 (d), 113.7 (d),
103.3 (s), 102.0 (d), 86.5 (s), 80.8 (d), 79.8 (d), 74.4 (d), 73.2 (t), 71.7 (d), 56.6
(q), 56.1 (q), 55.3 (q), 52.9 (q), 52.5 (q), 37.3 (t), 35.8 (t), 27.1 (t), 25.9 (q), 18.1
(s), 13.4 (q), 0.1 (q), -4.3 (q), -4.7 (q); m/z (FAB) Found: 685.3972, ([M+Na]+
C3A207NaSi2 requires 685.3932).
(3R, SR, 6R, llR)-6-(tert-Butyl-dimethyl-siianyloxy)-3,II-dimethoxy-
S-(4'-methoxy-benzyloxy)-R-methyl-14-(trimethyl-silanyl)-tetradeca-di-
(7E, 9E)-en-13-ynal (314)
OMe OMe 0
A solution of dimethylboron bromide135 (0.61ml, 1.14M in CH2Ch, 0.70mmol) was
added dropwise to a solution of the dimethyl acetal (313) (58mg, 87J1mol)in diethyl
ether (5ml) at -78°C, under a nitrogen atmosphere. The solution was stirred at -78°C
for 2h before being transferred via cannula to a vigourously stirring suspension of THF
(5ml) and saturated aqueous sodium bicarbonate (5m1).The mixture was then extracted
with ethyl acetate (3 x 15ml) and the combined organic layers dried (Na2S04) and
concentrated in vacuo to leave a colourless oil. The oil was purified by chromatography
on silica eluting with 40% ethyl acetate in petroleum ether (b.p. 40-60°C), to give the
aldehyde (50mg, 93%) as a colourless oil; [a]o = +50.4 (c = 0.9, CHCI3); Umax (soln.,
CHCI3) 1725cm-1; BH (360MHz) 9.75 (t, J 2.4, 1H, H-1), 7.27 (d, J 8.6, 2H, Ar),
6.89 (d, J 8.6, 2H, Ar), 6.25 (d, J 15.7, IH, H-9), 5.55 (dd, J 15.7, 7.8, IH, H-10),
5.44 (d, J 9.2, IH, H-7), 4.76 (d, JILl, IH, OCHHAr), 4.62 (dd, J 9.2, 5.6, 1H,
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H-6), 4.48 (d, JILl, IH, OCHHAr), 3.86-3.75 (m, 2H, H-3, H-11), 3.81 (s, 3H,
ArOCH3), 3.63 (ddd, J 10.3, 5.6, 2.0, IH, H-5) 3.31 (s, 3H, OCH3), 3.23 (s, 3H,
OCH3), 2.63-2.55 (m, 3H, H-2, H-12), 2.44 (dd, J 16.7, 7.2, IH, H-12), 1.87 (ddd,
J 14.4, 9.0, 2.0, IH, H-4), 1.80 (d, J 1.1, 3H, CH3C=CH), 1.47 (ddd, J 14.4, 10.4,
3.8, IH, H-4), 0.89 (s, 9H, SiC(CH3)3), 0.14 (s, 9H, Si(CH3)3), 0.06 (s, 3H,
SiCH3), 0.01 (s, 3H, SiCH3); Be (90MHz) 201.4 (d), 159.3 (s), 137.4 (d), 134.3 (s),
132.4 (d), 130.6 (s), 129.6 (d), 127.7 (d), 113.8 (d), 103.3 (s), 86.5 (s), 80.7 (d),
79.5 (d), 73.2 (d), 73.1 (t), 70.9 (d), 56.7 (q), 56.3 (q), 55.3 (q), 48.3 (t), 35.6 (t),
27.1 (t), 25.8 (q), 18.1 (s), 13.4 (q), 0.1 (q), -4.3 (q), -4.8 (q).
(SR, 7R, 8R, 13R)-8-(tert-Butyl-dimethyl-silanyloxy)-5,13-dimethoxy-
7_(4' -methoxy- benzyloxy )-1O-methyl-3-oxo-16-(trimethyl-silanyl)-
hexadeca-di-(9E, llE)-en-15-ynoic acid ethyl ester (315)
TMS OMe OMe 0
Ethyl diazoacetate (2.6....1,25....mol) was added in one portion to a suspension of tin(ll)
chloride (0.4mg, 2....mol) in dichloromethane (lml) at room temperature, under a
nitrogen atmosphere. A solution of the aldehyde (314) (l4mg, 23....mol) in
dichloromethane (lml + Irnl rinse) was then added dropwise by cannula. The
suspension was stirred for 2h before being concentrated in vacuo to leave a yellow
residue. The oil was purified by chromatography on silica eluting with 20% ethyl
acetate in petroleum ether (b.p. 40-60°C), to give the fJ-keto ester (12mg, 74%) as a
colourless oil; [a]o = +39.5 (c = 1.2, CHCI3); umax (soln., CHCI3) 1740, 1716cm-1;
BH (360MHz) 7.27 (d, J 8.6, 2H, Ar), 6.88 (d, J 8.6, 2H, Ar), 6.25 (d, J 15.7, ra,
H-11), 5.54 (dd, J 15.7, 7.8, IH, H-12), 5.43 (d, J 8.9, IH, H-9), 4.75 (d, J 11.0,
IH, OCHHAr), 4.60 (dd, J 9.2,5.6, IH, H-8), 4.48 (d, J 11.0, IH, OCHHAr), 4.18
(q, J 7.1, 2H, C02CH2), 3.86-3.74 (m, 2H, H-5, H-13), 3.81 (s, 3H, ArOCH3), 3.58
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(ddd, J 10.0, 5.5, 1.8, 1H, H-7), 3.42 (5, 2H, H-2) 3.31 (5, 3H, OCH3), 3.21 (5,
3H, OCH3), 2.74 (dd, J 16.1, 7.1, 1H, H-4), 2.63 (dd, J 16.1,9.7, 1H, H-4), 2.59
(dd, J 16.7, 5.6, 1H, H-14), 2.44 (dd, J 16.7, 7.1, IH, H-14), 1.81-1.73 (m, IH, H-
6), 1.79·(d, J 1.0, 3H, CH3C=CH), 1.44 (ddd, J 14.5, 10.3,4.3, 1H, H-6), 1.27 (t,
J 7.1, 3H, C02CH2CH3), 0.88 (5, 9H, SiC(CH3)3), 0.14 (5, 9R, Si(CH3)3), 0.05 (5,
3R, SiCH3), 0.00 (5, 3H, SiCH3); Oe (90MHz) 201.4 (5), 167.0 (5), 159.2 (s), 137.5
(d), 134.2 (5), 132.5 (d), 130.7 (s), 129.6 (d), 127.6 (d), 113.8 (d), 103.3 (5), 86.5
(5), 80.7 (d), 79.8 (d), 74.2 (d), 72.9 (t), 71.0 (d), 61.3 (t), 56.6 (2x q), 55.3 (q),
50.0 (t), 48.1 (t), 35.3 (t), 27.1 (t), 25.8 (q), 18.1 (5), 14.1 (q), 13.4 (q), 0.1 (q),
-4.3 (q), -4.8 (q); m/z (FAB) Found: 725.3815, ([M+Na]+ C3sH620sNaSh requires
725.3881).
(2R, 4R, 6R, l'R, 6'R)-{6-[I'-(tert-Butyl-dimethyl-silanyloxy)-6'-
methoxy-3' -methyl-9' -(trimethyl-silanyl)-nona-di-(2' E,4' E)-en-8'-
ynyl]-2-hydroxy-4-methoxy-tetrahydro-pyran-2-yl}-acetic acid ethyl
ester (316)
OMs
OMs
7' i OH
OTBS
2,3-Dichloro-5,6-dicyano-1,4-benzoquinone (lO.7mg, 47J.1mol)was added in one
portion to a solution of the J:l-ketoester (315) (22mg, 31J.1mol)in dichloromethane
(4ml) and water (O.3ml) at room temperature. The solution was stirred for 2h before
addition of a saturated solution of sodium bicarbonate (O.lml). The suspension was
filtered through a small pad of Celite and the solid residue washed with
dichloromethane (50ml). The solvent was removed in vacuo and the residual oil was
purified by chromatography on silica eluting with 10% ethyl acetate in petroleum ether
(b.p. 40-60°C), to give the hemi-acetal (16mg, 88%) as a colourless oil; [a]D = +3.4 (c
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= 0.55, CHCl3); Urnax (soln., CHCI3) 3466, 1714cm-1; ~H (500MHz) 6.24 (d, J 15.7,
1H, H-4'), 5.54 (dd, J 15.7, 7.8, 1H, H-5'), 5.40 (d, J 8.8, IH, H-2'), 4.45 (dd, J
8.9, 6.0, IH, H-1 ,), 4.24-4.15 (m, 2H, C02CH2), 3.89 (ddd, J 12.0, 6.0, 2.0, 1H,
H-6), 3.81-3.76 (m, IH, H-6'), 3.72-3.67 (m, 1H, H-4), 3.35 (s, 3H, OCH3), 3.33
(s, 3H, OCH3), 2.65-2.56 (m, 3H, CH2C02Et, H-7'), 2.45 (dd, J 16.8, 7.2, 1H, H-
7'), 2.23-2.17 (m, 1H, H-3eq), 2.06-2.00 (m, 1H, H-5eq), 1.75 (d, J 1.0, 3H,
CH3C=CH), 1.29 (t, J 7.1, 3H, C02CH2CH3), 1.16 (ddd, J 11.9, 11.9,2.4, 1H, H-
3ax), 1.05 (app. q, J 12.0, 1H, H-5ax), 0.85 (s, 9H, SiC(CH3)3), 0.14 (s, 9H,
Si(CH3)3)' 0.02 (s, 3H, SiCH3), -0.01 (s, 3H, SiCH3); ~c (90MHz) 172.1 (8), 137.6
(d), 134.1 (s), 132.6 (d), 127.3 (d), 103.3 (s), 96.5 (s), 86.5 (s), 80.5 (d), 73.2 (d),
73.1 (d), 71.4 (d), 60.8 (t), 56.6 (q), 55.6 (q), 44.5 (t), 40.7 (t), 32.1 (t), 26.9 (t),
25.8 (q), 18.2 (s), 14.0 (q), 13.3 (q), 0.1 (q), -4.5 (q), -4.8 (q); m/z (FAB) Found:
605.3347, ([M+Na]+ C3oH!l407NaSi2requires 605.3330).
(2R, 4R, 6R, 1 'R, 6'R)-{ 6-[1' -(tert-Butyl-dimethyl-silanyloxy)-6'-
methoxy-3'-methyl-9'-(trimethyl-silanyl)-nona-di-(2 'E,4'E)-en-8'-
ynyl]-2,4-dimethoxy-tetrahydro-pyran-2-yl}-acetic acid ethyl ester
(317)
Pyridinium p-toluenesulfonate (4.3mg, 17J.UIlol)was added in one portion to a solution
of the hemi-acetal (316) (lOmg, 17Jlmol) in methanol (1.0ml) and dichloromethane
(0.7ml) at room temperature, under a nitrogen atmosphere. The solution was stirred for
66h at this temperature before addition of a saturated solution of sodium bicarbonate
(2ml). The residue was extracted with ethyl acetate (3 x 10ml), the combined extracts
were then dried (Na2S04) and the solvent removed in vacuo to leave a colourless oil.
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The oil was purified by chromatography on silica eluting with 10% ethyl acetate in
petroleum ether (b.p. 40-60°C), to give the methyl ketal (6mg, 59%) as a colourless oil;
[a]D = -30.6 (c = 0.24, CHCI3); 'Umax (soln., CHCI3) 1729cm-1; OH (360MHz) 6.25
(d, J 15.7, IH, H-4'), 5.56 (dd, J 15.6, 7.6, IH, H-51, 5.39 (d, J 9.2, IH, H-2'),
4.42 (dd, J 9.1,7.0, IH, H-1'), 4.20-4.12 (m, 2H, C02CH2), 3.78 (app. q, J 7.5,
IH, H-6'), 3.59 (tt, J 11.0, 4.5, IH, H-4), 3.47 (ddd, J 12.0, 7.0, 1.9, IH, H-6),
3.33 (s, 3H, OCH3), 3.32 (s, 3H, OCH3), 3.27 (s, 3H, OCH3), 2.83 (d, J 14.0, IH,
CHHC02Et), 2.60 (dd, J 17.0, 5.6, IH, H-7'), 2.57 (d, J 14.0, IH, CHHC02Et),
2.44 (dd, J 17.0, 7.3, IH, H-7'), 2.45-2.42 (m, IH, H-3eq), 1.93-1.88 (m, IH, H-
5eq), 1.80 (d, J 1.1, 3H, CH3C=CH), 1.44 (dd, J 15.7, 11.1, IH, H-3ax), 1.28 (t, J
7.1, 3H, C02CH2CH3), 1.04 (app. q, J 12.2, IH, H-5ax), 0.87 (s, 9H, SiC(CH3)3),
0.14 (s, 9H, Si(CH3)3), 0.07 (s, 3H, SiCH3), 0.01 (s, 3H, SiCH3); Oe (90MHz)
169.1 (s), 137.3 (d), 134.2 (s), 132.2 (d), 127.8 (d), 103.2 (s), 99.4 (s), 86.6 (s),
80.7 (d), 73.4 (2x d), 72.1 (d), 60.5 (t), 56.6 (q), 55.6 (q), 47.9 (q), 42.0 (t), 39.3
(t), 32.6 (t), 27.0 (t), 25.8 (q), 18.2 (s), 14.2 (q), 13.4 (q), 0.1 (q), -4.6 (q), -4.7 (q);
m/z (FAB) Found: 595.3467, ([M-H]+ C31HssO,Sh requires 595.3486).
(SR, 7R, 4'R)-7-(2' ,2'-Dimethyl-U' ,3']dioxolan-4'-yl)-5-methoxy-7.
(4"-methoxy.benzyloxy)·3·oxo-heptanoic acid ethyl ester (319)
PMBO OMe 0,
4'
l' 0 J 7 6 4
~03'
2
Ethyl diazoacetate (50,.d, 0.48mmol) was added in one portion to a suspension of
tin(II) chloride (7.5mg, 40JA,mol)in dichloromethane (6ml) at O'C, under a nitrogen
atmosphere. A solution of the aldehyde (275)(l40mg, O.40mmol) in dichloromethane
(2ml + lml rinse) was then added dropwise by cannula. The suspension was allowed
to warm to room temperature and stirred for Ih before addition of a saturated solution
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of sodiumbicarbonate (lOml). The biphasic mixture was extracted with ethyl acetate (3
x 15m1),the combined extracts were then dried (Na2S04)and concentrated in vacuo to
leave a yellow residue. The residue was purified by chromatography on silica eluting
with 50% ethyl acetate in petroleum ether (b.p. 40-60°C), to give the fJ-keto ester
(l34mg, 77%) as a colourless oil; [a]D = +42.1 (c = 2.4, CHCIl);Umax (soln., CHCIl)
1739, 1716, 1651cm-1; bH (360MHz) 7.28 (d, J 8.6, 2H, Ar), 6.87 (d, J 8.6, 2H,
Ar), 4.72 (d, J 11.2, IH, OCHHAr), 4.51 (d, J 11.2, IH, OCHHAr), 4.21-4.16 (m,
IH, H-5'), 4.17 (q, J 7.1, 2H, C02CH2), 3.95 (dd, J 8.3, 7.6, IH, H-5'), 3.86-3.80
(m, IH, H-4'), 3.79 (s, 3H, ArOCH3), 3.69-3.63 (m, 2H, H-5, H-7), 3.42 (s, 2H,
CH2C02Et), 3.22 (s, 3H, OCHl), 2.75 (dd, J 16.3, 6.3, IH, H-4), 2.65 (dd, J 16.3,
5.4, IH, H-4), 1.54-1.49 (m, 2H, H-6), 1.43 (s, 3H, CCH3), 1.35 (s, 3H, CCH3),
1.26 (t, J 7.1, 3H, C02CH2CHl); be (90MHz) 201.3 (8), 167.0 (s), 159.2 (8), 130.7
(s), 129.6 (d), 113.8 (d), 109.4 (s), 78.2 (d), 76.0 (d), 73.7 (d), 72.5 (t), 65.8 (t),
61.3 (t), 57.1 (q), 55.3 (q), 50.1 (t), 47.6 ro. 36.1 (t), 26.5 (q), 25.3 (q) 14.1 (q); m/z
(EI) Found: 438.2247, (M+ C23H340srequires438.2254); Found: C, 62.7; H, 8.0%,
C2lH340srequiresC, 63.0; H, 7.8% ..
(2S, 4R, 6R, 4'R)·[[6.(2' ,2'·Dimetbyl-[1' ,3']dioxolan.4'.yl)-2.
bydroxy.4-metboxy-tetrabydro-pyran·2·yl]-acetic acid ethyl ester, (320)
OMe
4'
o J
~o
2,3-Dichloro-5,6-dicyano-1,4-benzoquinone (22mg, 97JLmol) was added in one
portion to a solution of the p-keto ester (319) (28mg, 64JLmol)in dichlorometbane
(3ml) and water (0.2ml) at room temperature. The solution was stirred for 2h before
addition of a saturated solution of sodium bicarbonate (O.lml). The suspension was
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filtered through a small pad of Celite and the solid residue washed with
dichloromethane (50ml). The filtrate was concentrated in vacuo and the residual oil was
purified by chromatography on silica eluting with 20% ethyl acetate in petroleum ether
(b.p. 40-60°C), to give the hemi-acetal (16mg, 80%) as a colourless oil; [a]D = -20.7
(c = 2.5, CHCI3); \)max (soln., CHC13) 3619, 3462, 1713cm-1; OH (360MHz) 4.99 (d,
J 2.5, IH, OH), 4.25-4.09 (m, 3H, C02CH2, H-4'), 3.98-3.93 (m, 2H, H-6, H-51,
3.83 (dd, J 8.2, 6.9, IH, H-5'), 3.75 (app. tt, JILl, 4.5, IH, H-4), 3.36 (s, 3H,
OCH3), 2.67 (d, J 15.3, IH, CHHC02Et), 2.59 (d, J 15.3, IH, CHHC02Et), 2.22
(ddd, J 11.2,4.6, 1.8, IH, H-3eq), 2.02-1.98 (m, IH, H-5eq), 1.38 (s, 3H, CCH3),
1.36 (5, 3H, CCH3), 1.28 (t, J 7.2, 3H, C02CH2CH3) 1.31-1.24 (obs. m, 2H, H-
3ax, H-5ax); Oc (90MHz) 172.0 (s), 109.3 (s), 96.6 (s), 77.2 (d), 72.8 (d), 68.3 (d),
65.2 (t), 61.0 (t), 55.5 (q), 44.7 (t), 40.6 (t), 32.3 (t), 26.0 (q), 25.6 (q), 14.0 (q);
m/z (EI) Found: 303.1439, ([M-Me]+ C14H2307requires 303.1444); Found: C, 56.6;
H, 8.4%, C1SH2607requires C, 56.6; H, 8.2%.
(2S, 4R, 6R, 1'R)- [6- (1,,2' -Dihydroxy-etbyl)-2,4-dimetboxy-
tetrahydro-pyran-2-yl}-acetic acid ethyl ester (321)
HO i
OH
Pyridinium p-toluenesulfonate (26mg, 1.0mmol) was added in one portion to a solution
of the hem i-acetal (320) (33mg, 1.0mmol) in methanol (3ml) at room temperature,
under a nitrogen atmosphere. The solution was stirred for 60h at this temperature
before addition of a saturated solution of sodium bicarbonate (lOml). The residue was
extracted with ethyl acetate (3 x 1000), the combined extracts were then dried (N~S04)
and the solvent removed in vacuo to leave a colourless oil. The oil was purified by
chromatography on silica eluting with 50% ethyl acetate in petroleum ether (b.p. 40-
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60°C) increasing to 100% ethyl acetate, to give the methyl ketal (24mg, 79%) as a
colourless oil; [alD = -65.6 (c = 1.4, CHCI3); umax (soln., CHCI3) 3573, 1726,
1084cm-l; OH (360MHz) 4.11 (q, J 7.1. 2H, C02CH2), 3.70-3.57 (m, 5H, H-4, H-6,
H-1', H-2'), 3.30 (s, 3H, OCH3), 3.24 (br s, IH, OR), 3.19 (s, 3H, OCH3), 2.95
(br s. IH, OH), 2.70 (d, J 13.7, IH, CHHC0 2Et), 2.62 (d, J 13.7, IH,
CHHC02Et), 2.31 (ddd, J 12.8,4.5, 1.7, IH, H-3eq), 1.97-1.92 (m, IH, H-5eq),
1.42 (dd, J 12.7,11.1, IH, H-3ax), 1.30 (app. q, J 11.7, IH, R-5ax), 1.23 (t, J 7.1,
3H, C02CH2CH3); oe (90MHz) 169.1 (s), 99.5 (s), 73.7 (d), 72.6 (d), 70.3 (d), 63.3
(t), 60.7 (t), 55.5 (q). 48.0 (q), 41.9 (t), 39.1 (t), 32.4 (t), 14.0 (q); m/z (EI) Found:
231.1235, ([M-C2Hs021+ CuHl90"requires 231.1233).
(2S, 4R, 6R, 1'R)-{6-[l' ,2'-bis-(tert-Butyl-dimethyl-silanyloxy)-
ethyl]-2,4-dimethoxy-tetrahydro-pyran-2-yl}-acetic acid ethyl ester
(323)
OMe
18S0
Triethylamine (0.70ml, 5.0mmol) was added in one portion to a solution of the diol
(321) (0.29g, 1.0mmol) in dichloromethane (lOml) at O°C, under a nitrogen
atmosphere. The solution was stirred for 10min before tert-butyldimethylsilyl triflate
(0.50ml, 2.2mmol) was added dropwise over lmin. The solution was strirred for a
further 30min at O°C,before a saturated solution of ammonium chloride (lOml) was
added and the organic layer was separated. The aqueous phase was extracted with
dichloromethane (3 x 20ml) and the combined organic layers were dried and then
concentrated in vacuo to leave a colourless oil. The oil was purified by chromatography
on silica eluting with 10%ethyl acetate in petroleum ether (b.p. 4O-60°C), to give the
silyl ether (0.42g, 82%) as a colourless oil; [a]D = -37.5 (c = 1.1, CHCI3); 'Umax
(soln., CHeI3) 2931, 2857, 1730, 1463, 1370, 1315, 1085cm-1; OH (360MHz) 4.18-
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4.10 (m, 2H, C02CH2), 3.71 (dd, J 9.6,4.4, 1H, H-2'), 3.67-3.53 (m, 4H, H-4, H-
6, H-]', H-2'), 3.34 (s, 3H, OCH3), 3.24 (s, 3H, OCH3), 2.79 (d, J 13.8, 1H,
CHHC02Et), 2.57 (d, J 13.7, lH, CHHC02Et), 2.38 (ddd, J 12.7, 4.6, 1.9, IH, H-
3eq), 2.03-1.98 (m, 1H, H-5eq), 1.46 (dd, J 12.7, 11.1, lH, H-3ax), 1.26 (t, J 7.1,
3H, C02CH2CH3), 1.19 (app. q, J 11.7, 1H,H-5ax), 0.89 (2x s, 18H, SiC(CH3)3),
0.07 (2x s, 6H, SiCH3), 0.04 (s, 6H, Si(CH3)2); Oc (90MHz) 169.1 (s), 99.4 (s),
75.2 (d), 73.5 (d), 70.2 (d), 64.3 (t), 60.5 (t), 55.5 (q), 47.9 (q), 42.0 (t), 39.5 (t),
32.3 (t), 25.9 (2x q), 18.3 (s), 18.1 (s), 14.1 (q), -4.4 (q), -4.6 (q), -5.4 (2x q); mlz
(FAB) Found: 543.3172, ([M+Na]+ C2sHs207Si2Narequires 543.3149); Found: C,
57.8; H, 10.4%, C2sHs207Shrequires C, 57.7; H, 10.1%.
(2S, 4R, 6R, 1 'R)-{ 6-[1' ,2'-bis-(tert-Butyl-dimethyl-silanyloxy)-
ethyl]-2,4-dimethoxy-tetrahydro-pyran-2-yl}-acetic acid (324)
OMe
T8S0
Lithium hydroxide monohydrate (l09mg, 2.59nunol) was added in one portion to a
solution of the ester (323) (l3Smg, 0.26mmol) in methanol (3ml) and water (lml) at
room temperature and strirred vigourously for 16h. The solution was neutralised by
addition of 10% citric acid solution (Sml) and then extracted with ethyl acetate (3 x
ISml), the combined extracts were then dried (Na2S04) and concentrated in vacuo to
leave the crude acid as a colurless oil, which was used without further purification;
[a]o = -82.S (c = 0.9, CHCh); '\lmax (soln., CHCI3) 3216, 1746cm-1;OR(360MHz)
3.97 (br d, J 12.2, 1H, H-2'), 3.77-3.68 (m, 2H. H-l', B-2'), 3.61-3.54 (m, 2H, H-
4, H-6), 3.36 (s, 3H, OCH3)' 3.24 (s, 3H, OCH3), 2.98 (d, J lS.2, IH, CHHC02H),
2.S7 (d, J 15.2, IH, CHHC02H), 2.29 (ddd, J 12.8, 4.4. 1.7, 1H, H-3eq), 1.91-
1.86 (m, IH, H-5eq), 1.49 (app. q, J 12.1, IH, H-5ax), 1.40 (dd, J 12.8, 11.0, IH,
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H-3ax), 0.90 (s, 9H, SiC(CH3)3), 0.89 (s, 9H, SiC(CH3)3), 0.10 (s, 3H, SiCH3),
0.08 (s, 3H, SiCH3), 0.06 (s, 3H, SiCH3), 0.05 (s, 3H, SiCH3); Oc (90MHz) 171.6
(s), 99.1 (s), 74.5 (d), 72.9 (d), 69.4 (d), 63.2 (t), 55.5 (q), 48.0 (q), 41.9 (t), 38.9
(t), 32.6 (t), 25.8 (q), 25.7 (q), 18.2 (s), 18.0 (s), -4.5 (q), -4.7 (q), -5.4 (q), -5.5
(q); m/z (FAB) Found: 515.2864, ([M+Na]+ C23H.s07ShNarequires 515.2836).
(2S, 4R, 6R, l'R, 2"'S)-2"-(2-{6-[l ',2'-bis-(tert-Butyl-dlmethyl-
silanyloxy)-ethyl]-2,4-dimethoxy-tetrahydro-pyran-2-yl}-acetylamino)-
3"'-hydroxy-propionic acid methyl ester (325)
OMe
TBSO i
OTBS
Triethylamine (0.29ml, 2.lmmol) was added in one portion to a suspension of I-serine
methyl ester hydrochloride (8Img, 0.52mmol) in THF (5ml) at O°C,under a nitrogen
atmosphere and stirred for 30min. The crude acid (324) in THF (5ml) was then added,
followed by sequential addition of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide
hydrochloride (149mg, 0.78mmol) and I-hydroxybenzotriazole (B8mg, 0.65mmol).
The solution was stirred at O°Cfor lh before allowing to warm to room temperature
over a further lh, A saturated ammonium chloride solution (lOml) was added and the
solvent was removed in vacuo. The residuewas extracted with ethyl acetate (4 x 15ml),
the combined extracts were then dried (Na2S04)and concentrated in vacuo to leave a
yellow residue. The residue was purified by chromatography on silica, eluting with
20% ethyl acetate in petroleum ether (b.p. 40-60°C), to give the hydroxy-amide
(113mg, 73%, 2 steps) as a colourless oil; [a]D = -32.7 (c = 4.6, CHCI,); Umax (soln.,
CHCI3) 3626, 3360, 1746, 1667cm-1; OH (360MHz) 7.37 (d, J 7.6, IH, NH), 4.58
(dt, J 7.5, 3.7, IH, H-2"'), 3.99-3.88 (m, 2H, H-3"'), 3.81-3.65 (m, 4H, H-4, H-
6, H-}', H-2'), 3.78 (s, 3H, OCH3), 3.60 (dd, J 9.8,4.7, IH, B-2'), 3.34 (s, 3H,
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OCH3), 3.25 (s, 3H, OCH3), 3.06-2.98 (br m, IH, OH), 2.85 (d, J 14.7, IH,
CHHC02NH), 2.52 (d, J 14.7, IH, CHHC02NH), 2.28 (ddd, J 12.7, 4.6, 1.5, IH,
H-3eq), 1.99-1.95 (m, IH, H-5eq), 1.47 (dd, J 12.7, 11.1, IH, H-3ax), 1.30 (app.
q, J 12.0, IH, H-5ax), 0.90 (s, 9H, SiC(CH3)3), 0.89 (s, 9H, SiC(CH3h), 0.10 (s,
6H, Si(CH3)2), 0.06 (s, 6H, SiCH3); eSc (90MHz) 170.7 (s), 169.5 (s), 99.5 (s), 75.3
(d), 73.3 (d), 70.2 (d), 63.9 (t), 63.1 (t), 55.5 (q), 54.7 (d), 52.5 (q), 47.9 (q), 43.7
(t), 38.2 (t), 32.6 (t), 25.9 (2x q), 18.2 (s), -4.5 (q), -4.6 (q), -5.4 (2x q); m/z (FAB)
Found: 616.3306, ([M+Na]+ C27HssO~Si2Na requires 616.3313).
(2S, 4R, 6R, 1'R, 4S)-2"-{6-[1 ',2'-bis-(tert-Butyl-dimethyl-
silanyloxy)-ethyl]-2,4-dimethoxy-tetrahydro-pyran-2.ylmethyl}-4,S.
dihydro-oxazole-4-carboxylic acid methyl ester (326)
OMe
18S0
Diethylaminosulfur trifluoride (26J.LI,0.20mmol) was added dropwise to a solution of
the hydroxy-amide (32S)(83mg, 0.14mmol) in dichloromethane (2ml) at -78°C, under
a nitrogen atmosphere. The solution was stirred at -78°C for Ih before addition of a
solution of ammonium hydroxide (5ml, 4M) and ice (lOg). The biphasic mixture was
allowed to warm to room temperature and then extracted with dichloromethane (3 x
20ml), the combined extracts were then dried (Na2S0.) and concentrated in vacuo to
leave a yellow oil. The oil was purified by chromatography on silica, eluting with 50%
ethyl acetate in petroleum ether (b.p. 4O-60°C), to give the oxazoline (64mg, 80%) as a
colourless oil; [a]o = +12.6 (c = 2.7, CHCI3); 'Umax (soln., CHCI3) 2930, 2885, 2857,
1742, 1658, 1462, 1362, 1084, 992cm-1; eSH (360MHz) 4.73 (dd, J 10.7, 7.8, IH, H-
4''), 4.49 (dd, J 8.7, 7.8, 1H, H-5"), 4.40 (dd, J 10.7, 8.8, 1H, H-5"), 3.77 (8,
3H, OCH3), 3.75-3.52 (m, 5H, H-4, H-6, H-1', H-2'), 3.33 (s, 3H, OCH3), 3.25 (s,
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3H, OCR 3), 2.96 (d, J 14.4, 1H, CHHOx), 2.55 (d, J 14.4, 1H, CHHOx), 2.37
(ddd, J 12.7, 4.5, 1.7, 1H, H-3eq), 2.01-1.97 (m, 1H, H-5eq), 1.36 (dd, J 12.7,
11.2, IH, H-3ax), 1.30 (app. q, J 11.6, 1H, H-5ax), 0.88 (2x s, 18H, SiC(CH3)3),
0.06 (s, 6H, Si(CH3h), 0.03 (s, 6H, Si(CH3h); Oc (90MHz) 171.5 (s), 166.5 (s),
99.4 (s), 75.1 (d), 73.5 (d), 70.3 (d), 69.5 (t), 67.9 (d), 64.3 (t), 55.4 (q), 52.6 (q),
47.9 (q), 39.5 (t), 35.7 (t), 32.3 (t), 25.9 (q), 25.8 (q), 18.3 (s), 18.1 (s), -4.4 (q),
-4.7 (q), -5.4 (2x q); m/z (FAB) Found: 598.3165, ([M+Na]+ C27H.530sNSi2Na
requires 598.3207).
(2S, 4R, 6R, 1 'R)-2 "-{ 6-[1' ,2'-bis-(tert-Butyl-dimethyl-silanyloxy)-
ethyl]-2,4-dimethoxy-tetrahydro-pyran-2-ylmethyl}-oxazole-4"-
carboxylic acid methyl ester (327)
OMe
TBSO
1,8-Diazabicyclo[S.4.0]undec-7-ene (17,..a.l,0.12mmol) was added in one portion to a
solution of the oxazoline (326) (61mg, 0.11mmol) in dichloromethane (5ml) at oDe,
under a nitrogen atmosphere. Bromotrichloromethane (12,....1,0.12mmol) was then
added dropwise and the solution was stirred for 14h whilst allowing to wann to room
temperature. A saturated ammonium chloride solution (5ml) was added and the
organics were extracted with ethyl acetate (3 x lSml), the combined extracts were then
dried (Na2S04) and concentrated in vacuo to leave a yellow residue. The residue was
purified by chromatography on silica, eluting with 20% ethyl acetate in petroleum ether
(b.p. 40-60°C), to give the oxazole (sOmg, 82%) as a colourless oil; [a]D = -30.9 (c =
2.8, CHCI3); 'Umax (soln., CHCI3) 2929, 2885, 2857, 1739, 1586, 1462, 1381, 1360,
1324, 1083cm-1; OH (360MHz) 8.17 (s, IH, Ox-H), 3.91 (s, 3H, OCH]), 3.73-3.51
(m, SH, H-4, H-6, H-1', H-2'), 3.32 (s, 6H, OCH]), 3.29 (d, J 14.7, tH, CHHOx),
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3.14 (d, J 14.7, IH, CHHOx), 2.20 (ddd, J 12.6, 4.5, 1.6, IH, H-3eq), 2.00-1.95
(m, 1H, H-5eq), 1.43 (dd, J 12.6, 11.1, 1H, H-3ax), 1.18 (app. q, J 11.9, 1H, H-
5ax), 0.89 (s, 9H, SiC(CH3)3), 0.88 (s, 9H, SiC(CH3)3), 0.07 (2x s, 6H, SiCH3),
0.05 (s, 6H, Si(CH3)2); Be (90MHz) 161.6 (s), 161.3 (s), 144.3 (d), 133.3 (s), 99.6
(s), 75.0 (d), 73.5 (d), 70.3 (d), 64.1 (t), 55.5 (q), 52.1 (q), 48.0 (q), 39.3 (t), 35.7
(t), 32.2 (t), 25.9 (q), 25.8 (q), 18.3 (s), 18.1 (s), -4.4 (q), -4.7 (q), -5.4 (2x q); m/z
(FAB) Found: 596.3058, ([M+Na]+ C2,HsIN08Si2Narequires 596.3051).
(2S, 4R, 6R, 1'R).(2"-{6-[1 1,2'-bis-(tert-Butyl-dimethyl-silanyloxy)_
ethy I]-2,4-dimethoxy- tetrahydro-pyran-2-ylmethyl}-oxazol.4 I I_ yl)_
methanol (328)
OMe
TBSO
~J\OH
o
OMe
A solution of di-isobutylaluminium hydride (O.l1ml, 1.5M in toluene, 0.17mmol) was
added dropwise to a solution of the ester (327) (40mg, 70J.A.Ill0l)in dichloromethane
(3ml) at -78°C, under a nitrogen atmosphere. The solution was stirred at -78°C for lh
and then at room temperature for a further 1h, before dropwise addition of methanol
(O.Sml). The resultant suspension was then poured into a saturated solution of
potassium sodium tartrate (10ml) and stirred vigourously for 1h. The organics were
extractedwith ethyl acetate (3 x 15ml), the combined extracts were then dried (N~S04)
and concentrated in vacuo to leave a colourless oil. The oil was purified by
chromatography on silica, eluting with 70% ethyl acetate in petroleum ether (b.p. 40-
60°C), to give the alcohol (33mg, 87%) as a colourless oil; [a]o = -28.6 (c = 1.6,
CHCIl); \)max (soln., CHCIl) 3606, 1571, 1386, 1083cm-1; BH (360MHz) 7.52 (t, J
0.9, 1H, Ox-H), 4.58 (br d, J 4.3, 2H, CH20H), 3.73 (dd, J 9.8, 4.9, 1H, H-2'),
3.69-3.53 (m, 4H, H-4, H-6, H-}', H-2~, 3.33 (s, 3R, OCH3), 3.32 (s, 3H, OCH3),
3.26 (d, J 14.8, 1H, CHHOx), 3.03 (d, J 14.8, 1H, CHHOx), 2.26 (br t, J 4.3, 1H,
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OH), 2.22 (ddd, J 12.7,4.6, 1.7, IH, H-3eq), 2.02-1.98 (m, IH, H-5eq), 1.41 (dd,
J 12.6, 11.1, IH, H-3ax), 1.18 (app. q, J 11.9, IH, H-5ax), 0.90 (s, 18H,
SiC(CH3)3), 0.09 (s, 3H, SiCH3), 0.08 (s, 3H, SiCH3), 0.06 (s, 6H, Si(CH3)z); Sc
(90MHz) 160.7 (s), 140.2 (s), 135.2 (d), 99.7 (s), 75.1 (d), 73.6 (d), 70.3 (d), 64.3
(t), 56.9 (t), 55.5 (q), 47.9 (q), 39.3 (t), 35.7 (t), 32.2 (t), 25.9 (2x q), 18.3 (s), 18.1
(s), -4.4 (q), -4.7 (q), -5.4 (2x q).
(2S, 4R, 6R, 1 'R)-2" -{6-[1' -(tert-Butyl-dimethyl-silanyloxy)-2'-
hydroxy -ethy I]-2,4-dimethoxy -tetrahyd ro -pyran -2-yImethy Il-exazele-
4"-carboxylic acid methyl ester (330)
OMe
HO
~~C02M.
o
10-Camphorsulfonic acid (15mg, 66J.1mol)was added in one portion to a solution of
the his-silyl ether (327) (76mg, 0.13mmol) in methanol (2ml) and dichloromethane
(4ml) at O·C, under a nitrogen atmosphere. The solution was stirred at O·C for 2h and
then at room temperature for a further 4h. A saturated sodium bicarbonate solution
(2ml) was added and the solvent was removed in vacuo. The residue was taken up in
ethyl acetate (lOml) and the organic phase separated. The aqueous phase was extracted
with ethyl acetate (3 x lOml) and the combined organic layers were dried (N~S04) and
the solvent removed in vacuo to leave a colourless oil. The oil was purified by
chromatography on silica eluting with 50% ethyl acetate in petroleum ether (b.p. 40-
60°C), to give the alcohol (36mg, 59%) as a colourless oil; [a]D = -16.9 (c = 1.8,
CHCI3); umax (soln., CHCI3) 3565 (br), .1739, 1586, 1325, 1111, 1084cm-1; SH
(360MHz) 8.19 (s, 1H, Ox-H), 3.91 (s, 3H, OCB3), 3.76-3.56 (m, 5H, H-4, H-6,
H-l', H-2'), 3.33 (s, 3H, OCH3), 3.31 (s, 3H, OCH3), 3.30 (d, J 14.7, IH,
CHHOx), 3.13 (d, J 14.7, IH, CHHOx), 2.24-2.02 (m, 3H, OH, H-3eq. H-5eq),
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1.40 (dd, J 12.6, 11.2, IH, H-3ax), 1.12 (app. q, J 11.5, IH, H-5ax), 0.91 (s, 9H,
SiC(CH3)3), 0.13 (s, 3H, SiCH3), 0.11 (s, 3H, SiCH3); oe (90MHz) 161.4 (s), 160.9
(s), 144.3 (d), 133.3 (s), 99.7 (s), 74.0 (d), 73.0 (d), 71.4 (d), 63.5 (t), 55.6 (q),
53.1 (q), 48.1 (q), 39.2 (t), 35.6 (t), 31.8 (t), 25.8 (q), 18.0 (s), -4.5 (q), -4.8 (q);
m/z (FAB) Found: 460.2355, ([MH]+ C2JH38NOsSirequires 460.2367).
(2S, 4R, 6R, 1 'R)-2"-{ 6-[1 '-(tert-Butyl-dimethyl-silanyloxy)-2'-oxo-
ethy I]-2,4-dimethoxy -tetrahydro-pyran -2-ylmethyl }-oxazole-4"-
carboxylic acid methyl ester (331)
OMs
o
2,6-Di-tert-butyl-4-methyl-pyridine (91mg, O.44mmol), followed by Dess-Martin
periodinane (63mg, 0.15mmol) were added in one portion to a solution of the alcohol
(330) (34mg, 74J.Lmol)in dichloromethane (5ml) at room temperature, under a nitrogen
atmosphere. The mixture was stirred for 4h and then diethyl ether (20ml) was added
and the resulting suspension poured into a saturated solution of sodium thiosulfate and
sodium bicarbonate (1:1, 20ml) and stirred vigourously for 30min. The organic layer
was separated, the aqueous phase was extracted with ethyl acetate (3 x 15ml) and the
combined organic layers were dried (Na2S04)' The solvent was removed in vacuo to
leave a colourless oil, which was purified by chromatography on silica eluting with
20% ethyl acetate in petroleum ether (b.p. 40-60°C), to give the aldehyde (28mg, 83%)
as a colourless oil; OH (360MHz) 9.68 (5, IH, H-2'), 8.17 (s, IH, Ox-H), 3.94 (br s,
2H, H-6, H-1'), 3.91 (s, 3H, OCH3), 3.86-3.82 (m, IH, H-4), 3.31 (s, 3H, OCH3),
3.24 (s, 3R, OCH), 3.22 (d, J 14.8, IH, CHHOx), 3.13 (d, J 14.8, IH, CHHOx),
2.22-2.17 (m, IH, H-3eq), 1.91-1.86 (m, IH, H-5eq), 1.48-1.32 (m, 2H. H-3ax. H-
Sax), 0.92 (s, 9H. SiC(CH3)3)' 0.08 (s, 3H, SiCH), 0.07 (s, 3H, SiCH3).
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(2S, 4R, 6R, 1 'R)-2"-{6-[1 '-(tert-Butyl-dimethyl-silanyloxy)-3'-
methyl-4' -oxo-but-(2' E)-enyll-2,4-dimethoxy-tetrahydro-pyran-2-
ylmethyl}-oxazole-4"-carboxylic acid methyl ester (332)
OMe
H
o 1
OTes
2-(Triphenylphosphoranylidene)-propionaldehyde (262) (22mg, 68J,lmol) was added
in one portion to a solution of the aldehyde (331) (26mg, 57J,lmol) in benzene (4ml)
under a argon atmosphere. The solution was heated at reflux for 96h and then cooled
and concentrated in vacuo. The residue was purified by chromatography on silica
eluting with 20% ethyl acetate in petroleum ether (b.p. 40-60°C), to give the crude
aldehyde (7mg, 25%) as a colourless oil, which was used without charcaterisation.
(2S, 4R, 6R, l'R,6'R)-2"-{6-[1'-(tert-Butyl-dimethyl-silanyloxy)-6'-
methoxy-3'-methyl-9'-(trimethyl-silanyl)-nona-dl-(2'E,4'E)-en-8'-
ynyll -2,4-dimethoxy- tetrahydro- pyran-2- ylmethy I}-oxazole-4"-
carboxylic acid methyl ester (333)
OMs
TMS OMe
7' S' OMs
A solution of sodium bis(trimethylsilyl)amide (28J.Ll,1M in THF, 28J.Lmol)was added
dropwise to a solution of the sulfone (312) (lOmg, 28J.lmol) and the aldehyde (332)
(5mg, lOJ'ffiol) in THF (1.5ml) at _78°C, under a argon atmosphere. The solution was
stirred at -78°C for 3h and then a solution of saturated ammonium chloride (Iml) was
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added, and the suspension allowed to warm to room temperature. The organic layer
was extracted with ethyl acetate (3 x lOml)and the combined organic layers were dried
(Na2S04) and then concentrated in vacuo to leave a colourless oil. The oil was purified
by chromatography on silica eluting with 20%ethyl acetate in petroleum ether (b.p. 40-
60°C). to give the diene (3.8mg, 59%) as a colourless oil; oH(500MHz) 8.19 (s, IH,
Ox-H), 6.26 (d, J 15.7, IH, H-4'), 5.59 (dd, J 15.7, 7.5, IH, H-5'), 5.44 (d, J 8.4,
IH, H-2'), 4.48 (dd, J 8.4, 4.7, IH. H-1'), 3.92 (s, 3H, OCR3), 3.80 (app. q, J 6.7,
IH, H-6'), 3.59-3.55 (m, IH, R-4), 3.46-3.43 (m, IH, H-6), 3.34 (s, 3H, OCH3),
3.31 (s, 3H, OCH3), 3.30 (d, J 15.0, in, CHHOx), 3.26 (s, 3H, OCH3), 3.06 (d, J
15.0, IH, CHHOx), 2.60 (dd, J 16.8, 5.6, IH, H-7'), 2.46 (dd, J 16.8, 6.8, IH, H-
7,), 2.21-2.17 (m, IH, R-3eq), 2.08-2.05 (m, IH, H-5eq), 1.80 (s, 3R, CH3C=CH),
1.42 (app. t, J 11.8, IH, H-3ax), 1.28-1.24 (m, IH, H-5ax), 0.88 (s, 9H,
SiC(CH3)3), 0.14 (s, 9R, Si(CH3)3), 0.05 (s, 3R, SiCH3), 0.02 (s, 3H, SiCH3); Oe
(125MHz) 161.6 (s), 161.1 (s), 144.3 (d), 137.0 (d), 133.8 (s), 133.3 (8), 133.2 (d),
127.4 (d), 103.3 (s), 99.7 (8), 86.6 (8), 80.5 (d), 73.4 (d), 73.3 (d), 71.6 (d), 56.6
(q), 55.6 (q), 52.1 (q), 47.9 (q), 39.4 (t), 35.8 (t), 31.6 (t), 27.0 (t), 25.8 (q), 18.2
(s), 13.2 (q), 0.1 (q), -4.4 (q), -4.8 (q); m/z (FAB) Found: 672.3316, ([M+Na]+
C33HssNOsShNarequires 672.3364).
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4. APPENDIX
4.1 Contemporaneous Studies
During the course of the research described within this thesis, synthetic work towards
phorboxazole A (4) was being undertaken by Forsyth et alISO which culminated in a
total synthesis of phorboxazole A, 150dpublished in July 1998. This section is intended
to be a brief overview of the work of Forsyth's research group and not a rigorous
account, for contrast and comparison with our own synthetic efforts to date.
The approach of Forsyth and co-workers was indeed similar to our own. Disconnection
of phorboxazole A (4) gave three key fragments, the C3-C17 bis-pyran unit (336), the
C1S-C30 central pyran unit (335) and the C31-C46 side chain (334). The major
difference in Forsyth's approach was to make use of the 2,4-disubstituted oxazole units
for the assembly of these fragments, with macrocyclisation being viewed in a similar
light to our strategy via an olefination reaction (Scheme 95). Schemes 96, 97 and
98 show Forsyth's approach towards the C18-C30 central pyran unit (335),1508 the
C3-C17 bis-pyran unit (336),150b and the C31-C46 side chain (334) 1SOC respectively.
Finally schemes 99 and 100 show the assembly of these fragments and the
completion of the first total synthesis of phorboxazole A.lsOd
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periodinane, CH2Ch, 77% (3 steps); vi, Ph3PCHC02Me, eH3CN, 96%; vii, TBAF,
THF, 46%; viii, DffiAL-H, CH2C12; ix, Ph3PCHC02Me, CH3CN, 70% (2 steps).
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periodinane, 80%; vii, 347, CrChlNiCh (1% w/w), THF, 80% (349:3483:2); viii,
a) PNBA, PPh3, DEAD; b) K1C03, MeOH, 76% (2 steps); ix,MsCl, Et3N, CH1Cl1,
96%; x, TBAF, 94%; xi, Et~, CH3CN, 86%; xii, PTSA, MeOH, 97%; xiii, TES-Cl,
1m., 83%; xiv, (PhO)zPON3, PPh3, DEAD; XV, PPh3, H20, THF, 77% (2 steps).
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ix, TES-CI, Im., DMAP, CH2Ch, 78%; x, nBu3SnH, AIBN, CJl6; xi, NBS,
CH3CN, 70% (2 steps).
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viii, H02CCH2PO(OCH2CF3)2, EDC, HOBT, 86%; ix,DDQ, 87%; x, Dess-Martin
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